-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IGOmIPHIbewJe9C35H5mvS+LbLF0QD+dwEicAlyMPHe6mqOW4OyFRieFv9PNa6nk vVS04edU02GsACO0dJoxNQ== 0000903893-97-000026.txt : 19970113 0000903893-97-000026.hdr.sgml : 19970113 ACCESSION NUMBER: 0000903893-97-000026 CONFORMED SUBMISSION TYPE: POS AMI PUBLIC DOCUMENT COUNT: 57 FILED AS OF DATE: 19970110 SROS: NONE FILER: COMPANY DATA: COMPANY CONFORMED NAME: GMO TRUST CENTRAL INDEX KEY: 0000772129 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] STATE OF INCORPORATION: MA FISCAL YEAR END: 0228 FILING VALUES: FORM TYPE: POS AMI SEC ACT: 1940 Act SEC FILE NUMBER: 811-04347 FILM NUMBER: 97504373 BUSINESS ADDRESS: STREET 1: 40 ROWES WHARF CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 6173307500 FORMER COMPANY: FORMER CONFORMED NAME: GMO CORE TRUST DATE OF NAME CHANGE: 19900927 POS AMI 1 FORM N-1A File Nos. 2-98772 811-4347 As filed with the Securities and Exchange Commission On January 10, 1997 ================================================================================ SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM N-1A REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Pre-Effective Amendment No. ____ / / Post-Effective Amendment No. ____ / / REGISTRATION STATEMENT UNDER THE INVESTMENT COMPANY ACT OF 1940 Amendment No. 34 / X / --- GMO TRUST - -------------------------------------------------------------------------------- (Exact Name of Registrant as Specified in Charter) 40 Rowes Wharf, Boston, Massachusetts 02110 - -------------------------------------------------------------------------------- (Address of principal executive offices) 617-330-7500 - -------------------------------------------------------------------------------- (Registrant's telephone number, including area code) with a copy to: R. Jeremy Grantham J.B. Kittredge, Esq. GMO Trust Ropes & Gray 40 Rowes Wharf One International Place Boston, Massachusetts 02110 Boston, Massachusetts 02110 - -------------------------------------------------------------------------------- (Name and address of agents for service) Pursuant to Rule 24f-2 under the Investment Company Act of 1940, the Registrant has registered an indefinite number or amount of its shares of beneficial interest. The Registrant has filed a Rule 24f-2 Notice with respect to the Registrant's fiscal year ended February 29, 1996 on April 26, 1996. It is proposed that this filing will become effective: / X / Immediately upon filing pursuant to Section 8 of the Investment Company Act of 1940. ================================================================================

Part C Information to be included in Part C is set forth under the appropriate item, so numbered, in Part C of this Registration Statement. The following documents are incorporated herein by reference: (1) The Prospectus relating to the Core Fund, the Tobacco-Free Core Fund, the Value Fund, the Growth Fund, the U.S. Sector Fund, the Small Cap Value Fund, the Small Cap Growth Fund, the Fundamental Value Fund, the REIT Fund, the International Core Fund, the Currency Hedged International Fund, the Foreign Fund, the Global Fund, the International Small Companies Fund, the Japan Fund, the Emerging Markets Fund, the Short-Term Income Fund, the Global Hedged Equity Fund, the Domestic Bond Fund, the International Bond Fund, the Currency Hedged International Bond Fund, the Global Bond Fund, the Emerging Country Debt Fund, the Inflation Indexed Bond Fund, the International Equity Allocation Fund, the World Equity Allocation Fund, the Global (U.S.+) Equity Allocation Fund and the Global Balanced Allocation Fund, each a series of GMO Trust, contained in Post-Effective Amendment No. 33 to the Trust's Registration Statement under the Investment Company Act of 1940 and Post-Effective Amendment No. 32 to the Trust's Registration Statement under the Securities Act of 1933 (File Nos. 2-98772, 811-4347), filed with the Securities and Exchange Commission on November 27, 1996. (2) The Statement of Additional Information (including the audited and unaudited financial highlights contained therein and the audited and unaudited financial statements incorporated by reference therein) relating to the Core Fund, the Tobacco-Free Core Fund, the Value Fund, the Growth Fund, the U.S. Sector Fund, the Small Cap Value Fund, the Small Cap Growth Fund, the Fundamental Value Fund, the REIT Fund, the International Core Fund, the Currency Hedged International Fund, the Foreign Fund, the Global Fund, the International Small Companies Fund, the Japan Fund, the Emerging Markets Fund, the Short-Term Income Fund, the Global Hedged Equity Fund, the Domestic Bond Fund, the International Bond Fund, the Currency Hedged International Bond Fund, the Global Bond Fund, the Emerging Country Debt Fund, the Inflation Indexed Bond Fund, the International Equity Allocation Fund, the World Equity Allocation Fund, the Global (U.S.+) Equity Allocation Fund and the Global Balanced Allocation Fund, each a series of GMO Trust, contained in Post-Effective Amendment No. 33 to the Trust's Registration Statement under the Investment Company Act of 1940 and Post-Effective Amendment No. 32 to the Trust's Registration Statement under the Securities Act of 1933 (File Nos. 2-98772, 811- 4347), filed with the Securities and Exchange Commission on November 27, 1996. (3) The Prospectus relating to the Pelican Fund, a series of GMO Trust, contained in Post- Effective Amendment No. 29 to the Trust's Registration Statement (File Nos. 2-98772, 811-4347) filed with the Securities and Exchange Commission on June 28, 1996; (4) The Statement of Additional Information (including the audited financial highlights contained therein and the audited financial statements incorporated by reference therein) relating to the Pelican Fund, a series of GMO Trust, contained in Post-Effective Amendment No. 29 to the Trust's Registration Statement (File Nos. 2-98772, 811-4347) filed with the Securities and Exchange Commission on June 28, 1996. PRIVATE PLACEMENT MEMORANDUM DECEMBER 20, 1996 GMO GLOBAL PROPERTIES FUND 40 ROWES WHARF, BOSTON, MASSACHUSETTS 02110 The GMO GLOBAL PROPERTIES FUND (the "Fund") is one of thirty separate investment portfolios of GMO Trust (the "Trust"), an open-end management investment company. The other portfolios are offered pursuant to a separate prospectus. The Fund's investment manager is GRANTHAM, MAYO, VAN OTTERLOO & CO. LLC (the "MANAGER" or "GMO"). The principal investment objective of the Fund is long-term capital growth primarily through investment in securities of issuers throughout the world which are engaged in or related to the real estate industry or which own significant real estate assets. Consideration of current income is secondary to this principal objective. The Fund invests at least 65 percent of its total assets in securities of real estate companies principally traded in the securities markets of at least three countries, one of which may be the United States. The Fund is a "non-diversified" portfolio, as defined in the Investment Company Act of 1940 (the "1940 Act"). See "Description and Risks of Fund Investments--Non-Diversified Portfolio" on page 8. A TABLE OF CONTENTS APPEARS ON PAGE 4 OF THIS PRIVATE PLACEMENT MEMORANDUM. The Fund offers three classes of shares: Class I, Class II and Class III. Eligibility for the classes is generally based on the total amount of assets that a client has invested with GMO (with Class I requiring the least total assets and Class III the most), all as described more fully herein. See "Multiple Classes--Eligibility for Classes" on pages 14 through 15. The classes differ solely with regard to (i) whether GMO or the GMO FUNDS DIVISION provides client service and reporting to shareholders of the class and (ii) the level of SHAREHOLDER SERVICE FEE borne by the class. These differences are described briefly below and in more detail elsewhere in this Private Placement Memorandum. ALL CLASSES OF THE FUND HAVE AN INTEREST IN THE SAME UNDERLYING ASSETS, ARE MANAGED BY GMO, AND PAY THE SAME INVESTMENT MANAGEMENT FEE. INVESTMENT MANAGER GMO Grantham, Mayo, Van Otterloo & Co. LLC

This Private Placement Memorandum concisely describes the information which investors ought to know about the Fund before investing. Please read this memorandum carefully and keep it for further reference. A Statement of Additional Information dated December 20, 1996, as revised from time to time, is available free of charge by writing to GMO Funds Division, 40 Rowes Wharf, Boston, Massachusetts 02110 or by calling (617)790-5000. The Statement, which contains more detailed information about the Fund, has been filed with the Securities and Exchange Commission ("SEC") and is incorporated by reference into this Private Placement Memorandum. THE FUND MAY INVEST UP TO 5% OF ITS NET ASSETS IN LOWER-RATED BONDS, COMMONLY KNOWN AS "JUNK BONDS." INVESTMENTS OF THIS TYPE ARE SUBJECT TO A GREATER RISK OF LOSS OF PRINCIPAL AND NON-PAYMENT OF INTEREST. INVESTORS SHOULD CAREFULLY ASSESS THE RISKS ASSOCIATED WITH AN INVESTMENT IN THIS FUND. PLEASE SEE "DESCRIPTION AND RISKS OF FUND INVESTMENTS -- LOWER RATED SECURITIES." IN MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. THESE SECURITIES HAVE NOT BEEN RECOMMENDED BY ANY FEDERAL OR STATE SECURITIES COMMISSION OR REGULATORY AUTHORITY. FURTHERMORE, THE FOREGOING AUTHORITIES HAVE NOT CONFIRMED THE ACCURACY OR DETERMINED THE ADEQUACY OF THIS DOCUMENT. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE. THE SECURITIES OFFERED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED OR THE SECURITIES LAWS OF ANY STATE, AND MAY NOT BE TRANSFERRED OR RESOLD UNLESS SO REGISTERED OR EXEMPT THEREFROM. HOWEVER, THE SECURITIES ARE REDEEMABLE AS DESCRIBED IN THIS PRIVATE PLACEMENT MEMORANDUM. IN CERTAIN CASES INVESTORS MAY BE REDEEMED "IN KIND" AND RECEIVE PORTFOLIO SECURITIES HELD BY THE FUND IN LIEU OF CASH UPON REDEMPTION. IN SUCH CASE, AN INVESTOR WILL INCUR COSTS WHEN THE INVESTOR SELLS THE SECURITIES DISTRIBUTED. NO PERSON HAS BEEN AUTHORIZED TO MAKE ANY REPRESENTATIONS OR PROVIDE ANY INFORMATION WITH RESPECT TO THE SHARES EXCEPT SUCH INFORMATION AS IS CONTAINED IN THIS MEMORANDUM AND IN THE STATEMENT OF ADDITIONAL INFORMATION OR IN OTHER MATERIALS APPROVED BY THE TRUST. NO SALES MADE HEREUNDER SHALL UNDER ANY CIRCUMSTANCES CREATE AN IMPLICATION THAT THERE HAS BEEN NO CHANGE IN MATTERS DISCUSSED HEREIN SINCE THE DATE HEREOF. -2- CLASSES AND FEES ---------------- ELIGIBILITY REQUIREMENT* SHAREHOLDER SERVICE FEE** ------------ ------------------------- Class I $1 million 0.28% Class II $10 million 0.22% Class III $35 million 0.15% - ------------------------------ * More detailed explanation of eligibility criteria is provided on page 14 and under "Multiple Classes -- Eligibility for Classes." ** As noted above, all classes of shares of the Fund pay the same investment management fee. CLASS ELIGIBILITY - ----------------- For full details of the class eligibility criteria summarized below and an explanation of how conversions between classes will occur, see "Multiple Classes - - Eligibility for Classes" and "Multiple Classes - Conversions Between Classes," beginning on page 15. CLASS I AND CLASS II SHARES: Recognizing that institutional and individual investors with assets under GMO's management totalling less than $35 million have different service and reporting needs than larger client relationships, GMO has created the GMO Funds Division. GMO Funds Division delivers institutional-quality client services to clients investing between $1 million and $35 million. These services include professional and informative reporting, and access to meaningful analysis and explanation. Class I Shares. Class I Shares are available to any investor who commits (after May 31, 1996) assets to GMO management to establish a "Total Investment" (as defined) with GMO of between $1 million and $10 million. In addition, all defined contribution retirement or pension plans are eligible only for Class I shares regardless of the size of their investment. Class I Shares will receive client service and reporting from GMO Funds Division and will bear a Shareholder Service Fee of 0.28%. Class II Shares. Class II Shares are available to any investor who (i) has less than $7 million (but more than $0) under the management of GMO as of May 31, 1996, or (ii) commits (after May 31, 1996) assets to GMO management to establish a "Total Investment" (as defined) with GMO of between $10 million and $35 million. Class II Shares will receive client service and reporting from GMO Funds Division and will bear a Shareholder Service Fee of 0.22%. Purchasers of Class I and Class II Shares should follow purchase instructions for such classes described under "Purchase of Shares" and direct questions to the Trust at (617) 790-5000. CLASS III SHARES: GMO provides direct client service and reporting to owners of Class III Shares. These clients must have a "Total Investment" (as defined) with GMO of at least $35 million. Class eligibility requirements for existing clients of GMO as of May 31, 1996 are governed by special rules described in this Private Placement Memorandum. Class III Shares. Class III Shares are available to any investor who (i) has at least $7 million under the management of GMO as of May 31, 1996, or (ii) commits (after May 31, 1996) assets to GMO management to establish a "Total Investment" (as defined) with GMO of at least $35 million. Class III Shares will receive client service and reporting directly from GMO, and will bear a Shareholder Service Fee of 0.15% of average net assets. Purchasers of Class III Shares should follow purchase instructions described under "Purchase of Shares" and direct questions to the Trust at (617) 330-7500. -3- TABLE OF CONTENTS SCHEDULE OF FEES AND EXPENSES.............................................5 INVESTMENT OBJECTIVE AND POLICIES.........................................7 DESCRIPTION AND RISKS OF FUND INVESTMENTS......................................................7 Portfolio Turnover....................................................7 Non-Diversified Portfolio.............................................8 Certain Risks of Foreign Investments..................................8 General ....................................................8 Emerging Markets............................................8 Securities Lending....................................................8 Depository Receipts...................................................9 Convertible Securities................................................9 Foreign Currency Transactions ........................................9 Repurchase Agreements................................................10 Debt and Other Fixed Income Securities Generally..................................................10 Temporary High Quality Cash Items....................................10 U.S. Government Securities and Foreign Government Securities......................................11 Mortgage-Backed and Other Asset-Backed Securities.................................................11 Collateralized Mortgage Obligations ("CMOs"); Strips and Residuals..........................................11 Commercial Mortgage-Related Securities.........................................12 Adjustable Rate Securities...........................................12 Lower Rated Securities...............................................12 Zero Coupon Securities...............................................13 Indexed Securities...................................................13 Firm Commitments.....................................................13 Reverse Repurchase Agreements and Dollar Roll Agreements.................................................13 Illiquid Securities..................................................14 MULTIPLE CLASSES.........................................................14 Shareholder Service Fees.............................................14 Client Service - GMO and GMO Funds...................................14 Eligibility for Classes..............................................14 Conversions Between Classes..........................................15 PURCHASE OF SHARES.......................................................15 Purchase Procedures..................................................16 REDEMPTION OF SHARES.....................................................17 DETERMINATION OF NET ASSET VALUE.........................................17 DISTRIBUTIONS............................................................18 TAXES....................................................................18 Withholding on Distributions to Foreign Investors..................................................19 Foreign Tax Credits..................................................19 Loss of Regulated Investment Company Status..........................19 MANAGEMENT OF THE TRUST..................................................19 ORGANIZATION AND CAPITALIZATION OF THE TRUST.........................................................20 -4- SCHEDULE OF FEES AND EXPENSES -----------------------------

Annual Operating Expenses shown are based on estimated amounts for the Fund's first fiscal year. The purpose of the foregoing table is to assist in understanding the various costs and expenses of the Fund that are borne by holders of Fund shares. THE FIVE PERCENT ANNUAL RETURN AND EXPENSE NUMBERS USED ARE NOT REPRESENTATIONS OF FUTURE PERFORMANCE OR EXPENSES. SUBJECT TO THE MANAGER'S UNDERTAKING TO WAIVE ITS FEE AND/OR BEAR CERTAIN EXPENSES FOR EACH FUND AS DESCRIBED IN THE TABLES, ACTUAL PERFORMANCE AND/OR EXPENSES MAY BE MORE OR LESS THAN SHOWN. Where a purchase premium and/or redemption fee is indicated as being charged by the Fund in certain instances, the foregoing examples assume the payment of such purchase premium and/or redemption fee even though such purchase premium and/or redemption fee is not applicable in all cases. (See "Purchase of Shares" and "Redemption of Shares"). -5- NOTES TO SCHEDULE OF FEES AND EXPENSES 1. Purchase premiums and redemption fees apply only to cash transactions as set forth under "Purchase of Shares" and "Redemption of Shares" respectively. These fees are paid to and retained by the Fund itself and are designed to allocate transaction costs caused by shareholder activity to the shareholder generating the activity, rather than to the Fund as a whole. The Manager may reduce purchase premiums and/or redemption fees if the Manager determines there are minimal brokerage and/or other transaction costs caused by the purchase or occur under redemption. Generally, however, these fees are not waivable even when there are offsetting transactions. It is expected that the purchase premiums and redemption fees for this Fund will be eliminated once the net assets of the Fund exceed $100 million. However, even thereafter, the Fund will reserve the right to charge a purchase premium of up to 0.60% and a redemption fee of up to 0.30% on purchases or redemptions of amounts that are equal to or greater than 5% of the Fund's net assets. 2. Shareholder Service Fee ("SSF") paid to GMO for providing client services and reporting services. The level of SSF is the sole economic distinction between the various classes of Fund shares. A lower SSF for larger investments reflects that the cost of servicing client accounts is lower for larger accounts when expressed as a percentage of the account. See "Multiple Classes - Shareholder Service Fees" for more information. 3. The Manager has voluntarily undertaken to reduce its management fees and to bear certain expenses with respect to the Fund until further notice to the extent that the Fund's total annual operating expenses (excluding Shareholder Service Fees, brokerage commissions and other investment-related costs, hedging transaction fees, extraordinary, non-recurring and certain other unusual expenses (including taxes), securities lending fees and expenses and transfer taxes and excluding custodial fees would otherwise exceed 0.60% of the Fund's average daily net assets. Therefore, so long as the Manager agrees so to reduce its fees and bear certain expenses, total annual operating expenses (subject to such exclusions) of the Fund will not exceed this limitation. Absent such undertakings, the management fee for the Fund would be 0.75% and the total annual operating expenses for Class I, Class II and Class III shares would be 1.27%, 1.21% and 1.14%, respectively. -6- INVESTMENT OBJECTIVE AND POLICIES --------------------------------- The GMO Global Properties Fund (the "Fund") seeks long-term growth of capital. The Fund pursues its objective by investing primarily in securities of issuers throughout the world which are principally engaged in or related to the real estate industry or which own significant real estate assets ("Real Estate Companies"). The Fund will not invest directly in real estate. A Real Estate Company is principally engaged in or related to the real estate industry if at least 50% of its assets, gross income or net profits are attributable to ownership, construction, management or sale of residential, commercial or industrial real estate, or to products or services that are related to the real estate industry. For these purposes, Real Estate Companies whose products or services are related to the real estate industry include manufacturers and distributors of building supplies and financial institutions which issue or service mortgages. Real Estate Companies may also include: equity real estate investment trusts, which own real estate directly; mortgage real estate investment trusts, which make construction, development or long-term mortgage loans; real estate brokers or developers; and issuers with substantial real estate holdings. The responsibility for allocating the Fund's assets among the various securities markets of the world is borne by Grantham, Mayo, Van Otterloo & Co. LLC (the "Manager" or "GMO") In making these allocations, the Manager will consider such factors as the condition and growth potential of the various economic and securities markets, currency and taxation considerations and other pertinent financial, social, national and political factors. The Manager anticipates that the Fund will give particular consideration to investments in the United Kingdom, Western Europe, Australia, Canada, the Far East (Japan, Hong Kong, Singapore, Malaysia and Thailand) and the United States. The percentage of the Fund's assets invested in particular geographic regions will shift from time to time in accordance with the judgment of the Manager. Under normal market conditions, the Fund will invest at least 65% of its total assets in securities of Real Estate Companies principally traded in the securities markets of at least three countries (one of which may be the United States). A substantial portion of the assets of the Fund may be denominated or traded in foreign currencies. Although the Fund generally invests in common stocks, it may also invest in preferred stocks, convertible securities and fixed income securities including lower-rated fixed income securities (commonly known as "junk bonds"). Where lower-rated debt securities are secured by real estate assets, it is conceivable that the Fund could, in the event of default, end up holding the underlying real estate directly. Risks associated with such ownership could include potential liabilities under environmental laws and the costs of other regulatory compliance. If the Fund has rental income or income from the direct disposition of real property, the receipt of such income may adversely affect its ability to retain its tax status as a regulated investment company and thus its ability to avoid taxation on its income and gains distributed to its shareholders. See "Taxes." The investment objective of the Fund may be changed without shareholder approval. Unless specifically noted herein, the investment policies of the Fund may be changed without shareholder approval. There can be no assurance that the investment objective of the Fund will be achieved. Other Investments. The following describes or refers to a number of investments that may be made and investment practices that may be used by the Fund. For a more detailed description of the investment practices described and the risks associated with them, see "Description and Risks of Fund Investments" later in this Private Placement Memorandum. As indicated, the Fund expects to invest in securities of foreign issuers traded on U.S. exchanges and securities traded abroad, and may also invest in depository receipts and foreign exchange transactions. The Fund may also invest in adjustable rate securities, zero coupon securities and mortgage-backed and other asset-backed securities issued by the U.S. government, its agencies and by non-government issuers, including collateralized mortgage obligations ("CMO's"), strips and residuals. The Fund may lend portfolio securities valued at up to one-third of total assets and enter into repurchase agreements, reverse repurchase agreements and dollar roll agreements. The Fund may also invest in indexed securities the redemption values and/or coupons of which are indexed to the prices of other securities, securities indexes, currencies, precious metals or other commodities, or other financial indicators. The Fund may also enter into firm commitment agreements with banks or broker-dealers, and may invest up to 15% of its net assets in illiquid securities. The Fund may use forward foreign currency contracts, currency futures contracts, options on currencies and buy and sell foreign currencies for hedging and for currency risk management. The put and call options on currency futures written by the Fund will always be covered. The Fund may also invest in securities of investment companies, such as closed-end investment management companies which invest in foreign markets, to the extent permitted under the Investment Company Act of 1940, as amended (the "1940 Act"). As a shareholder of an investment company, the Fund may indirectly bear service fees which are in addition to the fees the Fund pays to its service providers. DESCRIPTION AND RISKS OF FUND ----------------------------- INVESTMENTS ----------- The following is a detailed description of the various investment practices in which the Fund may engage and the risks associated with their use. PORTFOLIO TURNOVER - ------------------ -7- Portfolio turnover is not a limiting factor with respect to investment decisions for the Fund. In any particular year, market conditions may well result in a greater rate than is presently anticipated. However, portfolio turnover for the Fund is not expected to exceed 100%. High portfolio turnover involves correspondingly greater brokerage commissions and other transaction costs, which will be borne directly by the Fund, and could involve realization of capital gains that would be taxable when distributed to shareholders of the Fund unless such shareholders are themselves exempt. See "Taxes" below. NON-DIVERSIFIED PORTFOLIO - ------------------------- The Fund is a "non-diversified" fund under the 1940 Act, and as such the Fund is permitted to (but is not required to) invest a higher percentage of its assets in the securities of fewer issuers. Such concentration could increase the risk of loss to the Fund should there be a decline in the market value of any one portfolio security. Investment in a non-diversified fund may therefore entail greater risks than investment in a diversified fund. Although the Fund is a "non-diversified" fund, it must meet certain diversification standards to qualify as a "regulated investment company" under the Internal Revenue Code of 1986. See "Taxes". CERTAIN RISKS OF FOREIGN INVESTMENTS - ------------------------------------ GENERAL. Investment in foreign issuers or securities principally traded overseas may involve certain special risks due to foreign economic, political and legal developments, including favorable or unfavorable changes in currency exchange rates, exchange control regulations (including currency blockage), expropriation of assets or nationalization, imposition of withholding taxes on dividend or interest payments, and possible difficulty in obtaining and enforcing judgments against foreign entities. Furthermore, issuers of foreign securities are subject to different, often less comprehensive, accounting, reporting and disclosure requirements than domestic issuers. The securities of some foreign governments and companies and foreign securities markets are less liquid and at times more volatile than comparable U.S. securities and securities markets. Foreign brokerage commissions and other fees are also generally higher than in the United States. The laws of some foreign countries may limit the Fund's ability to invest in securities of certain issuers located in these foreign countries. There are also special tax considerations which apply to securities of foreign issuers and securities principally traded overseas. Investors should also be aware that under certain circumstances, markets which are perceived to have similar characteristics to troubled markets may be adversely affected whether or not similarities actually exist. EMERGING MARKETS. The risks described above apply to an even greater extent to investments in emerging markets. The securities markets of emerging countries are generally smaller, less developed, less liquid, and more volatile than the securities markets of the U.S. and developed foreign markets. Disclosure and regulatory standards in many respects are less stringent than in the U.S. and developed foreign markets. There also may be a lower level of monitoring and regulation of securities markets in emerging market countries and the activities of investors in such markets, and enforcement of existing regulations has been extremely limited. Many emerging countries have experienced substantial, and in some periods extremely high, rates of inflation for many years. Inflation and rapid fluctuations in inflation rates have had and may continue to have very negative effects on the economies and securities markets of certain emerging countries. Economies in emerging markets generally are heavily dependent upon international trade and, accordingly, have been and may continue to be affected adversely by trade barriers, exchange controls, managed adjustments in relative currency values, and other protectionist measures imposed or negotiated by the countries with which they trade. These economies also have been and may continue to be adversely affected by economic conditions in the countries in which they trade. The economies of countries with emerging markets may also be predominantly based on only a few industries or dependent on revenues from particular commodities. In addition, custodial services and other costs relating to investment in foreign markets may be more expensive in emerging markets than in many developed foreign markets, which could reduce the Fund's income from such securities. Finally, because publicly traded debt instruments of emerging markets represent a relatively recent innovation in the world debt markets, there is little historical data or related market experience concerning the attributes of such instruments under all economic, market and political conditions. In many cases, governments of emerging countries continue to exercise significant control over their economies, and government actions relative to the economy, as well as economic developments generally, may affect the capacity of issuers of emerging country debt instruments to make payments on their debt obligations, regardless of their financial condition. In addition, there is a heightened possibility of expropriation or confiscatory taxation, imposition of withholding taxes on interest payments, or other similar developments that could affect investments in those countries. There can be no assurance that adverse political changes will not cause the Fund to suffer a loss of any or all of its emerging markets investments and/or, in the case of fixed-income securities, interest thereon. SECURITIES LENDING - ------------------ The Fund may make secured loans of portfolio securities amounting to not more than one-third of its total assets. The risks in lending portfolio securities, as with other extensions of credit, consist of possible delay in recovery of the securities or possible loss of rights in the collateral should the borrower fail financially. However, such loans will be made only to broker-dealers that are believed by the Manager to be of relatively high credit standing. Securities loans are made to broker-dealers pursuant to agreements requiring that loans be continuously secured by collateral in cash or U.S. Government Securities at least equal at all times to the market value of the securities lent. The borrower pays to the lending Fund an amount equal to any dividends or interest the Fund would have received had the securities not been lent. If the loan is -8- collateralized by U.S. Government Securities, the Fund will receive a fee from the borrower. In the case of loans collateralized by cash, the Fund typically invests the cash collateral for its own account in interest-bearing, short-term securities and pays a fee to the borrower. Although voting rights or rights to consent with respect to the loaned securities pass to the borrower, the Fund retains the right to call the loans at any time on reasonable notice, and it will do so in order that the securities may be voted by the Fund if the holders of such securities are asked to vote upon or consent to matters materially affecting the investment. The Fund may also call such loans in order to sell the securities involved. The Manager has retained lending agents on behalf of several Funds of the Trust that are compensated based on a percentage of a Fund's return on the securities lending activity. The Fund also pays various fees in connection with such loans including shipping fees and reasonable custodian fees approved by the Trustees of the Trust or persons acting pursuant to direction of the Board. DEPOSITORY RECEIPTS - ------------------- The Fund may invest in American Depositary Receipts (ADRs), Global Depository Receipts (GDRs) and European Depository Receipts (EDRs) (collectively, "Depository Receipts") if issues of such Depository Receipts are available that are consistent with the Fund's investment objective. Depository Receipts generally evidence an ownership interest in a corresponding foreign security on deposit with a financial institution. Transactions in Depository Receipts usually do not settle in the same currency in which the underlying securities are denominated or traded. Generally, ADRs, in registered form, are designed for use in the U.S. securities markets and EDRs, in bearer form, are designed for use in European securities markets. GDRs may be traded in any public or private securities markets and may represent securities held by institutions located anywhere in the world. CONVERTIBLE SECURITIES - ---------------------- A convertible security is a fixed-income security (a bond or preferred stock) which may be converted at a stated price within a specified period of time into a certain quantity of the common stock of the same or a different issuer. Convertible securities are senior to common stock in a corporation's capital structure, but are usually subordinated to similar non-convertible securities. Convertible securities provide, through their conversion feature, an opportunity to participate in capital appreciation resulting from a market price advance in a convertible security's underlying common stock. The price of a convertible security is influenced by the market value of the underlying common stock and tends to increase as the market value of the underlying stock rises, whereas it tends to decrease as the market value of the underlying stock declines. The Manager regards convertible securities as a form of equity security. FOREIGN CURRENCY TRANSACTIONS - ----------------------------- To the extent the Fund is invested in foreign securities, it may buy or sell foreign currencies or may deal in forward foreign currency contracts, that is, agree to buy or sell a specified currency at a specified price and future date. The Fund may use forward contracts for hedging, investment or currency risk management. The Fund may enter into forward contracts for hedging under three circumstances. First, when the Fund enters into a contract for the purchase or sale of a security denominated in a foreign currency, it may desire to "lock in" the U.S. dollar price of the security. By entering into a forward contract for the purchase or sale, for a fixed amount of dollars, of the amount of foreign currency involved in the underlying security transaction, the Fund will be able to protect itself against a possible loss resulting from an adverse change in the relationship between the U.S. dollar and the subject foreign currency during the period between the date on which the security is purchased or sold and the date on which payment is made or received. Second, when the Manager of the Fund believes that the currency of a particular foreign country may suffer a substantial decline against the U.S. dollar, it may enter into a forward contract to sell, for a fixed amount of dollars, the amount of foreign currency approximating the value of some or all of the Fund's portfolio securities denominated in such foreign currency. Maintaining a match between the forward contract amounts and the value of the securities involved will not generally be possible since the future value of such securities in foreign currencies will change as a consequence of market movements in the value of those securities between the date the forward contract is entered into and the date it matures. Third, the Fund may engage in currency "cross hedging" when, in the opinion of the Manager, the historical relationship among foreign currencies suggests that the Fund may achieve the same protection for a foreign security at reduced cost through the use of a forward foreign currency contract relating to a currency other than the U.S. dollar or the foreign currency in which the security is denominated. By engaging in cross hedging transactions, the Fund assumes the risk of imperfect correlation between the subject currencies. These practices may present risks different from or in addition to the risks associated with investments in foreign currencies. See Appendix A, "Risks and Limitations of Options, Futures and Swaps." The Fund is not required to enter into hedging transactions with regard to its foreign currency-denominated securities and will not do so unless deemed appropriate by the Manager. By entering into the above hedging transactions, the Fund may be required to forego the benefits of advantageous changes in the exchange rates. The Fund may also enter foreign currency forward contracts for investment and currency risk management. When the Fund uses currency instruments for such purposes, the foreign currency -9- exposure of the Fund may differ substantially from the currencies in which the Fund's investment securities are denominated. However, the Fund's aggregate foreign currency exposure will not normally exceed 100% of the value of the Fund's securities, except that the Fund may use currency instruments without regard to this limitation if the amount of such excess, when aggregated with futures contracts, equity swap contracts and contracts for differences used in similar ways, does not exceed 10% of the Fund's net assets. The Fund may also enter into foreign currency forward contracts to give fixed income securities denominated in one currency (generally the U.S. dollar) the risk characteristics of similar securities denominated in another currency or for risk management in a manner similar to the Fund's use of futures contracts and related options. Except to the extent that the Fund may use such contracts for risk management, whenever the Fund enters into a foreign currency forward contract, other than a forward contract entered into for hedging, it will maintain cash, U.S. Government securities or other high grade debt obligations in a segregated account with its custodian with a value, marked to market daily, equal to the amount of the currency required to be delivered. The Fund's ability to engage in forward contracts may be limited by tax considerations. The Fund may use currency futures contracts and related options and options on currencies for the same reasons for which they use currency forwards. Except to the extent that the Fund may use futures contracts and related options for risk management, the Fund will, so long as it is obligated as the writer of a call option on currency futures, own on a contract-for-contract basis an equal long position in currency futures with the same delivery date or a call option on currency futures with the difference, if any, between the market value of the call written and the market value of the call or long currency futures purchased maintained by the Fund in cash, U.S. Government securities or other high grade debt obligations in a segregated account with its custodian. If at the close of business on any day the market value of the call purchased by the Fund falls below 100% of the market value of the call written by the Fund, the Fund will maintain an amount of cash, U.S. Government securities or other high grade debt obligations in a segregated account with its custodian equal in value to the difference. Alternatively, the Fund may cover the call option by owning securities denominated in the currency with a value equal to the face amount of the contract(s) or through segregating with the custodian an amount of the particular foreign currency equal to the amount of foreign currency per futures contract option times the number of options written by the Fund. REPURCHASE AGREEMENTS - --------------------- The Fund may enter into repurchase agreements with banks and broker-dealers by which the Fund acquires a security (usually an obligation of the Government where the transaction is initiated or in whose currency the agreement is denominated) for a relatively short period (usually not more than a week) for cash and obtains a simultaneous commitment from the seller to repurchase the security at an agreed-on price and date. The resale price is in excess of the acquisition price and reflects an agreed-upon market rate unrelated to the coupon rate on the purchased security. Such transactions afford an opportunity for the Fund to earn a return on temporarily available cash at no market risk, although there is a risk that the seller may default in its obligation to pay the agreed-upon sum on the redelivery date. Such a default may subject the Fund to expenses, delays and risks of loss including: (a) possible declines in the value of the underlying security during the period while the Fund seeks to enforce its rights thereto, (b) possible reduced levels of income and lack of access to income during this period and (c) inability to enforce rights and the expenses involved in attempted enforcement. DEBT AND OTHER FIXED INCOME SECURITIES GENERALLY - ------------------------------------------------ Debt and Other Fixed Income Securities include fixed income securities of any maturity. Fixed income securities pay a specified rate of interest or dividends, or a rate that is adjusted periodically by reference to some specified index or market rate. Fixed income securities include securities issued by federal, state, local and foreign governments and related agencies, and by a wide range of private issuers. Fixed income securities are subject to market and credit risk. Market risk relates to changes in a security's value as a result of changes in interest rates generally. In general, the values of fixed income securities increase when prevailing interest rates fall and decrease when interest rates rise. Credit risk relates to the ability of the issuer to make payments of principal and interest. Obligations of issuers are subject to the provisions of bankruptcy, insolvency and other laws, such as the Federal Bankruptcy Reform Act of 1978, affecting the rights and remedies of creditors. Fixed income securities denominated in foreign currencies are also subject to the risk of a decline in the value of the denominating currency. Because interest rates vary, it is impossible to predict the future income of the Fund investing in such securities. The net asset value of the Fund's shares will vary as a result of changes in the value of the securities in its portfolio and will be affected by the absence and/or success of hedging strategies. TEMPORARY HIGH QUALITY CASH ITEMS - --------------------------------- As described under "Investment Objectives and Policies" above, the Fund may temporarily invest a portion of its assets in cash or cash items pending other investments or in connection with the maintenance of a segregated account. These cash items must be of high quality and may include a number of money market instruments such as securities issued by the United States government and agencies thereof, bankers' acceptances, commercial paper, and bank certificates of deposit. By investing only in high quality money market securities the Fund will seek to minimize credit risk with respect to such investments. -10- U.S. GOVERNMENT SECURITIES AND FOREIGN GOVERNMENT SECURITIES - ------------------------------------------------------------ U.S. Government Securities include securities issued or guaranteed by the U.S. government or its authorities, agencies or instrumentalities. Foreign Government Securities include securities issued or guaranteed by foreign governments (including political subdivisions) or their authorities, agencies or instrumentalities or by supra-national agencies. U.S. Government Securities and Foreign Government Securities have different kinds of government support. For example, some U.S. Government Securities, such as U.S. Treasury bonds, are supported by the full faith and credit of the United States, whereas certain other U.S. Government Securities issued or guaranteed by federal agencies or government-sponsored enterprises are not supported by the full faith and credit of the United States. Similarly, some Foreign Government Securities are supported by the full faith and credit of a foreign national government or political subdivision and some are not. In the case of certain countries, Foreign Government Securities may involve varying degrees of credit risk as a result of financial or political instability in such countries and the possible inability of the Fund to enforce its rights against the foreign government issuer. Supra-national agencies are agencies whose member nations make capital contributions to support the agencies' activities, and include such entities as the International Bank for Reconstruction and Development (the World Bank), the Asian Development Bank, the European Coal and Steel Community and the Inter-American Development Bank. Like other fixed income securities, U.S. Government Securities and Foreign Government Securities are subject to market risk and their market values fluctuate as interest rates change. Thus, for example, the value of an investment in the Fund which holds U.S. Government Securities or Foreign Government Securities may fall during times of rising interest rates. Yields on U.S. Government Securities and Foreign Government Securities tend to be lower than those of corporate securities of comparable maturities. In addition to investing directly in U.S. Government Securities and Foreign Government Securities, the Fund may purchase certificates of accrual or similar instruments evidencing undivided ownership interests in interest payments or principal payments, or both, in U.S. Government Securities and Foreign Government Securities. These certificates of accrual and similar instruments may be more volatile than other government securities. MORTGAGE-BACKED AND OTHER ASSET-BACKED SECURITIES - ------------------------------------------------- Mortgage-backed and other asset-backed securities may be issued by the U.S. government, its agencies or instrumentalities, or by non-governmental issuers. Interest and principal payments (including prepayments) on the mortgages underlying mortgage-backed securities are passed through to the holders of the mortgage-backed security. Prepayments occur when the mortgagor on an individual mortgage prepays the remaining principal before the mortgage's scheduled maturity date. As a result of the pass-through of prepayments of principal on the underlying mortgages, mortgage-backed securities are often subject to more rapid prepayment of principal than their stated maturity would indicate. Because the prepayment characteristics of the underlying mortgages vary, there can be no certainty as to the predicted yield or average life of a particular issue of pass-through certificates. Prepayments are important because of their effect on the yield and price of the securities. During periods of declining interest rates, such prepayments can be expected to accelerate and the Fund would be required to reinvest the proceeds at the lower interest rates then available. In addition, prepayments of mortgages which underlie securities purchased at a premium could result in capital losses because the premium may not have been fully amortized at the time the obligation was prepaid. As a result of these principal prepayment features, the values of mortgage-backed securities generally fall when interest rates rise, but their potential for capital appreciation in periods of falling interest rates is limited because of the prepayment feature. The mortgage-backed securities purchased by the Fund may include Adjustable Rate Securities as such term is defined in "Descriptions and Risks of Fund Investment Practices -- Adjustable Rate Securities" below. Other "asset-backed securities" include securities backed by pools of automobile loans, educational loans and credit card receivables. Mortgage-backed and asset-backed securities of non-governmental issuers involve prepayment risks similar to those of U.S. government guaranteed mortgage-backed securities and also involve risk of loss of principal if the obligors of the underlying obligations default in payment of the obligations. COLLATERALIZED MORTGAGE OBLIGATIONS ("CMOS"); STRIPS AND RESIDUALS. A CMO is a security backed by a portfolio of mortgages or mortgage-backed securities held under an indenture. The issuer's obligation to make interest and principal payments is secured by the underlying portfolio of mortgages or mortgage-backed securities. CMOs are issued in multiple classes or series which have different maturities representing interests in some or all of the interest or principal on the underlying collateral or a combination thereof. CMOs of different classes are generally retired in sequence as the underlying mortgage loans in the mortgage pool are repaid. In the event of sufficient early prepayments on such mortgages, the class or series of CMO first to mature generally will be retired prior to its stated maturity. Thus, the early retirement of a particular class or series of CMO held by the Fund would have the same effect as the prepayment of mortgages underlying a mortgage-backed pass-through security. CMOs include securities ("Residuals") representing the interest in any excess cash flow and/or the value of any collateral remaining on mortgages or mortgage-backed securities from the payment of principal of and interest on all other CMOs and the administrative expenses of the issuer. Residuals have value only to the extent income from such underlying mortgages or mortgage-backed securities exceeds the amounts necessary to satisfy the issuer's debt obligations represented by all other outstanding CMOs. -11- CMOs also include certificates representing undivided interests in payments of interest-only or principal-only ("IO/PO Strips") on the underlying mortgages. IO/PO Strips and Residuals tend to be more volatile than other types of securities. IO Strips and Residuals also involve the additional risk of loss of a substantial portion of or the entire value of the investment if the underlying securities are prepaid. In addition, if a CMO bears interest at an adjustable rate, the cash flows on the related Residual will also be extremely sensitive to the level of the index upon which the rate adjustments are based. COMMERCIAL MORTGAGE-RELATED SECURITIES. The Fund may invest in commercial mortgage-related securities. Commercial mortgage-related securities are securities that represent an interest in, or are secured by, mortgage loans secured by commercial property, such as industrial and warehouse properties, office buildings, retail space and shopping malls, multifamily properties and cooperative apartments, hotels and motels, nursing homes, hospitals, and senior living centers. The commercial mortgage-related securities market is newer and in terms of total outstanding principal amount of issues is relatively small compared to the total size of the market for residential mortgage-related securities. Commercial mortgage-related securities are generally structured similarly to pass-through securities or to CMOs, although other structures are possible. They may pay fixed or adjustable rates of interest. Commercial mortgage-related securities have been issued in public or private transactions by a variety of public and private issuers. The commercial mortgage loans that underlie commercial mortgage-related securities generally lack standardized terms, which may complicate their structure. Commercial properties themselves tend to be unique and are more difficult to value than single family residential properties. Commercial mortgage loans also tend to have shorter maturities than residential mortgage loans, and may not be fully amortizing, meaning that they may have a significant principal balance, or "balloon" payment, due on maturity. Assets underlying commercial mortgage-related securities may relate only to a few properties or a single property. The risk involved in single property financings is highly concentrated. In addition, commercial properties, particularly industrial and warehouse properties, are subject to environmental risks and the burdens and costs of compliance with environmental laws and regulations. At the same time, commercial mortgage-related securities may have a lower prepayment risk than residential mortgage-related securities, because commercial mortgage loans generally prohibit or impose penalties on prepayments of principal. In addition, as described in the next paragraph, commercial mortgage-related securities often are structured with some form of credit enhancement to protect against potential losses on the underlying mortgage loans. Mortgage-related securities are often backed by a pool of assets representing the obligations of a number of different parties. To lessen the effect of failures by obligors to make payments, such securities may contain elements of credit support. Such credit support falls into two categories: (i) liquidity protection and (ii) protection against losses resulting from ultimate default by an obligor on the underlying assets. Liquidity protection refers to the provision of advances, generally by the entity administering the pool of assets, designed to ensure that the receipt of payments on the underlying pool occurs in a timely fashion. Protection against losses resulting from ultimate default is designed to ensure timely payment of the obligations on at least a portion of the assets in the pool. Such protection may be provided through subordination of other debt, guarantees, insurance policies, or letters of credit obtained by the issuer or sponsor from third parties, through various means of structuring the transaction or through a combination of such approaches. The degree of credit support provided for each issue is generally based on historical information with respect to the level of credit risk associated with the underlying assets. There can be no assurance that credit support will be sufficient to ensure the timely payment of principal and/or interest. Delinquencies or losses in excess of those anticipated could adversely affect the return on investment in such security. The Fund will not pay any separately stated fees for such credit support, although the existence of credit support may increase the price of a security. ADJUSTABLE RATE SECURITIES - -------------------------- Adjustable rate securities are securities that have interest rates that are reset at periodic intervals, usually by reference to some interest rate index or market interest rate. They may be U.S. Government Securities or securities of other issuers. Some adjustable rate securities are backed by pools of mortgage loans. Although the rate adjustment feature may act as a buffer to reduce sharp changes in the value of adjustable rate securities, these securities are still subject to changes in value based on changes in market interest rates or changes in the issuer's creditworthiness. Because the interest rate is reset only periodically, changes in the interest rates on adjustable rate securities may lag changes in prevailing market interest rates. Also, some adjustable rate securities (or, in the case of securities backed by mortgage loans, the underlying mortgages) are subject to caps or floors that limit the maximum change in interest rate during a specified period or over the life of the security. Because of the resetting of interest rates, adjustable rate securities are less likely than non-adjustable rate securities of comparable quality and maturity to increase significantly in value when market interest rates fall. LOWER RATED SECURITIES - ---------------------- The Fund may invest up to 5% of its assets in securities rated below investment grade (that is, rated below BBB by Standard & Poor's or below Baa by Moody's) at the time of purchase, including securities in the lowest rating categories, and comparable unrated securities ("Lower Rated Securities"). The Fund will not necessarily dispose of a security when its rating is reduced below its rating at the time of purchase, although the Manager will monitor the investment to determine whether continued investment -12- in the security will assist in meeting the Fund's investment objective. Lower Rated Securities generally provide higher yields, but are subject to greater credit and market risk, than higher quality fixed income securities. Lower Rated Securities are considered predominantly speculative with respect to the ability of the issuer to meet principal and interest payments. To the extent the Fund invests in Lower Rated Securities achievement of the Fund's investment objective may be more dependent on the Manager's own credit analysis than is the case with higher quality bonds. The market for Lower Rated Securities may be more severely affected than some other financial markets by economic recession or substantial interest rate increases, by changing public perceptions of this market or by legislation that limits the ability of certain categories of financial institutions to invest in these securities. In addition, the secondary market may be less liquid for Lower Rated Securities. This reduced liquidity at certain times may affect the values of these securities and may make the valuation and sale of these securities more difficult. Securities of below investment grade quality are commonly referred to as "junk bonds." Securities in the lowest rating categories may be in poor standing or in default. Securities in the lowest investment grade category (BBB or Baa) have some speculative characteristics. ZERO COUPON SECURITIES - ---------------------- When investing in "zero coupon" fixed income securities, the Fund is required to accrue interest income on these securities at a fixed rate based on the initial purchase price and the length to maturity, but these securities do not pay interest in cash on a current basis. The Fund is required to distribute the income on these securities to its shareholders as the income accrues, even though the Fund is not receiving the income in cash on a current basis. Thus, the Fund may have to sell other investments to obtain cash to make income distributions. The market value of zero coupon securities is often more volatile than that of non-zero coupon fixed income securities of comparable quality and maturity. Zero coupon securities include IO and PO strips. INDEXED SECURITIES - ------------------ Indexed Securities are securities the redemption values and/or the coupons of which are indexed to the prices of a specific instrument or statistic. Indexed securities typically, but not always, are debt securities or deposits whose value at maturity or coupon rate is determined by reference to other securities, securities indexes, currencies, precious metals or other commodities, or other financial indicators. Gold-indexed securities, for example, typically provide for a maturity value that depends on the price of gold, resulting in a security whose price tends to rise and fall together with gold prices. Currency-indexed securities typically are short-term to intermediate-term debt securities whose maturity values or interest rates are determined by reference to the values of one or more specified foreign currencies, and may offer higher yields than U.S. dollar-denominated securities of equivalent issuers. Currency- indexed securities may be positively or negatively indexed; that is, their maturity value may increase when the specified currency value increases, resulting in a security that performs similarly to a foreign-denominated instrument, or their maturity value may decline when foreign currencies increase, resulting in a security whose price characteristics are similar to a put on the underlying currency. Currency-indexed securities may also have prices that depend on the values of a number of different foreign currencies relative to each other. The performance of indexed securities depends to a great extent on the performance of the security, currency, or other instrument to which they are indexed, and may also be influenced by interest rate changes in the U.S. and abroad. At the same time, indexed securities are subject to the credit risks associated with the issuer of the security, and their values may decline substantially if the issuer's creditworthiness deteriorates. Recent issuers of indexed securities have included banks, corporations, and certain U.S. government agencies. Indexed securities in which the Fund may invest include so-called "inverse floating obligations" or "residual interest bonds" on which the interest rates typically decline as short-term market interest rates increase and increase as short-term market rates decline. Such securities have the effect of providing a degree of investment leverage, since they will generally increase or decrease in value in response to changes in market interest rates at a rate which is a multiple of the rate at which fixed-rate long-term securities increase or decrease in response to such changes. As a result, the market values of such securities will generally be more volatile than the market values of fixed rate securities. FIRM COMMITMENTS - ---------------- A firm commitment agreement is an agreement with a bank or broker-dealer for the purchase of securities at an agreed-upon price on a specified future date. The Fund may enter into firm commitment agreements with such banks and broker-dealers with respect to any of the instruments eligible for purchase by the Fund. The Fund will only enter into firm commitment arrangements with banks and broker-dealers which the Manager determines present minimal credit risks. The Fund will maintain in a segregated account with its custodian cash, U.S. Government Securities or other liquid high grade debt obligations in an amount equal to the Fund's obligations under firm commitment agreements. REVERSE REPURCHASE AGREEMENTS AND DOLLAR ROLL AGREEMENTS - -------------------------------------------------------- The Fund may enter into reverse repurchase agreements and dollar roll agreements with banks and brokers to enhance return. Reverse repurchase agreements involve sales by the Fund of portfolio assets concurrently with an agreement by the Fund to repurchase the same assets at a later date at a fixed price. During the reverse repurchase agreement period, the Fund continues to receive principal and interest payments on these securities and also -13- has the opportunity to earn a return on the collateral furnished by the counterparty to secure its obligation to redeliver the securities. Dollar rolls are transactions in which the Fund sells securities for delivery in the current month and simultaneously contracts to repurchase substantially similar (same type and coupon) securities on a specified future date. During the roll period, the Fund forgoes principal and interest paid on the securities. The Fund is compensated by the difference between the current sales price and the forward price for the future purchase (often referred to as the "drop") as well as by the interest earned on the cash proceeds of the initial sale. In making such investments, the Fund will establish segregated accounts with its custodian in which the Fund will maintain cash, U.S. Government Securities or other liquid high grade debt obligations equal in value to its obligations in respect of reverse repurchase agreements and dollar rolls. Reverse repurchase agreements and dollar rolls involve the risk that the market value of the securities retained by the Fund may decline below the price of the securities the Fund has sold but is obligated to repurchase under the agreement. In the event the buyer of securities under a reverse repurchase agreement or dollar roll files for bankruptcy or becomes insolvent, the Fund's use of the proceeds of the agreement may be restricted pending a determination by the other party or its trustee or receiver whether to enforce the Fund's obligation to repurchase the securities. Reverse repurchase agreements and dollar rolls are not considered borrowings by the Fund for purposes of the Fund's fundamental investment restriction with respect to borrowings. ILLIQUID SECURITIES - ------------------- The Fund may purchase "illiquid securities," i.e., securities which may not be sold or disposed of in the ordinary course of business within seven days at approximately the value at which the Fund has valued the investment, which include securities whose disposition is restricted by securities laws, so long as no more than 15% of net assets would be invested in such illiquid securities. The Fund currently intends to invest in accordance with the SEC staff view that repurchase agreements maturing in more than seven days are illiquid securities. The SEC staff has stated informally that it is of the view that over-the-counter options and securities serving as cover for over-the-counter options are illiquid securities. While the Trust does not agree with this view, it will operate in accordance with any relevant formal guidelines adopted by the SEC. MULTIPLE CLASSES ---------------- The Fund offers three classes of shares: Class I, Class II and Class III. Eligibility generally depends on the size of a client's total investment with GMO, as described more fully in this section. See "Eligibility for Classes." SHAREHOLDER SERVICE FEES - ------------------------ The principal economic difference among the various classes of shares is the level of Shareholder Service Fee which the classes bear for client and shareholder service, reporting and other support. The existence of multiple classes reflects the fact that, as the size of a client relationship increases, the cost to service that client decreases as a percentage of the assets in that account. Thus, the Shareholder Service Fee is lower for classes where eligibility criteria require greater total assets under GMO's management. The Trust has adopted a Shareholder Servicing Plan with respect to the multiple classes of shares. Pursuant to the terms of the Shareholder Servicing Plan, the classes will pay the following Shareholder Service Fees, expressed as an annual percentage of the average daily net assets attributable to that class of shares: Shareholder Service Fee ----------------------- Class I Class II Class III ------- -------- --------- 0.28% 0.22% 0.15% CLIENT SERVICE - GMO AND GMO FUNDS - ---------------------------------- A significant distinction among classes is that clients eligible for Class I or Class II Shares are serviced by the Manager's GMO FUNDS DIVISION, a division of GMO established in April of 1996 to deliver institutional quality service and reporting to clients generally committing between $1 million and $35 million to GMO's management. ELIGIBILITY FOR CLASSES - ----------------------- Class I, Class II and Class III Shares: With certain exceptions described below, eligibility for Class I, Class II, and Class III Shares depends on a client's "TOTAL INVESTMENT" with GMO. For clients establishing a relationship with GMO on or after June 1, 1996: A client's Total Investment is equal at any time to the aggregate of all amounts contributed by the client to any registered investment company for which GMO acts as investment manager (a "GMO Fund"), less the "INVESTMENT COST" of all redemptions by the client from such Funds. Where applicable, the market value of assets managed by GMO for the client other than in a mutual fund, as of the prior month end, will be added to the client's Total Investment. For purposes of class eligibility, market appreciation or depreciation of a client's mutual fund account is not considered; the Total Investment of a client is affected only by the amount of purchases and redemptions made by the client. Further, it is assumed that any redemptions made by a client are satisfied first by market appreciation so that a redemption does not have Investment Cost except to the extent that the redemption or withdrawal exceeds the market appreciation of the client's account in a GMO Fund. -14- Subject to the exceptions set forth following this table, the minimum Total Investment for a new client (establishing a GMO Account after June 1, 1996) to be eligible for Class I, II or III Shares is set forth below: MINIMUM TOTAL INVESTMENT ------------------------ Class I $1 Million Class II $10 Million Class III $35 Million Investments by defined contribution pension plans (such as 401(k) plans) will be accepted only in Class I Shares regardless of the size of the investment, and will not be eligible to convert to other classes. For Clients with Accounts as of May 31, 1996: Any client of GMO whose Total Investment as of May 31, 1996 was equal to or greater than $7 million will remain eligible for Class III Shares indefinitely, provided that such client does not make a withdrawal or redemption that causes the client's Total Investment to fall below $7 million. Any client whose Total Investment as of May 31, 1996 was less than $7 million, but greater than $0, will convert to Class II Shares on or shortly after July 31, 1997. For clients with GMO accounts as of May 31, 1996, their initial Total Investment will equal the market value of all of their GMO investments as of the close of business on May 31, 1996 and will subsequently be calculated as described in the preceding section. There is no minimum for subsequent investments into any class of shares. The Manager will make all determinations as to aggregation of client accounts for purposes of determining eligibility. CONVERSIONS BETWEEN CLASSES - --------------------------- On July 31 of each year (the "DETERMINATION DATE") the value of each client's Total Investment with GMO, as defined above, will be determined. Based on that determination, each client's shares of all GMO Funds will be automatically converted to the class with the lowest Shareholder Service Fee for which the client is eligible based on the amount of the client's Total Investment. The conversion will occur within 15 business days following the Determination Date. Also, if a client makes an investment in a GMO Fund or puts additional assets under GMO's Management so as to cause the client to be eligible for a new class of shares, such determination will be made as of the close of business on the last day of the month in which the investment was made, and the conversion will be effected within 15 business days of that month-end. The Trust received a tax ruling from the Internal Revenue Service to the effect that the conversion of a client's investment from one class of shares to another class of shares in the same Fund should not result in the recognition of gain or loss in the converted Fund's shares. The client's tax basis in the new class of shares immediately after the conversion should equal the client's basis in the converted shares immediately before conversion, and the holding period of the new class of shares should include the holding period of the converted shares. Certain special rules will be applied by the Manager with respect to clients for whom GMO managed assets prior to the creation of multiple classes for the Trust on May 31, 1996. Clients whose Total Investment as of May 31, 1996 is equal to $7 million or more will be eligible to remain invested in Class III Shares indefinitely (despite the normal $35 million minimum), provided that such client does not make a withdrawal or redemption that causes the client's Total Investment to fall below $7 million. Clients whose Total Investment as of May 31, 1996 is less than $7 million will be converted to Class II Shares (rather than Class I Shares) and such conversion will not occur until July 31, 1997 or slightly thereafter. Of course, if such a client makes an additional investment prior to July 31, 1997 such that their Total Investment on July 31, 1997 is $35 million or more, the client will remain eligible for Class III Shares. Investors should be aware that not all classes of all Funds are available in all jurisdictions. PURCHASE OF SHARES ------------------ Shares of the Fund are available only from the Trust and may be purchased on any day when the New York Stock Exchange is open for business (a "business day"). Class I and Class II Shares may be purchased by calling (617) 790-5000. Class III Shares may be purchased by calling (617) 330-7500. See "Purchase Procedures" below. The purchase price of a share of the Fund is (i) the net asset value next determined after a subscription agreement is received in good order plus (ii) a premium established from time to time by the Trust for the Fund. All purchase premiums are paid to and retained by the Fund and are intended to cover the brokerage and other costs associated with putting the investment to work in the relevant markets. Each class of shares of the Fund has the same rate of purchase premium. The purchase premium currently in effect for the Fund is 0.60%. The Manager may reduce purchase premiums if the Manager determines that there are minimal brokerage and/or other transaction costs caused by the purchase. Generally, however, the premium is not waivable even when there are offsetting transactions. The purchase premium applies only to cash transactions. These fees are paid to and retained by the Fund itself and are designed to allocate transaction costs caused by shareholder activity to the -15- shareholder generating the activity, rather than to the Fund as a whole. Purchase premiums are not sales loads. It is expected that the purchase premium for the Fund will be eliminated once the net assets of the Fund exceed $100 million. However, even thereafter, the Fund will reserve the right to charge a purchase premium of up to 0.60% on purchases that are equal to or greater than 5% of the Fund's net assets prior to the purchase. Shares may be purchased (i) in cash, (ii) in exchange for securities on deposit at The Depository Trust Company ("DTC") (or such other depository acceptable to the Manager), subject to the determination by the Manager that the securities to be exchanged are acceptable, or (iii) by a combination of such securities and cash. In all cases, the Manager reserves the right to reject any particular investment. Securities acceptable to the Manager as consideration for Fund shares will be valued as set forth under "Determination of Net Asset Value" (generally the last quoted sale price) as of the time of the next determination of net asset value after such acceptance. All dividends, subscription or other rights which are reflected in the market price of accepted securities at the time of valuation become the property of the Fund and must be delivered to the Trust upon receipt by the investor from the issuer. A gain or loss for federal income tax purposes may be realized by investors subject to federal income taxation upon the exchange, depending upon the investor's basis in the securities tendered. The Manager will not approve securities as acceptable consideration for Fund shares unless (1) the Manager, in its sole discretion, believes the securities are appropriate investments for the Fund; (2) the investor represents and agrees that all securities offered to the Fund are not subject to any restrictions upon their sale by the Fund under the Securities Act of 1933, or otherwise; and (3) the securities may be acquired under the investment restrictions applicable to the Fund. Investors interested in making in-kind purchases should telephone the Manager at (617) 330-7500. For purposes of calculating the purchase price of Trust shares, a subscription agreement is received by the Trust on the day that it is in "good order" and is accepted by the Trust. For a subscription agreement to be in "good order" on a particular day, the investor's consideration must be received before the relevant deadline on that day. If the investor makes a cash investment, the deadline for wiring Federal funds to the Trust is 2:00 p.m.; if the investor makes an investment in-kind, the investor's securities must be placed on deposit at DTC (or such other depository as is acceptable to the Manager) and 2:00 p.m. is the deadline for transferring those securities to the account designated by the transfer agent, Investors Bank & Trust Company, One Lincoln Plaza, Boston, Massachusetts 02205. Investors should be aware that approval of the securities to be used for purchase must be obtained from the Manager prior to this time. When the consideration is received by the Trust after the relevant deadline, the subscription agreement is not considered to be in good order and is required to be resubmitted on the following business day. With the prior consent of the Manager, in certain circumstances the Manager may, in its discretion, permit purchases based on receiving adequate written assurances that Federal Funds or securities, as the case may be, will be delivered to the Trust by 2:00 p.m. on or prior to the fourth business day after such assurances are received. PURCHASE PROCEDURES: (a) General: Investors should call the Trust at (617) 790-5000 before attempting to place an order for Class I or Class II Shares. Investors should call the Trust at (617) 330-7500 before attempting to place an order for Class III Shares. The Trust reserves the right to reject any order for Trust shares. DO NOT SEND CASH, CHECKS OR SECURITIES DIRECTLY TO THE TRUST. Wire transfer and mailing instructions are contained on the SUBSCRIPTION AGREEMENT which can be obtained from the Trust at the telephone numbers set forth above. Purchases will be made in full and fractional shares of the Fund calculated to three decimal places. The Trust will send a written confirmation (including a statement of shares owned) to shareholders at the time of each transaction. (b) Subscription Agreement: Investors must submit a Subscription Agreement to the Trust and it must be accepted by the Trust before it will be considered in "good order." Class I and Class II Shares: A Subscription Agreement for Class I and Class II Shares may be obtained by calling the Trust at (617) 790-5000. This Subscription Agreement may be submitted to the Trust (i) By Mail to GMO Trust c/o GMO Funds Division, 40 Rowes Wharf, Boston, MA 02110; or (ii) By Facsimile to (617) 439-4290. Class III Shares: A Subscription Agreement for Class III Shares may be obtained by calling the Trust at (617) 330-7500. This Subscription Agreement may be submitted to the Trust (i) By Mail to GMO Trust c/o Grantham, Mayo, Van Otterloo & Co. LLC, 40 Rowes Wharf, Boston, MA 02110; Attention: Shareholder Services, or (ii) By Facsimile to (617) 439-4192; Attention: Shareholder Services. (c) Acceptance of Subscription Agreement: No Subscription Agreement is in "good order" until it has been accepted by the Trust. As noted above, investors should call the Trust at the telephone numbers indicated before attempting to place an order. If a Subscription Agreement is faxed to the Trust without first contacting the Trust, investors should not consider their order acknowledged until they have received notification from the Trust or have confirmed receipt of the order by contacting the Trust. A shareholder may confirm acceptance of a mailed or faxed Subscription Agreement by calling the Trust at (617) 330-7500 in the case of Class III Shares, or at (617) 790-5000 in the case of Class I or II Shares. If a Subscription Agreement is mailed to the Trust, it will be acted upon when received. -16- (d) Payment: All Federal funds must be transmitted to Investors Bank & Trust Company for the account of the GMO Global Properties Fund. "Federal funds" are monies credited to Investors Bank & Trust Company's account with the Federal Reserve Bank of Boston. Note: The Trust may attempt to process orders for Trust shares that are submitted less formally than as described above but, in such cases, the investor should carefully review confirmations sent by the Trust to verify that the order was properly executed. The Trust cannot be held responsible for failure to execute orders or improperly executing orders that are not submitted in accordance with these procedures. REDEMPTION OF SHARES -------------------- Shares of the Fund may be redeemed on any business day in cash or in kind. The redemption price is the net asset value per share next determined after receipt of the redemption request in "good order" less any applicable redemption fee. All redemption fees are paid to and retained by the Fund and are intended to cover the brokerage and other Fund costs associated with redemptions. All classes of the Fund bear the same redemption fee rate. The redemption fee currently in effect for the Fund is 0.30%. The Manager may reduce redemption fees if the Manager determines that there are minimal brokerage and/or other transaction costs caused by the redemption. Generally, however, the fee is not waivable even where there are offsetting transactions. The redemption fee applies only to cash transactions. These fees are paid to and retained by the Fund itself and are employed to allocate transaction costs caused by shareholder activity to the shareholder generating the activity, rather than to the Fund as a whole. Redemption fee is not sales loads or contingent deferred sales charges. It is expected that the redemption fee for the Fund will be eliminated once the net assets of the Fund exceed $100 million. However, even thereafter, the Fund will reserve the right to charge a redemption fee of up to 0.30% on redemptions that are equal to or greater than 5% of the Fund's net assets prior to the redemption. If the Manager determines, in its sole discretion, that it would be detrimental to the best interests of the remaining shareholders of the Fund to make payment wholly or partly in cash, the Fund may pay the redemption price in whole or in part by a distribution in-kind of securities held by the Fund in lieu of cash. Securities used to redeem Fund shares in-kind will be valued in accordance with the Fund's procedures for valuation described under "Determination of Net Asset Value." Securities distributed by the Fund in-kind will be selected by the Manager in light of the Fund's objective and will not generally represent a pro rata distribution of each security held in the Fund's portfolio. Any in-kind redemptions will be of readily marketable securities to the extent available. Investors may incur brokerage charges on the sale of any such securities so received in payment of redemptions. Payment on redemption will be made as promptly as possible and in any event within seven days after the request for redemption is received by the Trust in "good order." A redemption request is in "good order" if it includes the exact name in which shares are registered, the investor's account number and the number of shares or the dollar amount of shares to be redeemed and if it is signed exactly in accordance with the form of registration. In addition, for a redemption request to be in "good order" on a particular day, the investor's request must be received by the Trust by 4:15 p.m. on a business day. When a redemption request is received after 4:15 p.m., the redemption request will not be considered to be in "good order" and is required to be resubmitted on the following business day. Persons acting in a fiduciary capacity, or on behalf of a corporation, partnership or trust must specify, in full, the capacity in which they are acting. The redemption request will be considered "received" by the Trust only after (i) it is mailed to, and received by, the Trust at the appropriate address set forth above for purchase orders, or (ii) it is faxed to the Trust at the appropriate facsimile number set forth above for purchase orders, and the investor has confirmed receipt of the faxed request by calling the Trust at (617) 330-7500 in the case of Class III Shares, or at (617) 790-5000 in the case of Class I or Class II Shares. In-kind distributions will be transferred and delivered as directed by the investor. Cash payments will be made by transfer of Federal funds for payment into the investor's account. When opening an account with the Trust, shareholders will be required to designate the account(s) to which funds or securities may be transferred upon redemption. Designation of additional accounts and any change in the accounts originally designated must be made in writing. The Fund may suspend the right of redemption and may postpone payment for more than seven days when the New York Stock Exchange is closed for other than weekends or holidays, or if permitted by the rules of the Securities and Exchange Commission during periods when trading on the Exchange is restricted or during an emergency which makes it impracticable for the Fund to dispose of its securities or to fairly determine the value of the net assets of the Fund, or during any other period permitted by the Securities and Exchange Commission for the protection of investors. Because the Fund will hold portfolio securities listed on foreign exchanges which may trade on days on which the New York Stock Exchange is closed, the net asset value of the Fund's shares may be significantly affected on days when shareholders have no access to such Funds. DETERMINATION OF NET ASSET VALUE -------------------------------- The net asset value of a share is determined for the Fund once on each day on which the New York Stock Exchange is open as of 4:15 p.m., New York City Time, except that the Fund may not determine its net asset value on days during which no security is tendered for redemption and no order to purchase or sell such security is received by the Fund. The Fund's net asset value is determined by dividing the total market value of the Fund's -17- portfolio investments and other assets, less any liabilities, by the total outstanding shares of the Fund. Portfolio securities listed on a securities exchange for which market quotations are available are valued at the last quoted sale price on each business day, or, if there is no such reported sale, at the most recent quoted bid price. Price information on listed securities is generally taken from the closing price on the exchange where the security is primarily traded. Unlisted securities for which market quotations are readily available are valued at the most recent quoted bid price, except that debt obligations with sixty days or less remaining until maturity may be valued at their amortized cost, unless circumstances dictate otherwise. Circumstances may dictate otherwise, among other times, when the issuer's creditworthiness has become impaired. All other fixed income securities (which includes bonds, loans and structured notes) and options thereon are valued at the closing bid for such securities as supplied by a primary pricing source chosen by the Manager. While the Manager evaluates such primary pricing sources on an ongoing basis, and may change any pricing source at any time, the Manager will not normally evaluate the prices supplied by the pricing sources on a day-to-day basis. However, the Manager is kept informed of erratic or unusual movements (including unusual inactivity) in the prices supplied for a security and has the power to override any price supplied by a source (by taking a price supplied from another source) because of such price activity or because the Manager has other reasons to suspect that a price supplied may not be reliable. Other assets and securities for which no quotations are readily available are valued at fair value as determined in good faith by the Trustees or persons acting at their direction. The values of foreign securities quoted in foreign currencies are translated into U.S. dollars at current exchange rates or at such other rates as the Trustees may determine in computing net asset value. Because of time zone differences, foreign exchanges and securities markets will usually be closed prior to the time of the closing of the New York Stock Exchange and values of foreign options and foreign securities will be determined as of the earlier closing of such exchanges and securities markets. However, events affecting the values of such foreign securities may occasionally occur between the earlier closings of such exchanges and securities markets and the closing of the New York Stock Exchange which will not be reflected in the computation of the net asset value of the Fund. If an event materially affecting the value of such foreign securities occurs during such period, then such securities will be valued at fair value as determined in good faith by the Trustees or persons acting at their direction. Because foreign securities, options on foreign securities and foreign futures are quoted in foreign currencies, fluctuations in the value of such currencies in relation to the U.S. dollar will affect the net asset value of shares of the Fund even though there has not been any change in the values of such securities and options, measured in terms of the foreign currencies in which they are denominated. DISTRIBUTIONS ------------- The Fund intends to pay out as dividends substantially all of its net investment income (which comes from dividends and interest it receives from its investments and net short-term capital gains). For these purposes and for federal income tax purposes, a portion of the premiums from certain expired call or put options written by the Fund, net gains from certain closing purchase and sale transactions with respect to such options and a portion of net gains from other options and futures transactions are treated as short-term capital gain. The Fund also intends to distribute substantially all of its net long-term capital gains, if any, after giving effect to any available capital loss carryover. The policy of the Fund is to declare and pay distributions of its dividends, interest and foreign currency gains semi-annually. The Fund also intends to distribute net short-term capital gains and net long-term gains at least annually. All dividends and/or distributions will be paid in shares of the Fund, at net asset value, unless the shareholder elects to receive cash. There is no purchase premium on reinvested dividends or distributions. Shareholders may make this election by marking the appropriate box on theSubscription Agreement or by writing to the Trust. TAXES ----- The Fund is treated as a separate taxable entity for federal income tax purposes. The Fund intends to qualify each year as a regulated investment company under Subchapter M of the Internal Revenue Code of 1986, as amended. So long as the Fund so qualifies, the Fund itself will not pay federal income tax on the amount distributed. Fund distributions derived from interest, dividends and certain other income, including in general short-term capital gains, will be taxable as ordinary income to shareholders subject to federal income tax whether received in cash or reinvested shares. Designated distributions of any long-term capital gains whether received in cash or reinvested shares are taxable as such to shareholders subject to federal income tax, regardless of how long a shareholder may have owned shares in the Fund. Any loss realized upon a taxable disposition of shares held for six months or less will be treated as long-term capital loss to the extent of any long-term capital gain distributions received by a shareholder with respect to those shares. A distribution paid to shareholders by the Fund in January of a year generally is deemed to have been received by shareholders on December 31 of the preceding year, if the distribution was declared and payable to shareholders of record on a date in October, November or December of that preceding year. The Trust will provide federal tax information annually, including information about dividends and distributions paid during the preceding year to taxable investors and others requesting such information. -18- For corporate shareholders, any distributions received by the Fund from REITs will not qualify for the corporate dividends-received deduction. The Fund's investments in REIT equity securities may require the Fund to accrue and distribute income not yet received. In order to generate sufficient cash to make the requisite distributions, the Fund may be required to sell securities in its portfolio that it otherwise would have continued to hold. The Fund's investments in REIT equity securities may at other times result in the Fund's receipt of cash in excess of the REIT's earnings; if the Fund distributes such amounts, such distribution could constitute a return of capital to Fund shareholders for federal income tax purposes. The back-up withholding rules do not apply to tax exempt entities so long as each such entity furnishes the Trust with an appropriate certification. However, other shareholders are subject to back-up withholding at a rate of 31% on all distributions of net investment income and capital gain, whether received in cash or reinvested in shares of the Fund, and on the amount of the proceeds of any redemption of Fund shares paid or credited to any shareholder account for which an incorrect or no taxpayer identification number has been provided, where appropriate certification has not been provided for a foreign shareholder, or where the Trust is notified that the shareholder has underreported income in the past (or the shareholder fails to certify that he is not subject to such withholding). The foregoing is a general summary of the federal income tax consequences for shareholders who are U.S. citizens, residents or domestic corporations. Shareholders should consult their own tax advisors about the tax consequences of an investment in the Fund in light of each shareholder's particular tax situation. Shareholders should also consult their own tax advisors about consequences under foreign, state, local or other applicable tax laws. WITHHOLDING ON DISTRIBUTIONS TO FOREIGN INVESTORS - ------------------------------------------------- Dividend distributions (including distributions derived from short-term capital gains) are in general subject to a U.S. withholding tax of 31% when paid to a nonresident alien individual, foreign estate or trust, a foreign corporation, or a foreign partnership ("foreign shareholder"). Persons who are resident in a country, such as the U.K., that has an income tax treaty with the U.S. may be eligible for a reduced withholding rate (upon filing of appropriate forms), and are urged to consult their tax advisors regarding the applicability and effect of such a treaty. Distributions of net long-term capital gains to a foreign shareholder, and any gain realized upon the sale of Fund shares by such a shareholder will ordinarily not be subject to U.S. taxation, unless the recipient or seller is a nonresident alien individual who is present in the United States for more than 182 days during the taxable year. However, foreign shareholders with respect to whom income from the Fund is "effectively connected" with a U.S. trade or business carried on by such shareholder will in general be subject to U.S. federal income tax on the income derived from the Fund at the graduated rates applicable to U.S. citizens, residents or domestic corporations, whether received in cash or reinvested in shares, and, in the case of a foreign corporation, may also be subject to a branch profits tax. Again, foreign shareholders who are resident in a country with an income tax treaty with the United States may obtain different tax results, and are urged to consult their tax advisors. FOREIGN TAX CREDITS - ------------------- If, at the end of the fiscal year, more than 50% of the total assets of the Fund is represented by stock of foreign corporations, the Fund intends to make an election allows shareholders whose income from the Fund is subject to U.S. taxation at the graduated rates applicable to U.S. citizens, residents or domestic corporations to claim a foreign tax credit or deduction (but not both) on their U.S. income tax return. In such case, the amounts of foreign income taxes paid by the Fund would be treated as additional income to Fund shareholders from non-U.S. sources and as foreign taxes paid by Fund shareholders. Investors should consult their tax advisors for further information relating to the foreign tax credit and deduction, which are subject to certain restrictions and limitations. Shareholders of the Fund whose income from the Fund is not subject to U.S. taxation at the graduated rates applicable to U.S. citizens, residents or domestic corporations may receive substantially different tax treatment of distributions by the Fund, and may be disadvantaged as a result of the election described in this paragraph. LOSS OF REGULATED INVESTMENT COMPANY STATUS - ------------------------------------------- The Fund may experience particular difficulty qualifying as a regulated investment company in the case of highly unusual market movements, in the case of high redemption levels and/or during the first year of its operations. If the Fund does not qualify for taxation as a regulated investment company for any taxable year, the Fund's income will be taxed at the Fund level at regular corporate rates, and all distributions from earnings and profits, including distributions of net long-term capital gains, will be taxable to shareholders as ordinary income and subject to withholding in the case of non-U.S. shareholders. In addition, in order to requalify for taxation as a regulated investment company, the Fund may be required to recognize unrealized gains, pay taxes on such gains, and make certain distributions. MANAGEMENT OF THE TRUST ----------------------- The Fund is advised and managed by Grantham, Mayo, Van Otterloo & Co. LLC, 40 Rowes Wharf, Boston, Massachusetts 02110 (the "Manager" or "GMO") which provides investment advisory services to a substantial number of institutional and other investors and to the other 29 GMO Funds. Each of the following four general partners holds a greater than 5% interest in the Manager: R. Jeremy Grantham, Richard A. Mayo, Eyk H.A. Van Otterloo and Kingsley Durant. -19- Under a Management Contract with the Trust, the Manager selects and reviews the Fund's investments and provides executive and other personnel for the management of the Trust. Pursuant to the Trust's Agreement and Declaration of Trust, the Board of Trustees supervises the affairs of the Trust as conducted by the Manager. In the event that the Manager ceases to be the manager of the Fund, the right of the Trust to use the identifying name "GMO" may be withdrawn. The Management Contract provides for payment to the Manager of a management fee at the stated annual rate set forth under Schedule of Fees and Expenses. The Management Fee is computed and accrued daily, and paid monthly. The Manager has voluntarily agreed to waive its fee and to bear certain expenses until further notice in order to limit each Fund's annual expenses to specified limits (with certain exclusions). These limits and the terms applicable to them are described under Schedule of Fees and Expenses. Eyk H. A. Van Otterloo is primarily responsible for the day-to-day management of the Fund. Mr. Van Otterloo has served as a member of GMO for more than 15 years. Pursuant to an Administrative Services Agreement with GMO, Investors Bank & Trust Company provides administrative services to the Fund. GMO pays Investors Bank & Trust Company an annual fee for its services to the Fund. Pursuant to a Servicing Agreement with the Trust on behalf of each class of shares of the Fund, Grantham, Mayo, Van Otterloo & Co. LLC, in its capacity as the Trust's shareholder servicer (the "Shareholder Servicer") provides direct client service, maintenance and reporting to shareholders of each class of shares. Such servicing and reporting services include, without limitation, professional and informative reporting, client account information, personal and electronic access to Fund information, access to analysis and explanations of Fund reports, and assistance in the correction and maintenance of client-related information. ORGANIZATION AND CAPITALIZATION ------------------------------- OF THE TRUST ------------ The Trust was established on June 24, 1985 as a business trust under Massachusetts law. The Trust has an unlimited authorized number of shares of beneficial interest which may, without shareholder approval, be divided into an unlimited number of series of such shares, and which are presently divided into thirty series of shares: one for the Fund and one for each of the other 29 GMO Funds. All shares of all series are entitled to vote at any meetings of shareholders. The Trust does not generally hold annual meetings of shareholders and will do so only when required by law. All shares entitle their holders to one vote per share. Matters submitted to shareholder vote must be approved by each GMO Fund separately except (i) when required by the 1940 Act shares shall be voted together as a single class and (ii) when the Trustees have determined that the matter does not affect a particular GMO Fund, then only shareholders of the GMO Fund(s) affected shall be entitled to vote on the matter. Shareholders of a particular class of shares do not have separate class voting rights except with respect to matters that affect only that class of shares or as otherwise required by law. Shares are freely transferable, are entitled to dividends as declared by the Trustees, and, in liquidation of the Trust, are entitled to receive the net assets of their GMO Fund, but not of any other GMO Fund. Shareholders holding a majority of the outstanding shares of all series may remove Trustees from office by votes cast in person or by proxy at a meeting of shareholders or by written consent. Shareholders could, under certain circumstances, be held personally liable for the obligations of the Trust. However, the risk of a shareholder incurring financial loss on account of that liability is considered remote since it may arise only in very limited circumstances. -20- ================================================================================ SHAREHOLDER INQUIRIES --------------------- Shareholders may direct inquiries regarding CLASS III Shares to Grantham, Mayo, Van Otterloo & Co. LLC, 40 Rowes Wharf, Boston, MA 02110 (1-617-330-7500) Shareholders may direct inquiries regarding CLASS I or CLASS II Shares to GMO Funds Division, 40 Rowes Wharf, Boston, MA 02110 (1-617-790-5000) ================================================================================ -21- GMO GLOBAL PROPERTIES FUND STATEMENT OF ADDITIONAL INFORMATION December 20, 1996 This Statement of Additional Information is not a prospectus. This Statement of Additional Information relates to the Private Placement Memorandum dated December 20, 1996, as amended from time to time and should be read in conjunction therewith. A copy of the Private Placement Memorandum may be obtained from GMO Trust, 40 Rowes Wharf, Boston, Massachusetts 02110. Table of Contents ----------------- Caption Page ------- ---- INVESTMENT OBJECTIVES AND POLICIES...........................................1 INVESTMENT RESTRICTIONS......................................................1 INCOME, DIVIDENDS, DISTRIBUTIONS AND TAX STATUS..............................4 MANAGEMENT OF THE TRUST......................................................6 INVESTMENT ADVISORY AND OTHER SERVICES.......................................7 PORTFOLIO TRANSACTIONS.......................................................9 DESCRIPTION OF THE TRUST AND OWNERSHIP OF SHARES............................10 FINANCIAL STATEMENTS .......................................................14 -i- INVESTMENT OBJECTIVES AND POLICIES The investment objective and policies of the Fund are described in the Private Placement Memorandum. Unless otherwise indicated in the Private Placement Memorandum or this Statement of Additional Information, the investment objective and policies of the Fund may be changed without shareholder approval. INVESTMENT RESTRICTIONS Without a vote of the majority of the outstanding voting securities of the Fund, the Trust will not take any of the following actions with respect to the Fund: (1) Borrow money except under the following circumstances: (i) The Fund may borrow money from banks so long as after such a transaction, the total assets (including the amount borrowed) less liabilities other than debt obligations, represent at least 300% of outstanding debt obligations; (ii) The Fund may also borrow amounts equal to an additional 5% of its total assets without regard to the foregoing limitation for temporary purposes, such as for the clearance and settlement of portfolio transactions and to meet shareholder redemption requests; (iii) The Fund may enter into transactions that are technically borrowings under the 1940 Act because they involve the sale of a security coupled with an agreement to repurchase that security (e.g., reverse repurchase agreements, dollar rolls and other similar investment techniques) without regard to the asset coverage restriction described in (i) above, so long as and to the extent that the Fund establishes a segregated account with its custodian in which it maintains cash and/or high grade debt securities equal in value to its obligations in respect of these transactions. Under current pronouncements of the Securities and Exchange Commission and its staff such transactions are not treated as senior securities so long as and to the extent that the Fund establishes a segregated account with its custodian in which it maintains liquid assets, such as cash, U.S. Government securities or other appropriate high grade debt securities equal in value to its obligations in respect of these transactions. (2) Purchase securities on margin, except such short-term credits as may be necessary for the clearance of purchases and sales of securities. (For this purpose, the deposit or payment of initial or variation margin in connection with futures contracts or related options transactions is not considered the purchase of a security on margin.) (3) Make short sales of securities or maintain a short position for the Fund's account unless at all times when a short position is open the Fund owns an equal amount of such securities or owns securities which, without payment of any further consideration, are convertible into or exchangeable for securities of the same issue as, and equal in amount to, the securities sold short. (4) Underwrite securities issued by other persons except to the extent that, in connection with the disposition of its portfolio investments, it may be deemed to be an underwriter under federal securities laws. (5) Purchase or sell real estate, although it may purchase securities of issuers which deal in real estate, including securities of real estate investment trusts, and may purchase securities which are secured by interests in real estate. (6) Make loans, except by purchase of debt obligations or by entering into repurchase agreements or through the lending of the Fund's portfolio securities. Loans of portfolio securities may be made with respect to up to 100% of the Fund's total assets. (7) Invest in securities of any issuer if, to the knowledge of the Trust, officers and Trustees of the Trust and officers and partners of Grantham, Mayo, Van Otterloo & Co. LLC (the "Manager") who beneficially own more than 1/2 of 1% of the securities of that issuer together beneficially own more than 5%. (8) Concentrate more than 25% of the value of its total assets in any one industry (except that, as described in the Private Placement Memorandum, the Fund may invest more than 25% of its assets in real estate-related securities). (9) Purchase or sell commodities or commodity contracts, except that the Fund may purchase and sell financial futures contracts and options thereon. (10) Issue senior securities, as defined in the 1940 Act and as amplified by rules, regulations and pronouncements of the SEC. The SEC has concluded that even though reverse repurchase agreements, firm commitment agreements and standby commitment agreements fall within the functional meaning of the term "evidence of indebtedness", the issue of compliance with Section 18 of the 1940 Act will not be raised with the SEC by the Division of Investment Management if a Fund covers such securities by maintaining certain "segregated accounts." Similarly, so long as such segregated accounts are maintained, the issue of compliance with Section 18 will not be raised with respect to any of the following: any swap contract or contract for differences; any pledge or encumbrance of assets permitted by non-fundamental policy (f) below; any borrowing permitted by restriction 1 above; any collateral arrangements with respect to initial and variational margin permitted by non-fundamental policy (f) below; and the purchase or sale of options, forward contracts, futures contracts or options on futures contracts. -2- Notwithstanding the latitude permitted by Restrictions 1, 3, and 5 above and non- fundamental policy (f) below, the Fund has no current intention of (a) borrowing money (other than temporary borrowings to meet redemption requests or to settle securities transactions) or (b) entering into short sales. It is contrary to the present policy of the Fund, which may be changed by the Trustees without shareholder approval, to: (a) Invest in warrants or rights excluding options (other than warrants or rights acquired by the Fund as a part of a unit or attached to securities at the time of purchase), except that the Fund may invest in such warrants or rights so long as the aggregate value thereof (taken at the lower of cost or market) does not exceed 5% of the value of the Fund's total net assets; provided that within this 5%, not more than 2% of its net assets may be invested in warrants that are not listed on the New York or American Stock Exchange or a recognized foreign exchange. (b) Invest in securities of an issuer, which, together with any predecessors or controlling persons, has been in operation for less than three consecutive years if, as a result, the aggregate of such investments would exceed 5% of the value of the Fund's net assets; except that this restriction shall not apply to any obligation of the U.S. Government or its instrumentalities or agencies. (c) Buy or sell oil, gas or other mineral leases, rights or royalty contracts. (d) Make investments for the purpose of gaining control of a company's management. (e) Invest more than 15% of net assets (or such lower percentage permitted by the states in which shares are eligible for sale) in illiquid securities. The securities currently thought to be included as "illiquid securities" are restricted securities under the Federal securities laws (including illiquid securities traded under Rule 144A), repurchase agreements and securities that are not readily marketable. To the extent the Trustees determine that restricted securities traded under Rule 144A are in fact liquid, they will not be included in the 15% limit on investment in illiquid securities. (f) Pledge, hypothecate, mortgage or otherwise encumber its assets in excess of 331/3% of the Fund's total assets (taken at cost). (For the purposes of this restriction, collateral arrangements with respect to swap agreements, the writing of options, stock index, interest rate, currency or other futures, options on futures contracts and collateral arrangements with respect to initial and variation margin are not deemed to be a pledge or other encumbrance of assets. The deposit of securities or cash or cash -3- equivalents in escrow in connection with the writing of covered call or put options, respectively is not deemed to be a pledge or encumbrance.) Except as indicated above in Restriction No. 1, all percentage limitations on investments set forth herein and in the Private Placement Memorandum will apply at the time of the making of an investment and shall not be considered violated unless an excess or deficiency occurs or exists immediately after and as a result of such investment. The phrase "shareholder approval," as used in the Private Placement Memorandum, and the phrase "vote of a majority of the outstanding voting securities," as used herein with respect to the Fund, means the affirmative vote of the lesser of (1) more than 50% of the outstanding shares of the Fund, or (2) 67% or more of the shares of the Fund present at a meeting if more than 50% of the outstanding shares are represented at the meeting in person or by proxy. INCOME, DIVIDENDS, DISTRIBUTIONS AND TAX STATUS The Fund intends to qualify each year as a regulated investment company under Subchapter M of the Internal Revenue Code of 1986, as amended (the "Code"). So long as a Fund qualifies for treatment as a regulated investment company, the Fund will not be subject to federal income tax on income paid to its shareholders in the form of dividends or capital gain distributions. The tax status of the Fund and the distributions which it may make are summarized in the Private Placement Memorandum under the heading "Taxes." The Fund intends to pay out substantially all of its ordinary income and net short-term capital gains, and to distribute substantially all of its net capital gain, if any, after giving effect to any available capital loss carryover. Net capital gain is the excess of net long-term capital gain over net short-term capital loss. It is the policy of the Fund to make distributions sufficient to avoid the imposition of a 4% excise tax on certain undistributed amounts. The recognition of certain losses upon the sale of shares of the Fund may be limited to the extent shareholders dispose of shares of one Fund and invest in shares of the same or another Fund. The Fund's transactions in options, futures contracts, hedging transactions, forward contracts, straddles and foreign currencies may accelerate income, defer losses, cause adjustments in the holding periods of the Fund's securities and convert short-term capital gains or losses into long-term capital gains or losses. Qualification segments noted above may restrict the Fund's ability to engage in these transactions, and these transactions may affect the amount, timing and character of distributions to shareholders. Investment by the Fund in certain "passive foreign investment companies" could subject the Fund to a U.S. federal income tax or other charge on distributions received from or -4- the sale of its investment in such a company, which tax cannot be eliminated by making distributions to Fund shareholders. However, the Fund may elect to treat a passive foreign investment company as a "qualified electing fund," or elect the mark-to-market election under proposed regulation 1.1291-8, which may have the effect of accelerating the recognition of income (without the receipt of cash) and increase the amount required to be distributed for the Fund to avoid taxation. Making either of these elections may therefore require the Fund to liquidate other investments to meet its distribution requirement, which may also accelerate the recognition of gain and affect the Fund's total return. In general, all dividends derived from ordinary income and short-term capital gain are taxable to investors as ordinary income (subject to special rules concerning the extent of the dividends received deduction for corporations) and long-term capital gain distributions are taxable to investors as long-term capital gains, whether such dividends or distributions are received in shares or cash. Tax exempt organizations or entities will generally not be subject to federal income tax on dividends or distributions from the Fund, except certain organizations or entities, including private foundations, social clubs, and others, which may be subject to tax on dividends or capital gains. Each organization or entity should review its own circumstances and the federal tax treatment of its income. The dividends-received deduction for corporations will generally apply to the Fund's dividends paid from investment income to the extent derived from dividends received by the Fund from domestic corporations. The Fund is subject to foreign withholding taxes on income and gains derived from foreign investments. Such taxes would reduce the yield on the Fund's investments, but, as discussed in the Private Placement Memorandum, may be taken as either a deduction or a credit by U.S. citizens and corporations if the Fund makes the election described in the Private Placement Memorandum. -5- MANAGEMENT OF THE TRUST The Trustees and officers of the Trust and their principal occupations during the past five years are as follows: R. Jeremy Grantham*. President-Domestic Quantitative and Trustee of the Trust. Partner, Grantham, Mayo, Van Otterloo & Co. Harvey R. Margolis. Trustee of the Trust. Mathematics Professor, Boston College. Eyk del Mol Van Otterloo. President-International of the Trust. Partner, Grantham, Mayo, Van Otterloo & Co. Jay O. Light. Trustee of the Trust. Professor of Business Administration, Harvard University; Senior Associate Dean, Harvard University (1988- 1992). Richard Mayo. President-Domestic Active of the Trust. Partner, Grantham, Mayo, Van Otterloo & Co. Kingsley Durant. Vice President, Treasurer and Secretary of the Trust. Partner, Grantham, Mayo, Van Otterloo & Co. Susan Randall Harbert. Secretary and Assistant Treasurer of the Trust. Partner, Grantham, Mayo, Van Otterloo & Co. William R. Royer, Esq.. Clerk of the Trust. General Counsel, Grantham, Mayo, Van Otterloo & Co. (January, 1995 - Present). Associate, Ropes & Gray, Boston, Massachusetts (September, 1992 - January, 1995). Margaret McGetrick. Secretary of the Trust. Partner, Grantham, Mayo, Van Otterloo & Co. Jui Lai. Secretary of the Trust. Partner, Grantham, Mayo, Van Otterloo & Co. Ann Spruill. Secretary of the Trust. Partner, Grantham, Mayo, Van Otterloo & Co. *Trustee is deemed to be an "interested person" of the Trust and the Manager, as defined by the 1940 Act. -6- The mailing address of each of the officers and Trustees is c/o GMO Trust, 40 Rowes Wharf, Boston, Massachusetts 02110. The Trustees and officers of the Trust as a group own less than 1% of any class of outstanding shares of the Trust. Except as stated above, the principal occupations of the officers and Trustees for the last five years have been with the employers as shown above, although in some cases they have held different positions with such employers. Other than as set forth in the table below, no Trustee or officer of the Trust receives any direct compensation from the Trust or any series thereof: NAME OF PERSON, TOTAL ANNUAL COMPENSATION POSITION FROM THE TRUST Harvey R. Margolis, Trustee $40,000 Jay O. Light, Trustee $40,000 Messrs. Grantham, Mayo, Van Otterloo and Durant, and Mses. Harbert, McGetrick, Lai and Spruill, as partners of the Manager, will benefit from the management fees paid by the Fund. INVESTMENT ADVISORY AND OTHER SERVICES Management Contracts - -------------------- As disclosed in the Private Placement Memorandum under the heading "Management of the Fund," under separate Management Contracts (each a "Management Contract") between the Trust and Grantham, Mayo, Van Otterloo & Co. (the "Manager"), subject to such policies as the Trustees of the Trust may determine, the Manager will furnish continuously an investment program for each Fund and will make investment decisions on behalf of the Fund and place all orders for the purchase and sale of portfolio securities. Subject to the control of the Trustees, the Manager also manages, supervises and conducts the other affairs and business of the Trust, furnishes office space and equipment, provides bookkeeping and certain clerical services and pays all salaries, fees and expenses of officers and Trustees of the Trust who are affiliated with the Manager. As indicated under "Portfolio Transactions --Brokerage and Research Services," the Trust's portfolio transactions may be placed with broker-dealers which furnish the Manager, at no cost, certain research, statistical and quotation services of value to the Manager in advising the Trust or its other clients. As is disclosed in the Private Placement Memorandum, the Manager's compensation will be reduced to the extent that the Fund's annual expenses incurred in the operation of the Fund (including the management fee but excluding Shareholder Service Fees, brokerage -7- commissions and other investment-related costs, hedging transaction fees, extraordinary, non-recurring and certain other unusual expenses (including taxes), securities lending fees and expenses and transfer taxes would exceed the percentage of the Fund's average daily net assets described therein. Because the Manager's compensation is fixed at an annual rate equal to this expense limitation, it is expected that the Manager will pay such expenses (with the exceptions noted) as they arise. In addition, the Manager's compensation under the Management Contract is subject to reduction to the extent that in any year the expenses of the Fund exceed the limits on investment company expenses imposed by any statute or regulatory authority of any jurisdiction in which shares of the Fund are qualified for offer and sale. The term "expenses" is defined in the statutes or regulations of such jurisdictions, and, generally speaking, excludes brokerage commissions, taxes, interest and extraordinary expenses. The Fund is not currently subject to any state imposed limit on expenses. The Management Contract provides that the Manager shall not be subject to any liability in connection with the performance of its services thereunder in the absence of willful misfeasance, bad faith, gross negligence or reckless disregard of its obligations and duties. The Management Contract was approved by the Trustees of the Trust (including a majority of the Trustees who are not "interested persons" of the Manager) and by the Fund's sole shareholder in connection with the organization of the Trust and the establishment of the Fund. The Management Contract will continue in effect for a period more than two years from the date of its execution only so long as its continuance is approved at least annually by (i) vote, cast in person at a meeting called for that purpose, of a majority of those Trustees who are not "interested persons" of the Manager or the Trust, and by (ii) the majority vote of either the full Board of Trustees or the vote of a majority of the outstanding shares of the Fund. The Management Contract automatically terminates on assignment, and is terminable on not more than 60 days' notice by the Trust to the Manager. In addition, the Management Contract may be terminated on not more than 60 days' written notice by the Manager to the Trust. Custodial Arrangements. Brown Brothers Harriman & Co. ("BBH"), 40 Water Street, Boston, Massachusetts 02109 serves as the Trust's custodian on behalf of the Fund. As such, BBH holds in safekeeping certificated securities and cash belonging to the Fund and, in such capacity, is the registered owner of securities in book-entry form belonging to the Fund. Upon instruction, BBH receives and delivers cash and securities of the Fund in connection with Fund transactions and collects all dividends and other distributions made with respect to Fund portfolio securities. BBH also maintains certain accounts and records of the Trust and calculates the total net asset value, total net income and net asset value per share of the Fund on a daily basis. The Manager has voluntarily agreed with the Trust to reduce its management fees and to bear certain expenses with respect to the Fund until further notice to the extent that the Fund's total annual operating expenses (excluding Shareholder Service Fees, brokerage commissions and other investment-related costs, hedging transaction fees, extraordinary, non-recurring and certain other unusual expenses (including taxes), securities -8- lending fees and expenses and transfer taxes would otherwise exceed the percentage of the Fund's daily net assets specified in the Private Placement Memorandum ("Schedule of Fees and Expenses"). Therefore so long as the Manager agrees so to reduce its fee and bear certain expenses, total annual operating expenses (subject to such exclusions) of the Fund will not exceed this stated limitation. Absent such agreement by the Manager to waive its fees, management fees for the Fund and the annual operating expenses for the Fund would be as stated in the Private Placement Memorandum. Shareholder Service Arrangements. As disclosed in the Private Placement Memorandum, pursuant to the terms of a single Servicing Agreement with each Fund of the Trust, Grantham, Mayo, Van Otterloo & Co. provides direct client service, maintenance and reporting to shareholders of the Funds. The Servicing Agreement was approved by the Trustees of the Trust (including a majority of the Trustees who are not "interested persons" of the Manager or the Trust). The Servicing Agreement will continue in effect for a period more than one year from the date of its execution only so long as its continuance is approved at least annually by (i) vote, cast in person at a meeting called for the purpose, of a majority of those Trustees who are not "interested persons" of the Manager or the Trust, and by (ii) the majority vote of the full Board of Trustees. The Servicing Agreement automatically terminates on assignment (except as specifically provided in the Servicing Agreement) and is terminable by either party upon not more than 60 days written notice to the other party. Independent Accountants. The Trust's independent accountants are Price Waterhouse LLP, 160 Federal Street, Boston, Massachusetts 02110. Price Waterhouse LLP conducts annual audits of the Trust's financial statements, assists in the preparation of each Fund's federal and state income tax returns, consults with the Trust as to matters of accounting and federal and state income taxation and provides assistance in connection with the preparation of various Securities and Exchange Commission filings. PORTFOLIO TRANSACTIONS The purchase and sale of portfolio securities for the Fund and for the other investment advisory clients of the Manager are made by the Manager with a view to achieving their respective investment objectives. For example, a particular security may be bought or sold for certain clients of the Manager even though it could have been bought or sold for other clients at the same time. Likewise, a particular security may be bought for one or more clients when one or more other clients are selling the security. In some instances, therefore, one client may sell indirectly a particular security to another client. It also happens that two or more clients may simultaneously buy or sell the same security, in which event purchases or sales are effected on a pro rata, rotating or other equitable basis so as to avoid any one account's being preferred over any other account. -9- Transactions involving the issuance of Fund shares for securities or assets other than cash, will be limited to a bona fide reorganization or statutory merger and to other acquisitions of portfolio securities that meet all of the following conditions: (a) such securities meet the investment objectives and policies of the Fund; (b) such securities are acquired for investment and not for resale; (c) such securities are liquid securities which are not restricted as to transfer either by law or liquidity of market; and (d) such securities have a value which is readily ascertainable as evidenced by a listing on the American Stock Exchange, the New York Stock Exchange, NASDAQ or a recognized foreign exchange. Brokerage and Research Services. In placing orders for the portfolio transactions of the Fund, the Manager will seek the best price and execution available, except to the extent it may be permitted to pay higher brokerage commissions for brokerage and research services as described below. The determination of what may constitute best price and execution by a broker-dealer in effecting a securities transaction involves a number of considerations, including, without limitation, the overall net economic result to the Fund (involving price paid or received and any commissions and other costs paid), the efficiency with which the transaction is effected, the ability to effect the transaction at all where a large block is involved, availability of the broker to stand ready to execute possibly difficult transactions in the future and the financial strength and stability of the broker. Because of such factors, a broker-dealer effecting a transaction may be paid a commission higher than that charged by another broker-dealer. Most of the foregoing are judgmental considerations. Over-the-counter transactions often involve dealers acting for their own account. Although the Manager does not consider the receipt of research services as a factor in selecting brokers to effect portfolio transactions for the Fund, the Manager will receive such services from brokers who are expected to handle a substantial amount of the portfolio transactions of each Fund of the Trust. Research services may include a wide variety of analyses, reviews and reports on such matters as economic and political developments, industries, companies, securities and portfolio strategy. The Manager uses such research in servicing other clients as well as the Fund. As permitted by Section 28(e) of the Securities Exchange Act of 1934 and subject to such policies as the Trustees of the Trust may determine, the Manager may pay an unaffiliated broker or dealer that provides "brokerage and research services" (as defined in the Act) to the Manager an amount of commission for effecting a portfolio investment transaction in excess of the amount of commission another broker or dealer would have charged for effecting that transaction. DESCRIPTION OF THE TRUST AND OWNERSHIP OF SHARES The Trust is organized as a Massachusetts business trust under the laws of Massachusetts by an Agreement and Declaration of Trust ("Declaration of Trust") dated June -10- 24, 1985. A copy of the Declaration of Trust is on file with the Secretary of The Commonwealth of Massachusetts. The fiscal year for the Fund ends on February 28. Pursuant to the Declaration of Trust, the Trustees have currently authorized the issuance of an unlimited number of full and fractional shares of thirty series: the Core Fund; the Value Fund; the Growth Fund; the Pelican Fund; the Short-Term Income Fund; the Small Cap Value Fund; the Fundamental Value Fund, the Tobacco-Free Core Fund; the U.S. Sector Fund; the Small Cap Growth Fund; the International Core Fund; the Japan Fund; the International Bond Fund; the Emerging Markets Fund; the Global Properties Fund; the Emerging Country Debt Fund; the Domestic Bond Fund; the Currency Hedged International Bond Fund; the Global Hedged Equity Fund; the Currency Hedged International Core Fund; the International Small Companies Fund; the REIT Fund; the Global Bond Fund; the Inflation Indexed Bond Fund; the Foreign Fund; the Global Fund; the International Equity Allocation Fund; the World Equity Allocation Fund; the Global (U.S.+) Equity Allocation Fund and the Global Balanced Allocation Fund. Interests in each portfolio (Fund) are represented by shares of the corresponding series. Each share of each series represents an equal proportionate interest, together with each other share, in the corresponding Fund. The shares of such series do not have any preemptive rights. Upon liquidation of a Fund, shareholders of the corresponding series are entitled to share pro rata in the net assets of the Fund available for distribution to shareholders. The Declaration of Trust also permits the Trustees to charge shareholders directly for custodial and transfer agency expenses, but there is no present intention to make such charges. The Declaration of Trust also permits the Trustees, without shareholder approval, to subdivide any series of shares into various sub-series or classes of shares with such dividend preferences and other rights as the Trustees may designate. This power is intended to allow the Trustees to provide for an equitable allocation of the impact of any future regulatory requirements which might affect various classes of shareholders differently. The Trustees have currently authorized the establishment and designation of up to six classes of shares for each series of the Trust (except for the Pelican Fund): Class I Shares, Class II Shares, Class III Shares, Class IV Shares, Class V Shares and Class VI Shares. The Trustees may also, without shareholder approval, establish one or more additional separate portfolios for investments in the Trust or merge two or more existing portfolios (i.e., a new fund). Shareholders' investments in such a portfolio would be evidenced by a separate series of shares. The Declaration of Trust provides for the perpetual existence of the Trust. The Trust, however, may be terminated at any time by vote of at least two-thirds of the outstanding shares of the Trust. While the Declaration of Trust further provides that the Trustees may also terminate the Trust upon written notice to the shareholders, the 1940 Act requires that the Trust receive the authorization of a majority of its outstanding shares in order to change the nature of its business so as to cease to be an investment company. -11- Voting Rights - ------------- As summarized in the Private Placement Memorandum, shareholders are entitled to one vote for each full share held (with fractional votes for fractional shares held) and will vote (to the extent provided herein) in the election of Trustees and the termination of the Trust and on other matters submitted to the vote of shareholders. Shareholders vote by individual Fund on all matters except (i) when required by the Investment Company Act of 1940, shares shall be voted in the aggregate and not by individual Fund, and (ii) when the Trustees have determined that the matter affects only the interests of one or more Funds, then only shareholders of such affected Funds shall be entitled to vote thereon. Shareholders of one Fund shall not be entitled to vote on matters exclusively affecting another Fund, such matters including, without limitation, the adoption of or change in the investment objectives, policies or restrictions of the other Fund and the approval of the investment advisory contracts of the other Fund. Shareholders of a particular class of shares do not have separate class voting rights except with respect to matters that affect only that class of shares and as otherwise required by law. There will normally be no meetings of shareholders for the purpose of electing Trustees except that in accordance with the 1940 Act (i) the Trust will hold a shareholders' meeting for the election of Trustees at such time as less than a majority of the Trustees holding office have been elected by shareholders, and (ii) if, as a result of a vacancy in the Board of Trustees, less than two-thirds of the Trustees holding office have been elected by the shareholders, that vacancy may only be filled by a vote of the shareholders. In addition, Trustees may be removed from office by a written consent signed by the holders of two-thirds of the outstanding shares and filed with the Trust's custodian or by a vote of the holders of two-thirds of the outstanding shares at a meeting duly called for the purpose, which meeting shall be held upon the written request of the holders of not less than 10% of the outstanding shares. Upon written request by the holders of at least 1% of the outstanding shares stating that such shareholders wish to communicate with the other shareholders for the purpose of obtaining the signatures necessary to demand a meeting to consider removal of a Trustee, the Trust has undertaken to provide a list of shareholders or to disseminate appropriate materials (at the expense of the requesting shareholders). Except as set forth above, the Trustees shall continue to hold office and may appoint successor Trustees. Voting rights are not cumulative. No amendment may be made to the Declaration of Trust without the affirmative vote of a majority of the outstanding shares of the Trust except (i) to change the Trust's name or to cure technical problems in the Declaration of Trust and (ii) to establish, designate or modify new and existing series or sub-series of Trust shares or other provisions relating to Trust shares in response to applicable laws or regulations. Shareholder and Trustee Liability - --------------------------------- Under Massachusetts law, shareholders could, under certain circumstances, be held personally liable for the obligations of the Trust. However, the Declaration of Trust disclaims -12- shareholder liability for acts or obligations of the Trust and requires that notice of such disclaimer be given in each agreement, obligation, or instrument entered into or executed by the Trust or the Trustees. The Declaration of Trust provides for indemnification out of all the property of the relevant Fund for all loss and expense of any shareholder of that Fund held personally liable for the obligations of the Trust. Thus, the risk of a shareholder incurring financial loss on account of shareholder liability is considered remote since it is limited to circumstances in which the disclaimer is inoperative and the Fund of which he is or was a shareholder would be unable to meet its obligations. The Declaration of Trust further provides that the Trustees will not be liable for errors of judgment or mistakes of fact or law. However, nothing in the Declaration of Trust protects a Trustee against any liability to which the Trustee would otherwise be subject by reason of willful misfeasance, bad faith, gross negligence, or reckless disregard of the duties involved in the conduct of his office. The By-laws of the Trust provide for indemnification by the Trust of the Trustees and the officers of the Trust except with respect to any matter as to which any such person did not act in good faith in the reasonable belief that his action was in or not opposed to the best interests of the Trust. Such person may not be indemnified against any liability to the Trust or the Trust shareholders to which he would otherwise be subject by reason of willful misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in the conduct of his office. -13- FINANCIAL STATEMENTS The Trust's audited financial statements for the fiscal year ended February 29, 1996 included in the Trust's Annual Reports filed with the Securities and Exchange Commission on May 7, 1996 pursuant to Section 30(d) of the Investment Company Act of 1940, as amended, and the rules promulgated thereunder, are hereby incorporated in this Statement of Additional Information by reference. The Trust's unaudited financial statements for the six month period ended August 31, 1996 included in the Trust's Semi-Annual Reports filed with the Securities and Exchange Commission on November 8, 1996 pursuant to Section 30(d) of the Investment Company Act of 1940, as amended, and the rules promulgated thereunder, are also hereby incorporated in this Statement of Additional Information by reference. The Trustees of the Trust have approved, effective December 1, 1996, a change in the name of the Core II Secondaries Fund to the GMO Small Cap Value Fund. -14- GMO TRUST PART C. OTHER INFORMATION Item 24. Financial Statements and Exhibits (a) Financial Statements: See "Financial Statements" in the Statement of Additional Information. The Financial Statements required pursuant to Item 23 of Form N-1A are hereby incorporated by reference to the Annual Reports and Semi-Annual Reports to shareholders previously filed with the Commission by means of EDGAR pursuant to the requirements of Section 30(d) of the 1940 Act and the rules promulgated thereunder. (b) Exhibits 1. Amended and Restated Agreement and Declaration of Trust -- Exhibit 1. 2. Amended and Restated By-laws of the Trust -- Exhibit 2. 3. None. 4. Not Applicable. 5. (a) Form of Management Contracts between the Trust, on behalf of each of its GMO Core Fund, GMO Currency Hedged International Bond Fund, GMO International Core Fund, GMO Growth Fund (formerly "GMO Growth Allocation Fund"), Pelican Fund, GMO Value Fund (formerly "GMO Value Allocation Fund"), GMO International Small Companies Fund, GMO Japan Fund, GMO Short-Term Income Fund, GMO Small Cap Value Fund (formerly "GMO Core II Secondaries Fund"), GMO Fundamental Value Fund, GMO Tobacco-Free Core Fund, GMO U.S. Sector Fund (formerly "GMO U.S. Sector Allocation Fund"), GMO International Bond Fund, GMO Emerging Country Debt Fund, GMO Emerging Markets Fund, GMO Domestic Bond Fund, GMO Global Hedged Equity Fund and GMO Currency Hedged International Core Fund, and Grantham, Mayo, Van Otterloo & Co. ("GMO")1; (b) Form of Consulting Agreement (sub-advisory agreement) between GMO, on behalf of its GMO Emerging Markets Fund, and Dancing Elephant, Ltd.1; (c) Form of Management Contract between the Trust, on behalf of each of its GMO REIT Fund, GMO Global Bond Fund, GMO Foreign Fund, GMO International Equity Allocation Fund, GMO Global (U.S.+) Equity Allocation Fund, GMO World Equity Allocation Fund, GMO Global Balanced Allocation Fund, GMO Global Fund, GMO Small Cap Growth Fund and GMO Inflation Indexed Bond Fund, and GMO2; (d) Form of Management Contract between the Trust, on behalf of the GMO Global Properties Fund, and Grantham, Mayo, Van Otterloo & Co. LLC ("GMO LLC") - Exhibit 5. 6. None. 7. None. 8. (a) Custodian Agreement (the "IBT Custodian Agreement") among the Trust, on behalf of its GMO Core Fund, GMO Currency Hedged International Bond Fund (formerly "GMO SAF Core Fund"), GMO Value Fund (formerly "GMO Value Allocation Fund"), GMO Growth Fund (formerly "GMO Growth Allocation Fund"), and GMO Short-Term Income Fund, GMO and Investors Bank & Trust Company ("IBT")1; (b) Custodian Agreement ("BBH Custodian Agreement") among the Trust, on behalf of its GMO International Core Fund and GMO Japan Fund, GMO and Brown Brothers Harriman & Co. ("BBH")1; (c) Custodian Agreement ("State Street Custodian Agreement") among the Trust, on behalf of its Pelican Fund, GMO and State Street Bank and Trust Company ("State Street")1; (d) Forms of Letter Agreements with respect to the IBT Custodian Agreement among the Trust, on behalf of its GMO Tobacco-Free Core Fund, GMO Fundamental Value Fund, GMO U.S. Sector Fund (formerly "GMO U.S. Sector Allocation Fund"), GMO International Bond Fund, GMO Small Cap Value Fund (formerly "GMO Core II Secondaries Fund"), GMO Emerging Country Debt Fund, GMO Domestic Bond Fund, GMO Currency Hedged International Core Fund, GMO and IBT1; (e) Forms of Letter Agreements with respect to the BBH Custodian Agreement among the Trust, on behalf of its GMO Emerging Markets Fund, GMO Global Hedged Equity Fund and GMO International Small Companies Fund, GMO and BBH1; -2- (f) Forms of Letter Agreements with respect to the IBT Custodian Agreement among the Trust, on behalf of its GMO REIT Fund, GMO Global Bond Fund, GMO International Equity Allocation Fund, GMO Global (U.S.+) Equity Allocation Fund, GMO World Equity Allocation Fund, GMO Global Balanced Allocation Fund, GMO Small Cap Growth Fund and Inflation Indexed Bond Fund, GMO and IBT2; (g) Forms of Letter Agreements with respect to the BBH Custodian Agreement among the Trust, on behalf of its GMO Foreign Fund, GMO Global Fund (formerly "GMO Global Active Fund"), GMO and BBH2. (h) Form of Letter Agreement with respect to the BBH Custodian Agreement among the Trust, on behalf of its GMO Global Properties Fund, GMO LLC and BBH - Exhibit 8. 9. (a) Transfer Agency Agreement among the Trust, on behalf of its GMO Core Fund, GMO Currency Hedged International Bond Fund, GMO Growth Fund (formerly "GMO Growth Allocation Fund"), GMO Value Fund (formerly "GMO Growth Allocation Fund"), GMO Short-Term Income Fund, GMO International Core Fund and GMO Japan Fund, GMO and IBT1; (b) Forms of Letter Agreements to the Transfer Agency Agreement among the Trust, on behalf of each of its GMO Fundamental Value Fund, GMO Tobacco-Free Core Fund, GMO U.S. Sector Fund, GMO International Bond Fund, GMO Emerging Markets Fund, GMO Emerging Country Debt Fund, GMO Domestic Bond Fund, GMO Global Hedged Equity Fund, GMO Small Cap Value Fund (formerly "GMO Core II Secondaries Fund"), GMO International Small Companies Fund, Pelican Fund and GMO Currency Hedged International Core Fund, GMO and IBT1; (c) Forms of Letter Agreements to the Transfer Agency Agreement among the Trust, on behalf of each of its GMO REIT Fund, GMO Global Bond Fund, GMO Foreign Fund, GMO International Equity Allocation Fund, GMO Global (U.S.+) Equity Allocation Fund, GMO World Equity Allocation Fund, GMO Global Balanced Allocation Fund, GMO Global Fund, GMO Small Cap Growth Fund and GMO Inflation Indexed Bond Fund, GMO and IBT2; (d) Form of Letter Agreement to the Transfer Agency Agreement among the Trust, on behalf of its GMO Global Properties Fund, GMO LLC and IBT -- Exhibit 9.1. -3- (e) Form of Notification of Fee Waiver and Expense Limitation by GMO LLC to the Trust relating to all Funds of the Trust -- Exhibit 9.2. (f) Form of Amended and Restated Servicing Agreement between the Trust, on behalf of the Funds, and GMO LLC -- Exhibit 9.3. 10. (a) Opinion and Consent of Ropes & Gray with respect to all Funds of the Trust (except with respect to the GMO REIT Fund, GMO Foreign Fund, GMO International Equity Allocation Fund, GMO World Equity Allocation Fund, GMO Global (U.S.+) Equity Allocation Fund, GMO Global Balanced Allocation Fund, GMO Global Fund, GMO Small Cap Growth Fund, GMO Inflation Indexed Bond Fund and GMO Global Properties Fund)2; (b) Opinion and Consent of Ropes & Gray with respect to the GMO REIT Fund, GMO Foreign Fund, GMO International Equity Allocation Fund, GMO Global (U.S.+) Equity Allocation Fund, GMO World Equity Allocation Fund, GMO Global Balanced Allocation Fund, GMO Global Active Fund, GMO Small Cap Growth Fund, GMO Inflation Indexed Bond Fund and GMO Global Properties Fund (to be filed with Rule 24f-2 Notice). 11. Consent of Price Waterhouse LLP -- Exhibit 11. 12. None. 13. None. 14. Prototype Retirement Plans1. 15. None. 16. Not Applicable. 17. Financial Data Schedule -- Exhibit 17. 18. Form of Rule 18f-3 Multiclass Plan2. Item 25. Persons Controlled by or Under Common Control with Registrant None. -4- Item 26. Number of Holders of Securities The following table sets forth the number of record holders of each class of securities of the Trust as of January 2, 1997: (1) (2) Number of Title of Class Record Holders -------------- -------------- Shares of Beneficial Interest Core Fund Class I - 3 Class II - 2 Class III - 246 Shares of Beneficial Interest Growth Fund Class III - 133 Shares of Beneficial Interest Value Fund Class III - 156 Shares of Beneficial Interest Short-Term Income Fund Class III - 61 Shares of Beneficial Interest International Core Fund Class I - 1 Class II - 2 Class III - 451 Shares of Beneficial Interest Japan Fund Class III - 51 Shares of Beneficial Interest Tobacco-Free Core Fund Class III - 5 -5- Shares of Beneficial Interest Fundamental Value Fund Class III - 14 Shares of Beneficial Interest International Small Companies Fund Class III - 257 Shares of Beneficial Interest Small Cap Value Fund Class III - 142 Shares of Beneficial Interest U.S. Sector Fund Class I - 1 Class III - 10 Shares of Beneficial Interest International Bond Fund Class III - 130 Shares of Beneficial Interest Small Cap Growth Fund Class III - 30 Shares of Beneficial Interest Emerging Markets Fund Class II - 1 Class III - 404 Shares of Beneficial Interest Emerging Country Debt Fund Class I - 6 Class III - 351 Shares of Beneficial Interest Global Hedged Equity Fund Class III - 122 -6- Shares of Beneficial Interest Domestic Bond Fund Class I - 1 Class III - 149 Shares of Beneficial Interest Currency Hedged Int'l Bond Fund Class III - 221 -7- Shares of Beneficial Interest Currency Hedged Int'l Core Fund Class III - 77 Shares of Beneficial Interest Global Bond Fund Class III - 11 Shares of Beneficial Interest REIT Fund Class I - 6 Class III - 101 Shares of Beneficial Interest Foreign Fund Class I - 6 Class II - 1 Class III - 63 Shares of Beneficial Interest International Equity Allocation Fund Class II - 1 Class III - 7 Shares of Beneficial Interest World Equity Allocation Fund Class I - 4 Class III - 4 Shares of Beneficial Interest Global (U.S.+) Equity Allocation Fund Class III - 94 Shares of Beneficial Interest Global Balanced Allocation Fund Class I - 7 Class II - 1 Shares of Beneficial Interest Global Properties Fund Class III - 16 Shares of Beneficial Interest - 997 -8- Pelican Fund (as of 5/31/96) Item 27. Indemnification See Item 27 of Pre-Effective Amendment No. 1 which is hereby incorporated by reference. Item 28. Business and Other Connections of Investment Adviser See Item 28 of Pre-Effective Amendment No. 1 which is hereby incorporated by reference. Item 29. Principal Underwriters Not Applicable. Item 30. Location of Accounts and Records See Item 30 of Pre-Effective Amendment No. 1 which is hereby incorporated by reference. Item 31. Management Services Not Applicable. Item 32. Undertakings (a) See Item 33 of Post-Effective Amendment No. 1 which is hereby incorporated by reference. (b) See Item 33 of Post-Effective Amendment No. 1 which is hereby incorporated by reference. (c) Registrant hereby undertakes to furnish each person to whom a prospectus is delivered with a copy of the Registrant's latest annual report to shareholders containing the information required by Item 5A of Form N-1A omitted from the Prospectus, upon request and without charge. - ---------------- -9- 1 = Previously manually filed with the Securities and Exchange Commission and incorporated herein by reference. 2 = Previously electronically filed with the Securities and Exchange Commission and incorporated herein by reference. -10- SIGNATURES Pursuant to the requirements of the Investment Company Act of 1940, the Registrant has duly caused this Post-Effective Amendment No. 34 under the Investment Company Act of 1940 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Boston and The Commonwealth of Massachusetts, on the 10th day of January, 1997. GMO Trust By: R. JEREMY GRANTHAM* ------------------------------- R. Jeremy Grantham President - Quantitative; Principal Executive Officer; Title: Trustee Pursuant to the Investment Company Act of 1940, this Post-Effective Amendment No. 34 to the Registration Statement has been signed below by the following persons in the capacities and on the dates indicated. Signatures Title Date - ---------- ----- ---- R. JEREMY GRANTHAM* President - Quantitative; Principal January 10, - ------------------------- Executive Officer; Trustee 1997 R. Jeremy Grantham KINGSLEY DURANT* - ------------------------- Treasurer; Principal Financial and January 10, Kingsley Durant Accounting Officer 1997 HARVEY R. MARGOLIS* Trustee January 10, - ------------------------- 1997 Harvey R. Margolis JAY O. LIGHT* Trustee January 10, - ------------------------- 1997 Jay O. Light * By: /s/ William R. Royer -------------------------- William R. Royer Attorney-in-Fact POWER OF ATTORNEY We, the undersigned officers and trustees of GMO Trust, a Massachusetts business trust, hereby severally constitute and appoint William R. Royer our true and lawful attorney, with full power to him to sign for us, and in our names and in the capacities indicated below, any and all amendments to the Registration Statement filed with the Securities and Exchange Commission for the purpose of registering shares of beneficial interest of GMO Trust, hereby ratifying and confirming our signatures as they may be signed by our said attorneys on said Registration Statement. Witness our hands and common seal on the date set forth below. (Seal) Signature Title Date - --------- ----- ---- President-Domestic; Principal Executive /S/ R. Jeremy Grantham Officer; Trustee March 12, 1996 - -------------------------- R. Jeremy Grantham /S/ Eyk H.A. Van Otterloo President-International March 12, 1996 - -------------------------- Eyk H.A. Van Otterloo /S/ Harvey Margolis Trustee March 12, 1996 - -------------------------- Harvey Margolis Treasurer; Principal Financial and /S/ Kingsley Durant Accounting Officer March 12, 1996 - -------------------------- Kingsley Durant POWER OF ATTORNEY I, the undersigned trustee of GMO Trust, a Massachusetts business trust, hereby constitute and appoint William R. Royer my true and lawful attorney, with full power to him to sign for me, and in my names and in the capacity indicated below, any and all amendments to the Registration Statement filed with the Securities and Exchange Commission for the purpose of registering shares of beneficial interest of GMO Trust, hereby ratifying and confirming my signature as it may be signed by my said attorney on said Registration Statement. Witness my hand and common seal on the date set forth below. (Seal) Signature Title Date - --------- ----- ---- /S/ JAY O. LIGHT Trustee May 23, 1996 - -------------------- Jay O. Light EXHIBIT INDEX GMO TRUST Exhibit No. Title of Exhibit - ----------- ---------------- 1 Form of Amended and Restated Agreement and Declaration of Trust. 2 Form of Amended and Restated By-Laws of the Trust. 5 Form of Management Contract between the Trust, on behalf of the GMO Global Properties Fund, and GMO LLC. 8 Form of Letter Agreement with respect to the BBH Custodian Agreement among the Trust, on behalf of its GMO Global Properties Fund, GMO LLC and BBH 9.1 Form of Letter Agreement to the Transfer Agency Agreement among the Trust, on behalf of its GMO Global Properties Fund, GMO LLC and IBT. 9.2 Form of Notification of Fee Waiver and Expense Limitation by GMO LLC to the Trust relating to all Funds of the Trust. 9.3 Form of Amended and Restated Servicing Agreement between the Trust, on behalf of the Funds, and GMO LLC. 11 Consent of Price Waterhouse LLP. 17 Financial Data Schedule. EX-99.1 2 AGREEMENT AND DECLARATION OF TRUST Exhibit 1 FIRST AMENDED AND RESTATED AGREEMENT AND DECLARATION OF TRUST GMO TRUST THIS FIRST AMENDED AND RESTATED AGREEMENT AND DECLARATION OF TRUST made at Boston, Massachusetts this 20th day of December, 1996 by the Trustees hereunder and the holders of shares of beneficial interest issued hereunder and to be issued hereunder as hereinafter provided: WITNESSETH that WHEREAS the Trustees desire to restate all prior Amendments to the original Agreement and Declaration of Trust made to date and additionally desire to amend and restate this Agreement and Declaration of Trust in connection with the creation of Classes within each Series of the GMO Trust pursuant to the power of the Trustees set forth in Article III, Section 5 of the original Agreement and Declaration of Trust. WHEREAS the Trustees have agreed to manage all property coming into their hands as trustees of a Massachusetts business trust in accordance with the provisions hereinafter set forth. NOW, THEREFORE, the Trustees hereby direct that this First Amended and Restated Agreement and Declaration of Trust be filed with the Secretary of The Commonwealth of Massachusetts and with the City Clerk of the City of Boston and do hereby declare that they will hold all cash, securities and other assets, which they may from time to time acquire in any manner as Trustees hereunder IN TRUST to manage and dispose of the same upon the following terms and conditions for the pro rata benefit of the holders from time to time of Shares in this Trust as hereinafter set forth. ARTICLE I. Name and Definitions Section 1. This Trust shall be known as GMO Trust and the Trustees shall conduct the business of the Trust under that name or any other name as they may from time to time determine. Section 2. Definitions. Whenever used herein, unless otherwise required by the context or specifically provided (a) "Trust" refers to the Massachusetts business trust established by this First Amended and Restated Agreement and Declaration of Trust, as amended from time to time; (b) "Trustees" refers to the Trustees of the Trust named in Article IV hereof or elected in accordance with such Article; (c) "Shares" means the equal proportionate units of interest into which the beneficial interest in the Trust or in the Trust property belonging to any Series of the Trust (or in the property belonging to any Series allocable to any Class of that Series) (as the context may require) shall be divided from time to time; (d) "Shareholder" means a record owner of Shares; (e) "1940 Act" refers to the Investment Company Act of 1940 and the Rules and Regulations thereunder, all as amended from time to time; (f) The terms "Commission" and "principal underwriter" shall have the meanings given to them in the 1940 Act; (g) "Declaration of Trust" shall mean this Agreement and Declaration of Trust, as amended or restated from time to time; (h) "By-Laws" shall mean the By-Laws of the Trust as amended from time to time; (i) "Series Company" refers to the form of registered open-end investment company described in Section 18(f)(2) of the 1940 Act or in any successor statutory provision; (j) "Series" refers to Series of Shares established and designated under or in accordance with the provisions of Article III; and (k) "Class" refers to any Class of Shares established and designated under or in accordance with the provisions of Article III. The Shares of any Class shall represent a subset of Shares of a Series, and together with all other Classes of the same Series, shall constitute all Shares of that Series. ARTICLE II. Purpose of Trust The purpose of the Trust is to provide investors a managed investment primarily in securities (including options), debt instruments, commodities, commodity contracts and options thereon. -2- ARTICLE III. Shares Section 1. Division of Beneficial Interest. The beneficial interest in the Trust shall at all times be divided into an unlimited number of Shares, without par value. Subject to the provisions of Section 6 of this Article III, each Share shall have voting rights as provided in Article V hereof, and holders of the Shares of any Series or Class shall be entitled to receive dividends, when and as declared with respect thereto in the manner provided in Article VI, Section 1 hereof. No Share shall have any priority or preference over any other Share of the same Series and Class with respect to dividends or distributions upon termination of the Trust or of such Series or Class made pursuant to Article VIII, Section 4 hereof. All dividends and distributions shall be made ratably among all Shareholders of a particular Series or Class from the assets belonging to such Series (or, in the case of a Class, allocable to such Class) according to the number of Shares of such Series or Class held of record by such Shareholders on the record date for any dividend or on the date of termination, as the case may be. Shareholders shall have no preemptive or other right to subscribe to any additional Shares or other securities issued by the Trust. The Trust may from time to time divide or combine the Shares of any particular Series or Class into a greater or lesser number of Shares of that Series or Class without thereby changing the proportionate beneficial interest of the Shares of that Series or Class in the assets belonging to that Series (or, in the case of a Class, allocable to such Class) in any way affecting the rights of Shares of any other Series or Class. Section 2. Ownership of Shares. The ownership of Shares shall be recorded on the books of the Trust or a transfer or similar agent for the Trust, which books shall be maintained separately for the Shares of each Series and Class. No certificates certifying the ownership of Shares shall be issued except as the Trustees may otherwise determine from time to time. The Trustees may make such rules as they consider appropriate for the transfer of Shares of each Series and Class and similar matters. The record books of the Trust as kept by the Trust or any transfer or similar agent, as the case may be, shall be conclusive as to who are the Shareholders of each Series and Class and as to the number of Shares of each Series and Class held from time to time by each. Section 3. Investments in the Trust. The Trustees shall accept investments in the Trust from such persons and on such terms and for such consideration as they from time to time authorize. Section 4. Status of Shares and Limitation of Personal Liability. Shares shall be deemed to be personal property giving only the rights provided in this instrument. Every Shareholder by virtue of having become a Shareholder shall be held to have expressly assented and agreed to the terms hereof and to have become a party hereto. The death of a Shareholder during the continuance of the Trust shall not operate to terminate the same nor entitle the representative of any deceased Shareholder to an accounting or to take any action in court or elsewhere -3- against the Trust or the Trustees, but entitles such representative only to the rights of said deceased Shareholder under this Trust. Ownership of Shares shall not entitle the Shareholder to any title in or to the whole or any part of the Trust property or right to call for a partition or division of the same or for an accounting, nor shall the ownership of Shares constitute the Shareholders partners. Neither the Trust nor the Trustees, nor any officer, employee or agent of the Trust shall have any power to bind personally any Shareholders, nor except as specifically provided herein to call upon any Shareholder for the payment of any sum of money or assessment whatsoever other than such as the Shareholder may at any time personally agree to pay. Section 5. Power of Trustees to Change Provisions Relating to Shares. Notwithstanding any other provisions of this Declaration of Trust and without limiting the power of the Trustees to amend the Declaration of Trust as provided elsewhere herein, the Trustees shall have the power to amend this Declaration of Trust, at any time and from time to time, in such manner as the Trustees may determine in their sole discretion, without the need for Shareholder action, so as to add to, delete, replace or otherwise modify any provisions relating to the Shares contained in this Declaration of Trust for the purpose of (i) responding to or complying with any regulations, orders, rulings or interpretations of any governmental agency or any laws, now or hereafter applicable to the Trust, or (ii) designating and establishing Series and Classes in addition to the Series and Classes established in Section 6 of this Article III; provided that before adopting any such amendment without Shareholder approval the Trustees shall determine that it is consistent with the fair and equitable treatment of all Shareholders. The establishment and designation of any Series or Class of Shares in addition to the Series and Classes established and designated in Section 6 of this Article III shall be effective upon the execution by a majority of the then Trustees of an amendment to this Declaration of Trust, taking the form of a complete restatement or otherwise, setting forth such establishment and designation and the relative rights and preferences of such Series or Class, as the case may be, or as otherwise provided in such instrument. Without limiting the generality of the foregoing, the Trustees may, for the above-stated purposes, amend the Declaration of Trust to: (a) create one or more Series or Classes of Shares (in addition to any Series or Classes already existing or otherwise) with such rights and preferences and such eligibility requirements for investment therein as the Trustees shall determine and reclassify any or all outstanding Shares as shares of particular Series or Classes in accordance with such eligibility requirements; (b) amend any of the provisions set forth in paragraphs (a) through (j) of Section 6 of this Article III; (c) combine one or more Series or Classes of Shares into a single Series or Class on such terms and conditions as the Trustees shall determine; -4- (d) change or eliminate any eligibility requirements for investment in Shares of any Series or Class, including without limitation the power to provide for the issue of Shares of any Series or Class in connection with any merger or consolidation of the Trust with another trust or company or any acquisition by the Trust of part or all of the assets of another trust or company; (e) change the designation of any Series or Class of Shares; (f) change the method of allocating dividends among the various Series and Classes of Shares; (g) allocate any specific assets or liabilities of the Trust or any specific items of income or expense of the Trust to one or more Series or Classes of Shares; (h) specifically allocate assets to any or all Series or Classes of Shares or create one or more additional Series or Classes of Shares which are preferred over all other Series or Classes of Shares in respect of assets specifically allocated thereto or any dividends paid by the Trust with respect to any net income, however determined, earned from the investment and reinvestment of any assets so allocated or otherwise and provide for any special voting or other rights with respect to such Series or Classes. Section 6. Establishment and Designation of Series. Without limiting the authority of the Trustees set forth in Section 5, inter alia, to establish and designate any further Series or Classes or to modify the rights and preferences of any Series, each Series set forth on Schedule 3.6 hereto (as may be amended from time to time by the Trustees) shall be, and are hereby, established and designated. In addition, with respect to each such Series, the Class I Shares, Class II Shares, Class III Shares, Class IV Shares, Class V Shares and Class VI Shares, which each such Series may issue from time to time, shall be, and are hereby, established and designated, which Classes shall have the respective rights and preferences as are set forth in Exhibit 3.6 attached hereto as it may be amended from time to time by the Board of Trustees. Shares of each Series (or Class, as the case may be) established in this Section 6 shall have the following relative rights and preferences: (a) Assets belonging to Series. All consideration received by the Trust for the issue or sale of Shares of a particular Series, together with all assets in which such consideration is invested or reinvested, all income, earnings, profits, and proceeds thereof from whatever source derived, including, without limitation, any proceeds derived from the sale, exchange or liquidation of such assets, and any funds or payments derived from any reinvestment of such proceeds in whatever form the same may be, shall irrevocably belong to that Series for all purposes, subject only to the rights of creditors, and shall be so recorded upon the books of -5- account of the Trust. Such consideration, assets, income, earnings, profits and proceeds thereof, from whatever source derived, including, without limitation, any proceeds derived from the sale, exchange or liquidation of such assets, and any funds or payments derived from any reinvestment of such proceeds, in whatever form the same may be, are herein referred to as "assets belonging to" that Series. In the event that there are any assets, income, earnings, profits and proceeds thereof, funds or payments which are not readily identifiable as belonging to any particular Series (collectively "General Assets"), the Trustees shall allocate such General Assets to, between or among any one or more of the Series established and designated from time to time in such manner and on such basis as they, in their sole discretion, deem fair and equitable, and any General Asset so allocated to a particular Series shall belong to that Series. Each such allocation by the Trustees shall be conclusive and binding upon the Shareholders of all Series for all purposes. (b) Liabilities Belonging to Series. The assets belonging to each particular Series shall be charged solely with the liabilities of the Trust in respect to that Series, expenses, costs, charges and reserves attributable to that Series, and any general liabilities of the Trust which are not readily identifiable as belonging to any particular Series but which are allocated and charged by the Trustees to and among any one or more of the Series established and designated from time to time in a manner and on such basis as the Trustees in their sole discretion deem fair and equitable. The liabilities, expenses, costs, charges, and reserves so charged to a Series are herein referred to as "liabilities belonging to" that Series. Each allocation of liabilities, expenses, costs, charges and reserves by the Trustees shall be conclusive and binding upon the holders of all Series for all purposes. (c) Dividends, Distributions, Redemptions, and Repurchases. Notwithstanding any other provisions of this Declaration, including, without limitation, Article VI, no dividend or distribution (including, without limitation, any distribution paid upon termination of the Trust or of any Series or Class) with respect to, nor any redemption or repurchase of, the Shares of any Series shall be effected by the Trust other than from the assets belonging to such Series, nor shall any Shareholder of any particular Series otherwise have any right or claim against the assets belonging to any other Series except to the extent that such Shareholder has such a right or claim hereunder as a Shareholder of such other Series. (d) Voting. Notwithstanding any of the other provisions of this Declaration, including, without limitation, Section 1 of Article V, the Shareholders of any particular Series or Class shall not be entitled to vote on any matters as to which such Series or Class is not affected except as otherwise required by the 1940 Act or other applicable law. On any matter submitted to a vote of Shareholders, all Shares of the Trust then entitled to vote shall be voted by individual Series, unless otherwise required by the 1940 Act or other applicable law. (e) Equality. All the Shares of each particular Class of a Series shall represent an equal proportionate interest in the assets allocable to that Class, and each Share of any particular -6- Series shall be equal to each other Share of that Series (subject to the liabilities allocated to each Class of that Series). (f) Fractions. Any fractional Share of a Series or Class shall carry proportionately all the rights and obligations of a whole share of that Series or Class, including rights with respect to voting, receipt of dividends and distributions, redemption of Shares and termination of the Trust. (g) Exchange Privilege. The Trustees shall have the authority to provide that the holders of Shares of any Series or Class shall have the right to exchange said Shares for Shares of one or more other Series or Class of Shares in accordance with such requirements and procedures as may be established by the Trustees. (h) Combination of Series or Classes. The Trustees shall have the authority, without the approval of the Shareholders of any Series or Class unless otherwise required by applicable law, to combine the assets and liabilities belonging to any two or more Series (or the assets allocable to any two or more Classes) into assets and liabilities belonging (or allocable) to a single Series (or Class). (i) Elimination of Series or Classes. At any time that there are no Shares outstanding of any particular Series or Class previously established and designated, the Trustees may amend this Declaration of Trust to abolish that Series or Class and to rescind the establishment and designation thereof, such amendment to be effected in the manner provided in Section 5 of this Article III. (j) Assets and Liabilities Allocable to a Class. The assets and liabilities belonging to a Series shall be proportionately allocated among all the Classes of that Series according to the percentage of net assets allocated to each particular Class. For purposes of determining the assets and liabilities belonging to a Series that are allocable to a Class of that Series, subject to the provisions of paragraph (g) of Section 5 of this Article III, expenses shall be accrued as set forth in Exhibit 3.6 attached hereto. Section 7. Indemnification of Shareholders. In case any Shareholder or former Shareholder shall be held to be personally liable solely by reason of his or her being or having been a Shareholder of the Trust or of a particular Series and not because of his or her acts or omissions or for some other reason, the Shareholder or former Shareholder (or his or her heirs, executors, administrators or other legal representatives or in the case of a corporation or other entity, its corporate or other general successor) shall be entitled out of the assets of the Series of which he is a Shareholder or former Shareholder to be held harmless from and indemnified against all loss and expense arising from such liability. Section 8. No Preemptive Rights. Shareholders shall have no preemptive or other right to subscribe to any additional Shares or other securities issued by the Trust. -7- The Trustees Section 9. Election and Tenure. The Trustees may fix the number of vacancies arising from an increase in the number of Trustees, or remove Trustees with or without cause. Each Trustee shall serve during the continued lifetime of the Trust until he dies, resigns or is removed, or if sooner, until the next meeting of Shareholders called for the purpose of electing Trustees and until the election and qualification of his successor. Any Trustee may resign at any time by written instrument signed by him and delivered to any officer of the Trust or to a meeting of the Trustees. Such resignation shall be effective upon receipt unless specified to be effective at some other time. Except to the extent expressly provided in a written agreement with the Trust, no Trustee resigning and no Trustee removed shall have any right to any compensation for any period following his resignation or removal, or any right to damages on account of such removal. The Shareholders may fix the number of Trustees and elect Trustees at any meeting of Shareholders called by the Trustees for that purpose. Section 10. Effect of Death, Resignation, etc. of a Trustee. The death, declination, resignation, retirement, removal, or incapacity of the Trustees, or any of them, shall not operate to annul the Trust or to revoke any existing agency created pursuant to the terms of this Declaration of Trust. Section 11. Powers. Subject to the provisions of this Declaration of Trust, the business of the Trust shall be managed by the Trustees, and they shall have all powers necessary or convenient to carry out that responsibility including the power to engage in securities transactions of all kinds on behalf of the Trust. Without limiting the foregoing, the Trustees may adopt By-Laws not inconsistent with this Declaration of Trust providing for the regulation and management of the affairs of the Trust and may amend and repeal them to the extent that such By-Laws do not reserve that right to the Shareholders; they may fill vacancies in or remove from their number (including any vacancies created by an increase in the number of Trustees); they may remove from their number with or without cause; they may elect and remove such officers and appoint and terminate such agents as they consider appropriate; they may appoint from their own number and terminate one or more committees consisting of two or more Trustees which may exercise the powers and authority of the Trustees to the extent that the Trustees determine; they may employ one or more custodians of the assets of the Trust and may authorize such custodians to employ subcustodians and to deposit all or any part of such assets in a system or systems for the central handling of securities or with a Federal Reserve Bank, retain a transfer agent or a shareholder servicing agent, or both, provide for the distribution of Shares by the Trust, through one or more principal underwriters or otherwise, set record dates for the determination of Shareholders with respect to various matters, and in general delegate such authority as they consider desirable to any officer of the Trust, to any committee of the Trustees and to any agent or employee of the Trust or to any such custodian or underwriter. -8- Without limiting the foregoing, the Trustees shall have power and authority: (a) To invest and reinvest cash, and to hold cash uninvested; (b) To sell, exchange, lend, pledge, mortgage, hypothecate, lease, or write options with respect to or otherwise deal in any property rights relating to any or all of the assets of the Trust; (c) To vote or give assent, or exercise any rights of ownership, with respect to stock or other securities or property; and to execute and deliver proxies or powers of attorney to such person or persons as the Trustees shall deem proper, granting to such person or persons such power and discretion with relation to securities or property as the Trustees shall deem proper; (d) To exercise power and rights of subscription or otherwise which in any manner arise out of ownership of securities; (e) To hold any security or property in a form not indicating any trust, whether in bearer, unregistered or other negotiable form, or in its own name or in the name of a custodian or subcustodian or a nominee or nominees or otherwise; (f) To consent to or participate in any plan for the reorganization, consolidation or merger of any corporation or issuer of any security which is held in the Trust; to consent to any contract, lease, mortgage, purchase or sale of property by such corporation or issuer; and to pay calls or subscriptions with respect to any security held in the Trust; (g) To join with other security holders in acting through a committee, depositary, voting trustee or otherwise, and in that connection to deposit any security with, or transfer any security to, any such committee, depositary or trustee, and to delegate to them such power and authority with relation to any security (whether or not so deposited or transferred) as the Trustees shall deem proper and to agree to pay, and to pay, such portion of the expenses and compensation of such committee, depositary or trustee as the Trustees shall deem proper; (h) To compromise, arbitrate or otherwise adjust claims in favor of or against the Trust or any matter in controversy, including but not limited to claims for taxes; (i) To enter into joint ventures, general or limited partnerships and any other combinations or associations; (j) To borrow funds or other property; -9- (k) To endorse or guarantee the payment of any notes or other obligations of any person; to make contracts of guaranty or suretyship, or otherwise assume liability for payment thereof; (l) To purchase and pay for entirely out of Trust property such insurance as they may deem necessary or appropriate for the conduct of the business, including without limitation, insurance policies insuring the assets of the Trust and payment of distributions and principal on its portfolio investments, and insurance policies insuring the Shareholders, Trustees, officers, employees, agents, investment advisers, principal underwriters, or independent contractors of the Trust individually against all claims and liabilities of every nature arising by reason of holding being or having held any such office or position, or by reason of any action alleged to have been taken or omitted by any such person as Trustee, officer, employee, agent, investment adviser, principal underwriter, or independent contractor, including any action taken or omitted that may be determined to constitute negligence, whether or not the Trust would have the power to indemnify such person against liability; and (m) To pay pensions as deemed appropriate by the Trustees and to adopt, establish and carry out pension, profit-sharing, share bonus, share purchase, savings, thrift and other retirement, incentive and benefit plans, trusts and provisions, including the purchasing of life insurance and annuity contracts as a means of providing such retirement and other benefits, for any or all of the Trustees, officers, employees and agents of the Trust. The Trustees shall not in any way be bound or limited by any present or future law or custom in regard to investments by Trustees. The Trustees shall not be required to obtain any court order to deal with any assets of the Trust or take any other action hereunder. Section 12. Payment of Expenses by the Trust. The Trustees are authorized to pay or cause to be paid out of the principal or income of the Trust, or partly out of principal and partly out of income, as they deem fair, all expenses, fees, charges, taxes and liabilities incurred or arising in connection with the Trust, or in connection with the management thereof, including but not limited to, the Trustees' compensation and such expenses and charges for the services of the Trust's officers, employees, investment adviser or manager, principal underwriter, auditor, counsel, custodian, transfer agent, shareholder servicing agent, and such other agents or independent contractors and such other expenses and charges as the Trustees may deem necessary or proper to incur. Section 13. Payment of Expenses by Shareholders. The Trustees shall have the power, as frequently as they may determine, to cause each Shareholder, or each Shareholder of any particular Series or Class, to pay directly, in advance or arrears, for charges of the Trust's custodian or transfer, shareholder servicing or similar agent, an amount fixed from time to time by the Trustees, by setting off such charges due from such Shareholder from declared but unpaid dividends owed such Shareholder and/or by reducing the number of Shares in the -10- account of such Shareholder by that number of full and/or fractional Shares which represents the outstanding amount of such charges due from such Shareholder. Section 14. Ownership of Assets of the Trust. Title to all of the assets of the Trust shall at all times be considered as vested in the Trustees. Section 15. Advisory, Management and Distribution Contracts. Subject to such requirements and restrictions as may be set forth in the By-Laws, the Trustees may, at any time and from time to time, contract for exclusive or nonexclusive advisory and/or management services for the Trust or for any Series with Grantham, Mayo, Van Otterloo & Co. (including any limited liability company, provided that a majority of the beneficial owners of Grantham, Mayo, Van Otterloo & Co. hold a majority of the equity interest in such entity and substantially all business of Grantham, Mayo, Van Otterloo & Co. is assigned thereto) or any other partnership, corporation, trust, association or other organization (the "Manager"); and any such contract may contain such other terms as the Trustees may determine, including, without limitation, authority for a Manager to determine from time to time without prior consultation with the Trustees what investments shall be purchased, held, sold or exchanged and what portion, if any, of the assets of the Trust shall be held uninvested and to make changes in the Trust's investments. The Trustees may also, at any time and from time to time, contract with the Manager or any other partnership, corporation, trust, association or other organization, appointing it exclusive or nonexclusive distributor or principal underwriter for the Shares, every such contract to comply with such requirements and restrictions as may be set forth in the By-Laws; and any such contract may contain such other terms as the Trustees may determine. The fact that: (i) any of the Shareholders, Trustees or officers of the Trust is a shareholder, director, officer, partner, trustee, employee, manager, adviser, principal underwriter, distributor or affiliate or agent of or for any partnership, corporation, trust, association, or other organization, or of or for any parent or affiliate of any organization, with which an advisory or management contract, or principal underwriter's or distributor's contract, or transfer, shareholder servicing or other agency contract may have been or may hereafter be made, or that any such organization, or any parent or affiliate thereof, is a Shareholder or has an interest in the Trust, or that (ii) any corporation, trust, association or other organization with which an advisory or management contract or principal underwriter's or distributor's contract, or transfer, shareholder servicing or other agency contract may have been or may hereafter be made also has an advisory or management contract, or principal underwriter's or distributor's contract, or transfer, shareholder servicing or other agency contract with one or more other corporations, trusts, associations, or other organizations, or has other business or interests, -11- shall not affect the validity of any such contract or disqualify any Shareholder, Trustee or officer of the Trust from voting upon or executing the same or create any liability or accountability to the Trust or its Shareholders. ARTICLE IV. Shareholders' Voting Powers and Meetings Section 1. Voting Powers. The Shareholders shall have power to vote only (i) for the election of Trustees as provided in Article IV, Section 1, (ii) with respect to any amendment of this Declaration of Trust to the extent and as provided in Article VIII, Section 8, (iii) to the same extent as the stockholders of a Massachusetts business corporation as to whether or not a court action, proceeding or claim should or should not be brought or maintained derivatively or as a class action on behalf of the Trust or the Shareholders, (iv) with respect to the termination of the Trust or any Series or Class to the extent and as provided in Article VIII, Section 4, and (v) with respect to such additional matters relating to the Trust as may be required by this Declaration of Trust, the By-Laws or any registration of the Trust with the Commission (or any successor agency) or any state, or as the Trustees may consider necessary or desirable. Each whole Share shall be entitled to one vote as to any matter on which it is entitled to vote and each fractional Share shall be entitled to a proportionate fractional vote. There shall be no cumulative voting in the election of Trustees. Shares may be voted in person or by proxy. A proxy with respect to Shares held in the name of two or more persons shall be valid if executed by any one of them unless at or prior to exercise of the proxy the Trust receives a specific written notice to the contrary from any one of them. A proxy purporting to be executed by or on behalf of a Shareholder shall be deemed valid unless challenged at or prior to its exercise and the burden of proving invalidity shall rest on the challenger. At any time when no Shares of a Series or Class are outstanding the Trustees may exercise all rights of Shareholders of that Series or Class with respect to matters affecting that Series or Class and may with respect to that Series or Class take any action required by law, this Declaration of Trust or the By-Laws to be taken by the Shareholders. Section 2. Voting Power and Meetings. Meetings of the Shareholders may be called by the Trustees for the purpose of electing Trustees as provided in Article IV, Section 1 and for such other purposes as may be prescribed by law, by this Declaration of Trust or by the ByLaws. Meetings of the Shareholders may also be called by the Trustees from time to time for the purpose of taking action upon any other matter deemed by the Trustees to be necessary or desirable. A meeting of Shareholders may be held at any place designated by the Trustees. Written notice of any meeting of Shareholders shall be given or caused to be given by the Trustees by mailing such notice at least seven days before such meeting, postage prepaid, stating the time and place of the meeting, to each Shareholder at the Shareholder's address as it appears on the records of the Trust. Whenever notice of a meeting is required to be given to a Shareholder under this Declaration of Trust or the By-Laws, a written waiver thereof, -12- executed before or after the meeting by such Shareholder or his attorney thereunto authorized and filed with the records of the meeting, shall be deemed equivalent to such notice. Section 3. Quorum and Required Vote. Except when a larger quorum is required by law, by the By-Laws or by this Declaration of Trust, 40% of the Shares entitled to vote shall constitute a quorum at a Shareholders' meeting. When any one Series or Class is to vote separately from any other Shares which are to vote on the same matters as a separate Series or Class, 40% of the Shares of each such Series or Class entitled to vote shall constitute a quorum at a Shareholder's meeting of that Series or Class. Any meeting of Shareholders may be adjourned from time to time by a majority of the votes property cast upon the question, whether or not a quorum is present, and the meeting may be held as adjourned within a reasonable time after the date set for the original meeting without further notice. When a quorum is present at any meeting, a majority of the Shares voted shall decide any questions and a plurality shall elect a Trustee, except when a larger vote is required by any provision of this Declaration of Trust or the By-Laws or by law. If any question on which the Shareholders are entitled to vote would adversely affect the rights of any Series or Class of Shares, the vote of a majority (or such larger vote as is required as aforesaid) of the Shares of such Series or Class which are entitled to vote, voting separately, shall also be required to decide such question. Section 4. Action by Written Consent. Any action taken by Shareholders may be taken without a meeting if Shareholders holding a majority of the Shares entitled to vote on the matter (or such larger proportion thereof as shall be required by any express provision of this Declaration of Trust or by the By-Laws) and holding a majority (or such larger proportion as aforesaid) of the Shares of any Series or Class entitled to vote separately on the matter consent to the action in writing and such written consents are filed with the records of the meetings of Shareholders. Such consent shall be treated for all purposes as a vote taken at a meeting of Shareholders. Section 5. Record Dates. For the purpose of determining the Shareholders of any Series or Class who are entitled to vote or act at any meeting or any adjournment thereof, the Trustees may from time to time fix a time, which shall be not more than 60 days before the date of any meeting of Shareholders, as the record date for determining the Shareholders of such Series or Class having the right to notice of and to vote at such meeting and any adjournment thereof, and in such case only Shareholders of record on such record date shall have such right, notwithstanding any transfer of shares on the books of the Trust after the record date. For the purpose of determining the Shareholders of any Series or Class who are entitled to receive payment of any dividend or of any other distribution, the Trustees may from time to time fix a date, which shall be before the date for the payment of such dividend or such other payment, as the record date for determining the Shareholders of such Series or Class having the right to receive such dividend or distribution. Without fixing a record date the Trustees may for voting and/or distribution purposes close the register or transfer books for one or more Series or Class for all or any part of the period between a record date and a -13- meeting of shareholders or the payment of a distribution. Nothing in this section shall be construed as precluding the Trustees from setting different record dates for different Series or Classes. Section 6. Additional Provisions. The By-Laws may include further provisions for Shareholders' votes and meetings and related matters. ARTICLE V. Net Income, Distributions, and Redemptions and Repurchases Section 1. Distributions of Net Income. The Trustees shall each year, or more frequently if they so determine in their sole discretion, distribute to the Shareholders of each Series or Class, in shares of that Series or Class, cash or otherwise, an amount approximately equal to the net income attributable to the assets belonging to such Series (or the assets allocable to such Class) and may from time to time distribute to the Shareholders of each Series or Class, in shares of that Series, cash or otherwise, such additional amounts, but only from the assets belonging to such Series (or allocable to that Class), as they may authorize. All dividends and distributions on Shares of a particular Series or Class shall be distributed pro rata to the holders of that Series or Class in proportion to the number of Shares of that Series or Class held by such holders and recorded on the books of the Trust at the date and time of record established for that payment or such dividend or distributions. The manner of determining net income, income, asset values, capital gains, expenses, liabilities and reserves of any Series or Class may from time to time be altered as necessary or desirable in the judgment of the Trustees to conform such manner of determination to any other method prescribed or permitted by applicable law. Net income shall be determined by the Trustees or by such person as they may authorize at the times and in the manner provided in the By-Laws. Determinations of net income of any Series or Class and determination of income, asset value, capital gains, expenses, and liabilities made by the Trustees, or by such person as they may authorize, in good faith, shall be binding on all parties concerned. The foregoing sentence shall not be construed to protect any Trustee, officer or agent of the Trust against any liability to the Trust or its security holders to which he would otherwise be subject by reason of willful misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in the conduct of his office. If, for any reason, the net income of any Series or Class determined at any time is a negative amount, the pro rata share of such negative amount allocable to each Shareholder of such Series or Class shall constitute a liability of such Shareholder to that Series or Class which shall be paid out of such Shareholder's account at such times and in such manner as the Trustees may from time to time determine (x) out of the accrued dividend account of such Shareholder, (y) by reducing the number of Shares of that Series or Class in the account of such Shareholder, or (z) otherwise. -14- Section 2. Redemptions and Repurchases. The Trust shall purchase such Shares as are offered by any Shareholder for redemption, upon the presentation of a proper instrument of transfer together with a request directed to the Trust or a person designated by the Trust that the Trust purchase such Shares or in accordance with such other procedures for redemption as the Trustees may from time to time authorize; and the Trust will pay therefor the net asset value thereof, as determined in accordance with the By-Laws, next determined. Payment for said Shares shall be made by the Trust to the Shareholder within seven days after the date on which the request is made. The obligation set forth in this Section 2 is subject to the provision that in the event that any time the New York Stock Exchange is closed for other than weekends or holidays, or if permitted by the rules of the Commission during periods when trading on the Exchange is restricted or during any emergency which makes it impracticable for the Trust to dispose of the investments of the applicable Series or to determine fairly the value of the net assets belonging to such Series (or net assets allocable to such Class) or during any other period permitted by order of the Commission for the protection of investors, such obligations may be suspended or postponed by the Trustees. The Trust may also purchase or repurchase Shares at a price not exceeding the net asset value of such Shares in effect when the purchase or repurchase or any contract to purchase or repurchase is made. The redemption price may in any case or cases be paid wholly or partly in kind if the Trustees determine that such payment is advisable in the interest of the remaining Shareholders of the Series or Class the Shares of which are being redeemed. In making any such payment wholly or partly in kind, the Trust shall, so far as may be practicable, deliver assets which approximate the diversification of all of the assets belonging at the time to the Series (or allocable to the Class) the Shares of which are being redeemed. Subject to the foregoing, the fair value, selection and quantity of securities or other property so paid or delivered as all or part of the redemption price may be determined by or under authority of the Trustees. In no case shall the Trust be liable for any delay of any corporation or other person in transferring securities selected for delivery as all or part of any payment in kind. Section 3. Redemptions at the Option of the Trust. The Trust shall have the right at its option and at any time to redeem Shares of any Shareholder at the net asset value thereof as described in Section 1 of this Article VI: (i) if at such time such Shareholder owns Shares of any Series or Class having an aggregate net asset value of less than an amount determined from time to time by the Trustees; or (ii) to the extent that such Shareholder owns Shares equal to or in excess of a percentage determined from time to time by the Trustees of the outstanding Shares of the Trust or of any Series or Class. ARTICLE VI. Compensation and Limitation of Liability of Trustees Section 1. Compensation. The Trustees as such shall be entitled to reasonable compensation from the Trust; they may fix the amount of their compensation. Nothing herein -15- shall in any way prevent the employment of any Trustee for advisory, management, legal, accounting, investment banking or other services and payment for the same by the Trust. Section 2. Limitation of Liability. The Trustees shall not be responsible or liable in any event for any neglect or wrong-doing of any officer, agent, employee, Manager or principal underwriter of the Trust, nor shall any Trustee be responsible for the act or omission of any other Trustee, but nothing herein contained shall protect any Trustee against any liability to which he would otherwise be subject by reason of willful misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in the conduct of his office. Every note, bond, contract, instrument, certificate or undertaking and every other act or thing whatsoever issued, executed or done by or on behalf of the Trust or the Trustees or any of them in connection with the Trust shall be conclusively deemed to have been issued, executed or done only in or with respect to their or his capacity as Trustees or Trustee, and such Trustees or Trustee shall not be personally liable thereon. ARTICLE VII. Miscellaneous Section 1. Trustees, Shareholders, etc. Not Personally Liable; Notice. All persons extending credit to, contracting with or having any claim against the Trust or any Series or Class shall look only to the assets of the Trust, or, to the extent that the liability of the Trust may have been expressly limited by contract to the assets of a particular Series (or the assets allocable to a particular Class), only to the assets belonging to the relevant Series (or allocable to the relevant Class), for payment under such credit, contract or claim; and neither the Shareholders nor the Trustees, nor any of the Trust's officers, employees or agents, whether past, present or future, shall be personally liable therefor. Nothing in this Declaration of Trust shall protect any Trustee against any liability to which such Trustee would otherwise be subject by reason of willful misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in the conduct of the office of Trustee. Every note, bond, contract, instrument, certificate or undertaking made or issued on behalf of the Trust by the Trustees, by any officers or officer or otherwise shall give notice that this Declaration of Trust is on file with the Secretary of The Commonwealth of Massachusetts and shall recite that the same was executed or made by or on behalf of the Trust or by them as Trustee or Trustees or as officers or officer or otherwise and not individually and that the obligations of such instrument are not binding upon any of them or the shareholders individually but are binding only upon the assets and property of the Trust or upon the assets belonging to the Series (or allocable to the Class) for the benefit of which the Trustees have caused the note, bond, contract, instrument, certificate or undertaking to be made, or issued, and may contain such further recital as he or they may deem appropriate, but -16- the omission of any such recital shall not operate to bind any Trustee or Trustees or officers or officer or Shareholders or any other person individually. Section 2. Trustee's Good Faith Action, Expert Advice, No Bond or Surety. The exercise by the Trustees of their powers and discretions hereunder shall be binding upon everyone interested. A Trustee shall be liable for his own willful misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in the conduct of the office of Trustee, and for nothing else, and shall not be liable for errors of judgment or mistakes of fact or law. The Trustees may take advice of counsel or other experts with respect to the meaning and operation of this Declaration of Trust, and shall be under no liability for any act or omission in accordance with such advice or for failing to follow such advice. The Trustees shall not be required to give any bond as such, nor any surety if a bond is required. Section 3. Liability of Third Persons Dealing with Trustees. No person dealing with the Trustees shall be bound to make any inquiry concerning the validity of any transaction made or to be made by the Trustees or to see to the application of any payments made or property transferred to the Trust or upon its order. Section 4. Termination of Trust or Series or Class. Unless terminated as provided herein, the Trust shall continue without limitation of time. The Trust may be terminated at any time by vote of at least 66-2/3% of the Shares of each Series entitled to vote and voting separately by Series or by the Trustees by written notice to the Shareholders. Any Series may be terminated at any time by vote of at least 66-2/3% of the Shares of that Series or by the Trustees by written notice to the Shareholders of that Series. Any Class may be separately terminated at any time by vote of at least a majority of the Shares of that Class present and voting on the question (a quorum being present) or by the Trustees by written notice to the Shareholders of that Class. Upon termination of the Trust (or any Series or Class, as the case may be), after paying or otherwise providing for all charges, taxes, expenses and liabilities belonging, severally, to each Series or allocable to each Class (or the applicable Series or Classes, as the case may be), whether due or accrued or anticipated as may be determined by the Trustees, the Trust shall in accordance with such procedures as the Trustees consider appropriate reduce the remaining assets belonging, severally, to each Series or allocable to each Class (or the applicable Series or Classes, as the case may be), to distributable form in cash or shares or other securities, or any combination thereof, and distribute the proceeds belonging to each Series or allocable to each Class (or the applicable Series or Classes, as the case may be), to the Shareholders of that Series or Class, as a Series or Class, ratably according to the number of Shares of that Series or Class held by the several Shareholders on the date of termination. Section 5. Merger and Consolidation. The Trustees may cause the Trust to be merged into or consolidated with another trust or company or its shares exchanged under or pursuant to any state or federal statute, if any, or otherwise to the extent permitted by law, if such merger -17- or consolidation or share exchange has been authorized by vote of a majority of the outstanding Shares; provided that in all respects not governed by statute or applicable law, the Trustees shall have power to prescribe the procedure necessary or appropriate to accomplish a sale of assets, merger or consolidation. Section 6. Filing of Copies, References, Headings. The original or a copy of this instrument and of each amendment hereto shall be kept at the office of the Trust where it may be inspected by any Shareholder. A copy of this instrument and of each amendment hereto shall be filed by the Trust with the Secretary of The Commonwealth of Massachusetts and with any other governmental office where such filing may from time to time be required. Anyone dealing with the Trust may rely on a certificate by an officer of the Trust as to whether or not any such amendments have been made and as to any matters in connection with the Trust hereunder; and, with the same effect as if it were the original, may rely on a copy certified by an officer of the Trust to be a copy of this instrument or of any such amendments. In this instrument and in any such amendment, references to this instrument, and all expressions like "herein", "hereof" and "hereunder", shall be deemed to refer to this instrument as amended or affected by any such amendments. Headings are placed herein for convenience of reference only and shall not be taken as a part hereof or control or affect the meaning, construction or effect of this instrument. This instrument may be executed in any number of counterparts each of which shall be deemed an original. Section 7. Applicable Law. This Declaration of Trust is made in The Commonwealth of Massachusetts, and it is created under and is to be governed by and construed and administered according to the laws of said Commonwealth. The Trust shall be of the type commonly called a Massachusetts business trust, and without limiting the provisions hereof, the Trust may exercise all powers which are ordinarily exercised by such a trust. Section 8. Amendments. This Declaration of Trust may be amended at any time by an instrument in writing signed by a majority of the then Trustees when authorized so to do by vote of a majority of the Shares entitled to vote, except that amendments described in Article III, Section 5 hereof or having the purpose of changing the name of the Trust or of supplying any omission, curing any ambiguity or curing, correcting or supplementing any defective or inconsistent provision contained herein shall not require authorization by Shareholder vote. -18- IN WITNESS WHEREOF, all of the Trustees as aforesaid do hereto set their hands this 20th day of December, 1996. /s/ R. Jeremy Grantham --------------------------- R. Jeremy Grantham /s/ Jay O. Light --------------------------- Jay O. Light --------------------------- Harvey R. Margolis -19- EXHIBIT 3.6 GMO TRUST Plan pursuant to Rule 18f-3 under the Investment Company Act of 1940 Effective June 1, 1996 This Plan (the "Plan") is adopted by GMO Trust (the "Trust") pursuant to Rule 18f-3 under the Investment Company Act of 1940 (the "Act") and sets forth the general characteristics of, and the general conditions under which the Trust may offer, multiple classes of shares of its now existing and hereafter created portfolios ("Funds"). This Plan may be revised or amended from time to time as provided below. CLASS DESIGNATIONS Each Fund of the Trust may from time to time issue one or more of the following classes of shares: Class I Shares, Class II Shares, Class III Shares, Class IV Shares, Class V Shares and Class VI Shares. Each of the classes of shares of any Fund will represent interests in the same portfolio of investments and, except as described herein, shall have the same rights and obligations as each other class. Each class shall be subject to such investment minimums and other conditions of eligibility as are set forth in the Trust's prospectus or statement of additional information as from time to time in effect (the "Prospectus"). CLASS ELIGIBILITY Class eligibility is generally dependent on the size of the client's total account under the management of Grantham, Mayo, Van Otterloo & Co., the Trust's investment adviser (referred to herein as "GMO" or the "Adviser"), as described from time to time in the Prospectus. Eligibility for Class I, Class II and Class III Shares in dependent on the size of a client's minimum "Total Investment" with GMO. For clients that have accounts with GMO as of May 31, 1996, their initial Total Investment will equal the market value of all of their investments advised by GMO as of the close of business on May 31, 1996. For clients establishing a relationship with GMO on or after June 1, 1996, their Total Investment at any date is equal to the aggregate of all amounts contributed (and less amounts withdrawn) to any Fund on or after June 1, 1996, plus the market value of any non-mutual fund investment with GMO as of the month-end prior to the date that "Total Investment" is being computed. For purposes of class eligibility, market appreciation or depreciation of a Fund's account is not considered; the Total Investment of a client is impacted only by the amount of contributions to and withdrawals from Funds made by the client. It is assumed that any Fund redemptions or withdrawals made by a client are satisfied first from market appreciation in their shares, so that a redemption or withdrawal does not lower a client's Total Investment unless the -20- redemption or withdrawal exceeds the value of market appreciation. Market value of non- mutual fund accounts at GMO will be considered, however. Eligibility for Class IV, Class V and Class VI Shares is dependent upon the client meeting either (i) a minimum "Total Fund Investment" requirement which includes only a client's total investment in the particular Fund, or (ii) a minimum "Total Investment" requirement (calculated as described above for Class I, II and III shares). A client's Total Fund Investment and Total Investment will be determined similarly to the determination of Total Investment for purposes of eligibility for Class I, Class II and Class III Shares, i.e., appreciation and depreciation of mutual fund shares is not considered but these two calculations do include the market value of all such accounts as of May 31, 1996, and the market value of non-mutual fund accounts as of the month-end prior to determination. CLASS CHARACTERISTICS The differences among the various classes of shares are solely (i) the level of shareholder service fee ("Shareholder Service Fee") borne by the class for client and shareholder service, reporting and other support, and (ii) whether GMO itself or the GMO Funds Division provides service and reporting to the shareholders. The multiple class structure reflects the fact that, as the size of the client relationship increases, the cost to service that relationship is expected to decrease as a percentage of the account. Thus, the Shareholder Service Fee is lower for classes for which eligibility criteria generally require greater assets under GMO's management. Certain Funds are subject to either an initial purchase premium, a redemption fee, or both. The initial purchase premium and redemption fee, if any, may, in some limited cases, be subject to reduction or waiver if the Adviser determines that there are minimal brokerage and/or transaction costs incurred as a result of the purchase or redemption, as set forth in the Prospectus in effect from time to time.1 - -------- 1 All purchase premiums are paid to and retained by the relevant Fund and are intended to cover the brokerage and other costs associated with putting an investment to work in the relevant markets. All redemption fees are paid to and retained by the relevant Fund and are designed to allocate transaction costs caused by shareholder activity to the shareholder generating the activity. -21- ALLOCATIONS TO EACH CLASS EXPENSE ALLOCATIONS Shareholder Service Fees payable by the Trust to the shareholder servicer of the Trust's shares (the "Shareholder Servicer") shall be allocated, to the extent practicable, on a class-by-class basis. Subject to the approval of the Trust's Board of Trustees, including a majority of the independent Trustees, the following "Class Expenses" may (if such expense is properly assessable at the class level) in the future be allocated on a class-by-class basis: (a) transfer agency costs attributable to each class, (b) printing and postage expenses related to preparing and distributing materials such as shareholder reports, prospectuses and proxy statements to current shareholders of a specific Class, (c) SEC registration fees incurred with respect to a specific class, (d) blue sky and foreign registration fees and expenses incurred with respect to a specific class, (e) the expenses of administrative personnel and services required to support shareholders of a specific class (including, but not limited to, maintaining telephone lines and personnel to answer shareholder inquiries about their accounts or about the Trust), (f) litigation and other legal expenses relating to a specific class of shares, (g) Trustees' fees or expenses incurred as a result of issues relating to a specific class of shares, (h) accounting and consulting expenses relating to a specific class of shares, (i) any fees imposed pursuant to a non-Rule 12b-1 shareholder service plan that relate to a specific class of shares, and (j) any additional expenses, not including advisory or custodial fees or other expenses related to the management of the Trust's assets, if these expenses are actually incurred in a different amount with respect to a class, or if services are provided with respect to a class, or if services are provided with respect to a class that are of a different kind or to a different degree than with respect to one or more other classes. All expenses not now or hereafter designated as Class Expenses ("Fund Expenses") will be allocated to each class on the basis of the net asset value of that class in relation to the net asset value of the relevant Fund. However, notwithstanding the above, a Fund may allocate all expenses other than Class Expenses on the basis of relative net assets (settled shares), as permitted by rule 18f-3(c)(2) under the Act. WAIVERS AND REIMBURSEMENTS The Adviser and the Shareholder Servicer may choose to waive or reimburse Shareholder Service Fees, or any other Class Expenses on a voluntary or temporary basis. -22- INCOME, GAINS AND LOSSES Income and realized and unrealized capital gains and losses shall be allocated to each class on the basis of the net asset value of that class in relation to the net asset value of the relevant Fund. Each Fund may allocate income and realized and unrealized capital gains and losses to each share based on relative net assets (i.e. settled shares), as permitted by Rule 18f-3(c)(2) under the Act. CONVERSION AND EXCHANGE FEATURES On July 31 of each year (the "Conversion Date") each client's Total Investment, as previously defined and as described in the Prospectus, will be determined. Based on that determination, the client's shares will be automatically converted to the class of shares (Class I, Class II or Class III Shares) of such Fund with the lowest Shareholder Service Fee which the client would be eligible to purchase based on such Total Investment. Further, if a client makes an investment in a GMO Fund or other product that causes the client to be eligible for a new class of shares, such conversion will be effected within 15 days after the end of the month during which such investment was made. The rules for conversion to and among Class IV, Class V and Class VI Shares are the same, with determinations of a client's Total Fund Investment and Total Investment made according to the same schedule, as described in the Prospectus. Shares of one class will always convert into shares of another class on the basis of the relative net asset value of the two classes, without the imposition of any sales load, fee or other charge. The conversion of a client's investment from one class of shares to another is not a taxable event, and will not result in the realization of gain or loss that may exist in Fund shares held by the client. The client's tax basis in the new class of shares will equal their basis in the old class before conversion. The conversion of shares from one class to another class of shares may be suspended if the opinion of counsel obtained by the Trust that the conversion does not constitute a taxable event under current federal income tax law is no longer available. Certain special rules will be applied by the Adviser with respect to clients who owned shares of the Funds upon the creation of multiple classes on May 31, 1996. First, all clients existing on May 31, 1996 will receive Class III Shares on June 1, 1996 regardless of the size of their GMO investment. Second, the conversion of existing clients to any class of shares with a higher Shareholder Service Fee will not occur until July 31, 1997, based on the client's Total Investment as of such date. Further, existing clients whose Total Investment as of May 31, 1996 is equal to $7 million or more will be eligible to remain invested in Class III Shares (despite the normal $35 million minimum), provided such client makes no subsequent redemptions or withdrawals other than of amounts attributable to market appreciation of their account value as of June 1, 1996. Existing clients whose Total Investment as of May 31, 1996 -23- is less than $7 million but greater than $0 will be eligible to convert to Class II Shares rather than Class I Shares on July 31, 1997, provided that such client makes no subsequent redemptions or withdrawals other than of amounts attributable to market appreciation of their account value as of June 1, 1996. Clients making additional investments prior to June 1, 1997, such that their Total Investment on June 1, 1997 is $35 million or more, will remain eligible for Class III Shares. DIVIDENDS Dividends paid by the Trust with respect to its Class I, Class II, Class III, Class IV, Class V and Class VI Shares, to the extent any dividends are paid, will be calculated in the same manner, at the same time and will be in the same amount, except that any Service Fee payments relating to a class of shares will be borne exclusively by that class and, if applicable, Class Expenses relating to a class shall be borne exclusively by that class. VOTING RIGHTS Each share of the Trust entitles the shareholder of record to one vote. Each class of shares of the Trust will vote separately as a class on matters for which class voting is required under applicable law. RESPONSIBILITIES OF THE TRUSTEES On an ongoing basis, the Trustees will monitor the Trust for the existence of any material conflicts among the interests of the six classes of shares. The Trustees shall further monitor on an ongoing basis the use of waivers or reimbursement of expenses by the Adviser to guard against cross-subsidization between classes. The Trustees, including a majority of the independent Trustees, shall take such action as is reasonably necessary to eliminate any such conflict that may develop. REPORTS TO THE TRUSTEES The Adviser and the Shareholder Servicer will be responsible for reporting any potential or existing conflicts among the six classes of shares to the Trustees. -24- AMENDMENTS The Plan may be amended from time to time in accordance with the provisions and requirements of Rule 18f-3 under the Act. Adopted this ____ day of ___________, 1996 By:________________________ William R. Royer Clerk -25- SCHEDULE 3.6 SERIES - ------ GMO Core Fund GMO Tobacco-Free Core Fund GMO Value Fund GMO Growth Fund GMO U.S. Sector Fund GMO Small Cap Value Fund GMO Fundamental Value Fund GMO REIT Fund GMO Small Cap Growth Fund GMO International Core Fund GMO Currency Hedged International Core Fund GMO Foreign Fund GMO Global Fund GMO International Small Companies Fund GMO Japan Fund GMO Emerging Markets Fund GMO Global Properties Fund GMO Short-Term Income Fund GMO Global Hedged Equity Fund GMO Domestic Bond Fund GMO International Bond Fund GMO Currency Hedged International Bond Fund GMO Global Bond Fund GMO Emerging Country Debt Fund GMO Inflation Indexed Bond Fund GMO International Equity Allocation Fund GMO World Equity Allocation Fund GMO Global (U.S.+) Equity Allocation Fund GMO Global Balanced Allocation Fund Pelican Fund -26- EX-99.2 3 AMENDED AND RESTATED BY-LAWS Exhibit 2 AMENDED AND RESTATED BY-LAWS OF GMO TRUST ARTICLE 1 Agreement and Declaration of Trust and Principal Office 1.1 Agreement and Declaration of Trust. These By-Laws shall be subject to the Agreement and Declaration of Trust, as from time to time in effect (the "Declaration of Trust"), of GMO Trust (the "Trust"), the Massachusetts business trust established by the Declaration of Trust. 1.2 Principal Office of the Trust. The principal office of the Trust shall be located in Boston, Massachusetts. ARTICLE 2 Meetings of Trustees 2.1 Regular Meetings. Regular meetings of the Trustees may be held without call or notice at such places and at such times as the Trustees may from time to time determine, provided that notice of the first regular meeting following any such determination shall be given to absent Trustees. 2.2 Special Meetings. Special meetings of the Trustees may be held, at any time and at any place designated in the call of the meeting, when called by the Chairman of the Board, if any, the President-Domestic or the Treasurer or by two or more Trustees, sufficient notice thereof being given to each Trustee by the Clerk or an Assistant Clerk or by the officer or the Trustees calling the meeting. 2.3 Notice. It shall be sufficient notice to a Trustee of a special meeting to send notice by mail at least forty-eight hours or by telegram at least twenty-four hours before the meeting addressed to the Trustee at his usual or last known business or residence address or to give notice to him in person or by telephone at least twenty-four hours before the meeting. Notice of a meeting need not be given to any Trustee if a written waiver of notice, executed by him before or after the meeting, is filed with the records of the meeting, or to any Trustee who attends the meeting without protesting prior thereto or at its commencement the lack of notice to him. Neither notice of a meeting nor a waiver of a notice need specify the purposes of the meeting. 2.4 Quorum. At any meeting of the Trustees a majority of the Trustees then in office shall constitute a quorum. Any meeting may be adjourned from time to time by a majority of the votes cast upon the question, whether or not a quorum is present, and the meeting may be held as adjourned without further notice. 2.5 Action by Vote. When a quorum is present at any meeting, a majority of Trustees present may take any action, except when a larger vote is expressly required by law, by the Declaration of Trust or by these By-Laws. 2.6 Action by Writing. Except as required by law, any action required or permitted to be taken at any meeting of the Trustees may be taken without a meeting if a majority of the Trustees (or such larger proportion thereof as shall be required by any express provision of the Declaration of Trust or these By-Laws) consent to the action in writing and such written consents are filed with the records of the meetings of Trustees. Such consent shall be treated for all purposes as a vote taken at a meeting of Trustees. 2.7 Presence through Communications Equipment. Except as required by law, the Trustees may participate in a meeting of Trustees by means of a conference telephone or similar communications equipment by means of which all persons participating in the meeting can hear each other at the same time and participation by such means shall constitute presence in person at a meeting. ARTICLE 3 Officers 3.1 Enumeration; Qualification. The officers of the Trust shall be a President-Domestic, a President-International, a Treasurer, a Clerk, and such other officers, if any, as the Trustees from time to time may in their discretion elect. The Trust may also have such agents as the Trustees from time to time may in their discretion appoint. If a Chairman of the Board is elected, he shall be a Trustee and may but need not be a Shareholder; and any other officer may be but none need be a Trustee or Shareholder. Any two or more offices may be held by the same person. 3.2 Election and Tenure. The President-Domestic, the President-International, the Treasurer, the Clerk and such other officers as the Trustees may in their discretion from time to time elect shall each be elected by the Trustees to serve until his successor is elected or qualified, or until he sooner dies, resigns, is removed or becomes disqualified. Each officer shall hold office and each agent shall retain authority at the pleasure of the Trustees. -2- 3.3 Powers. Subject to the other provisions of these By-Laws, in addition to the duties and powers set forth herein and in the Declaration of Trust and in addition to such duties and powers as may be determined by the Trustees, the President-Domestic shall have such duties and powers with respect to the GMO Core Fund, the GMO Growth Fund, the GMO Value Fund, the GMO Small Cap Growth Fund, the GMO Fundamental Value Fund, the GMO Tobacco-Free Core Fund, the Pelican Fund, the GMO Short-Term Income Fund, the GMO U.S. Sector Fund, the GMO Small Cap Value Fund, the GMO Inflation Indexed Bond Fund, the GMO REIT Fund, the GMO Global (U.S.+) Equity Allocation Fund and the GMO Domestic Bond Fund of the Trust as are commonly incident to the President of a Massachusetts business corporation as if each such Fund were organized as a separate Massachusetts business corporation; the President-International shall have such duties and powers with respect to the GMO International Core Fund, the GMO International Small Companies Fund, the GMO International Bond Fund, the GMO Currency Hedged International Bond Fund, the GMO Global Bond Fund, the GMO Japan Fund, the GMO Emerging Markets Fund, the GMO Global Properties Fund, the GMO Currency Hedged International Core Fund, the GMO Foreign Fund, the GMO Emerging Country Debt Fund, the GMO Global Hedged Equity Fund, the GMO International Equity Allocation Fund, the GMO World Equity Allocation Fund, the GMO Global Balanced Allocation Fund and the GMO Global Fund as are commonly incident to the president of a Massachusetts business corporation as if each such Fund were organized as a separate Massachusetts business corporation; and each other officer shall have such duties and powers as are commonly incident to the office occupied by him or her as if the Trust were organized as a Massachusetts business corporation. Notwithstanding any powers granted to the President- International, to the extent required in the particular circumstances, the President-Domestic shall have such powers with respect to the Trust as a whole as are commonly incident to the president of a Massachusetts business corporation as if the Trust were organized as a Massachusetts business corporation. 3.4 Presidents and Vice Presidents. The President-Domestic and the President- International shall each have the duties and powers specified in these By-Laws and shall have such other duties and powers as may be determined by the Trustees. Any Vice Presidents shall have such duties and powers as shall be designated from time to time by the Trustees. 3.5 Chief Executive Officer. The Chief Executive Officer of the Trust shall be the Chairman of the Board, if any, the President-Domestic or such other officer as is designated by the Trustees and shall, subject to the control of the Trustees, have general charge and supervision of the business of the Trust and, unless there is a Chairman of the Board, or except as the Trustees (or the Chairman of the Board if the Trustees do not act) shall otherwise determine, preside at all meetings of the stockholders and of the Trustees. If no such designation is made, the President-Domestic shall be the Chief Executive Officer. -3- 3.6 Chairman of the Board. If a Chairman of the Board of Trustees is elected, he shall have the duties and powers specified in these By-Laws and shall have such other duties and powers as may be determined by the Trustees. The Chairman of the Board shall, unless the Trustees (or the Chairman of the Board if the Trustees do not act) shall otherwise determine, preside at all meetings of the stockholders and of the Trustees. 3.7 Treasurer. The Treasurer shall be the chief financial and accounting officer of the Trust, and shall, subject to the provisions of the Declaration of Trust and to any arrangement made by the Trustees with a custodian, investment adviser or manager or transfer, shareholder servicing or similar agent, be in charge of the valuable papers, books of account and accounting records of the Trust, and shall have such other duties and powers as may be designated from time to time by the Trustees or by the Chief Executive Officer. 3.8 Clerk. The Clerk shall record all proceedings of the Shareholders and the Trustees in books to be kept therefor, which books or a copy thereof shall be kept at the principal office of the Trust. In the absence of the Clerk from any meeting of the Shareholders or Trustees, an assistant Clerk, or if there be none or if he is absent, a temporary clerk chosen at such meeting shall record the proceedings thereof in the aforesaid books. 3.9 Resignations and Removals. Any officer may resign at any time by written instrument signed by him and delivered to the President-Domestic or the Clerk or to a meeting of the Trustees. Such resignation shall be effective upon receipt unless specified to be effective at some other time. The Trustees may remove any officer with or without cause. Except to the extent expressly provided in a written agreement with the Trust, no officer resigning and no officer removed shall have any right to any compensation for any period following his resignation or removal, or any right to damages on account of such removal. ARTICLE 4 Indemnification 4.1 Trustees, Officers, etc. The Trust shall indemnify each of its Trustees and officers (including persons who serve at the Trust's request as directors, officers or trustees of another organization in which the Trust has any interest as a shareholder, creditor or otherwise) (hereinafter referred to as a "Covered Person") against all liabilities and expenses, including but not limited to amounts paid in satisfaction of judgments, in compromise or as fines and penalties, and counsel fees reasonably incurred by any Covered Person in connection with the defense or disposition of any action, suit or other proceedings, whether civil or criminal, before any court or administrative or legislative body, in which such Covered Person may be or may have been involved as a party or otherwise or with which such person may be or may have been threatened, while in office or thereafter, by reason of any alleged act or omission as a Trustee or officer or by reason -4- of his being or having been such a Trustee or officer, except with respect to any matter as to which such Covered Person shall have been finally adjudicated in any such action, suit or other proceeding not to have acted in good faith in the reasonable belief that such Covered Person's action was in the best interest of the Trust and except that no Covered Person shall be indemnified against any liability to the Trust or its Shareholders to which such Covered Person would otherwise be subject by reason of willful misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in the conduct of such Covered Person's office. Expenses, including counsel fees so incurred by any such Covered Person, may be paid from time to time by the Trust in advance of the final disposition of any such action, suit or proceeding on the condition that the amounts so paid shall be repaid to the Trust if it is ultimately determined that indemnification of such expenses is not authorized under this Article. 4.2 Compromise Payment. As to any matter disposed of by a compromise payment by any such Covered Person referred to in Section 4.1 above, pursuant to a consent decree or otherwise, no such indemnification either for said payment or for any other expenses shall be provided unless such compromise shall be approved as in the best interests of the Trust, after notice that it involved such indemnification, (a) by a disinterested majority of the Trustees then in office; or (b) by a majority of the disinterested Trustees then in office; or (c) by any disinterested person or persons to whom the question may be referred by the Trustees, provided that in the case of approval pursuant to clause (b) or (c) there has been obtained an opinion in writing of independent legal counsel to the effect that such Covered Person appears to have acted in good faith in the reasonable belief that his or her action was in the best interests of the Trust and that such indemnification would not protect such person against any liability to the Trust or its Shareholders to which such person would otherwise be subject by reason of willful misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in the conduct of office; or (d) by vote of Shareholders holding a majority of the Shares entitled to vote thereon, exclusive of any Shares beneficially owned by any interested Covered Person. Approval by the Trustees pursuant to clause (a) or (b) or by any disinterested person or persons pursuant to clause (c) of this Section shall not prevent the recovery from any Covered Person of any amount paid to such Covered Person in accordance with any of such clauses as indemnification if such Covered Person is subsequently adjudicated by a court of competent jurisdiction not to have acted in good faith in the reasonable belief that such Covered Person's action was in the best interests of the Trust or to have been liable to the Trust or its Shareholders by reason of willful misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in the conduct of such Covered Person's office. 4.3 Indemnification Not Exclusive. The right of indemnification hereby provided shall not be exclusive of or affect any other rights to which any such Covered Person may be entitled. As used in this Article 4, the term "Covered Person" shall include such person's heirs, executors and administrators; an "interested Covered Person" is one against whom the action, suit or other proceeding in question or another action, suit or other proceeding -5- on the same or similar grounds is then or has been pending; and a "disinterested Trustee" or "disinterested person" is a Trustee or a person against whom none of such actions, suits or other proceedings or another action, suit or other proceeding on the same or similar grounds is then or has been pending. Nothing contained in this Article shall affect any rights to indemnification to which personnel of the Trust, other than Trustees and officers, and other persons may be entitled by contract or otherwise under law, nor the power of the Trust to purchase and maintain liability insurance on behalf of any such person. ARTICLE 5 5.1 General. The Trustees and officers shall render reports at the time and in the manner required by the Declaration of Trust or any applicable law. Officers shall render such additional reports as they may deem desirable or as may from time to time be required by the Trustees. ARTICLE 6 Fiscal Year 6.1 General. Except as from time to time otherwise provided by the Trustees, the initial fiscal year of the Trust shall end on such date as is determined in advance or in arrears. ARTICLE 7 Seal 7.1 General. The seal of the Trust shall consist of a flat-faced die with the word "Massachusetts", together with the name of the Trust and the year of its organization cut or engraved thereon, but, unless otherwise required by the Trustees, the seal shall not be necessary to be placed on, and its absence shall not impair the validity of, any document, instrument or other paper executed and delivered by or on behalf of the Trust. ARTICLE 8 Execution of Papers 8.1 General. Except as the Trustees may generally or in particular cases authorize the execution thereof in some other manner, all checks, notes, drafts and other obligations and all registration statements and amendments thereto and all applications and amendments thereto to the Securities and Exchange Commission shall be signed by the Chairman, if any, the President-Domestic, the President-International, any Vice President or the Treasurer or any of such other officers or agents as shall be designated for that purpose by a vote of the Trustees. -6- ARTICLE 9 Provisions Relating to the Conduct of the Trust's Business 9.1 Certain Definitions. When used herein the following words shall have the following meanings: "Distributor" shall mean any one or more partnerships, corporations, firms or associations which have distributor's or principal underwriter's contracts in effect with the Trust providing that redeemable shares of any class or series issued by the Trust shall be offered and sold by such Distributor. "Adviser" shall mean any partnership, corporation, firm or association which may at the time have an advisory or management contract with the Trust. 9.2 Limitation on Dealings with Officers or Trustees. The Trust will not lend any of its assets to the Distributor or Adviser or to any officer or director of the Distributor or Adviser or any officer or Trustee of the Trust and shall not permit any officer or Trustee or any officer or director of the Distributor or Adviser, to deal for or on behalf of the Trust with himself as principal or agent, or with any partnership, association or corporation in which he has a financial interest; provided that the foregoing provisions shall not prevent (a) officers and Trustees of the Trust or officers and directors of the Distributor or Adviser from buying, holding or selling shares in the Trust or from being partners, officers or directors of or otherwise financially interested in the Distributor or the Adviser; (b) a purchase or sale of securities or other property if such transaction is permitted by or is exempt or exempted from the provisions of the Investment Company Act of 1940 and does not involve any commission or profit to any securities dealer who is, or one or more of whose partners, shareholders, officers or directors is, an officer or Trustee of the Trust or an officer or director of the Distributor or Adviser; (c) employment of legal counsel, registrars, transfer agents, shareholder servicing agents, dividend disbursing agents or custodians who are or any one of which has a partner, shareholder, officer or director who is, an officer or Trustee of the Trust or an officer or director of the Distributor or Adviser if only customary fees are charged for services to the Trust; (d) sharing of statistical, research, legal and management expenses and office hire and expenses with any other investment company in which an officer or Trustee of the Trust or an officer or director of the Distributor or Adviser is an officer or director or otherwise financially interested. 9.3 Limitation on Dealing in Securities of the Trust by Certain Officers, Trustees, Distributor or Adviser. Neither the Distributor nor Adviser, nor any officer or Trustee of the Trust or officer, director or partner of the Distributor or Adviser shall take long or short positions in securities issued by the Trust; provided, however, that: (a) The Distributor may purchase from the Trust and otherwise deal in shares issued by the Trust pursuant to the terms of its contract with the Trust; -7- (b) Any officer or Trustee of the Trust or officer or director or partner of the Distributor or Adviser or any trustee or fiduciary for the benefit of any of them may at any time, or from time to time, purchase from the Trust or from the Distributor shares issued by the Trust at the price available to the public or to such officer, Trustee, director, partner or fiduciary, no such purchase to be in contravention of any applicable state or federal requirement; and (c) The Distributor or the Adviser may at any time, or from time to time, purchase for investment shares issued by the Trust. 9.4 Securities and Cash of the Trust to be Held by Custodian Subject to Certain Terms and Conditions. (a) All securities and cash owned by the Trust shall, as hereinafter provided, be held by or deposited with one or more banks or trust companies having (according to its last published report) not less than $2,000,000 aggregate capital, surplus and undivided profits (any such bank or trust company being hereby designated as "Custodian"), provided such a Custodian can be found ready and willing to act. The Trust may, or may permit any Custodian to, deposit all or any part of the securities owned by any class or series of shares of the Trust in a system for the central handling of securities established by a national securities exchange or national securities association registered with the Securities and Exchange Commission under the Securities Exchange Act of 1934, or such other person as may be permitted by said Commission, including, without limitation, a clearing agency registered under Section 17A of said Securities Exchange Act of 1934, pursuant to which system all securities of any particular class or series of any issue deposited within the system are treated as fungible and may be transferred or pledged by bookkeeping entry, without physical delivery of such securities. (b) The Trust shall enter into a written contract with each Custodian regarding the powers, duties and compensation of such Custodian with respect to the cash and securities of the Trust held by such Custodian. Said contract and all amendments thereto shall be approved by the Trustees. (c) The Trust shall upon the resignation or inability to serve of any Custodian or upon change of any Custodian: (i) in case of such resignation or inability to serve, use its best efforts to obtain a successor Custodian; (ii) require that the cash and securities owned by any class or series of shares of the Trust and in the possession of the resigning or disqualified Custodian be delivered directly to the successor Custodian; and -8- (iii) in the event that no successor Custodian can be found, submit to the shareholders, before permitting delivery of the cash and securities owned by any class or series of shares of the Trust and in the possession of the resigning or disqualified Custodian otherwise than to a successor Custodian, the question whether that class or series shall be liquidated or shall function without a Custodian. 9.5 Determination of Net Asset Value. The Trustees or any officer or officers or agent or agents of the Trust designated from time to time for this purpose by the Trustees shall determine at least once daily the net income and the value of all the assets attributable to any class or series of shares of the Trust on each day upon which the New York Stock Exchange is open for unrestricted trading or at such other times as the Trustees shall, consistent with the 1940 Act and the rules of the Commission, designate. In determining asset values, all securities for which representative market quotations are readily available shall be valued at market value and other securities and assets shall be valued at fair value, all as determined in good faith by the Trustees or an officer or officers or agent or agents, as aforesaid, in accordance with accounting principles generally accepted at the time. Notwithstanding the foregoing, the assets belonging to any class or series of shares of the Trust may, if so authorized by the Trustees, be valued in accordance with the amortized cost method, subject to the power of the Trustees to alter the method for determining asset values. The value of such assets so determined, less total liabilities belonging to that class or series of shares (exclusive of capital stock and surplus) shall be the net asset value until a new asset value is determined by the Trustees or such officers or agents. In determining the net asset value the Trustees or such officers or agents may include in liabilities such reserves for taxes, estimated accrued expenses and contingencies in accordance with accounting principles generally accepted at the time as the Trustees or such officers or agents may in their best judgment deem fair and reasonable under the circumstances. The manner of determining net asset value may from time to time be altered as necessary or desirable in the judgment of the Trustees to conform it to any other method prescribed or permitted by applicable law or regulation. Determinations of net asset value made by the Trustees or such officers or agents in good faith shall be binding on all parties concerned. The foregoing sentence shall not be construed to protect any Trustee, officer or agent of the Trust against any liability to the Trust or its security holders to which he would otherwise be subject by reason of willful misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in the conduct of his office. ARTICLE 10 Amendment to the By-Laws 10.1 General. These By-Laws may be amended or repealed, in whole or in part, by a majority of the Trustees then in office at any meeting of the Trustees. -9- ARTICLE 11 Meetings of Shareholders 11.1 Presence through Communications Equipment. Except as required by law, the Shareholders of the Trust may participate in a meeting of Shareholders by means of a conference telephone or similar communications equipment by means of which all persons participating in the meeting can hear each other at the same time and participation by such means shall constitute presence in person at a meeting. Participation by such means shall be pursuant to reasonable procedures approved by the officers of the Trust in connection with such meeting. -10- EX-99.5 4 MANAGEMENT CONTRACT Exhibit 5 MANAGEMENT CONTRACT Management Contract executed as of December 20, 1996 between GMO TRUST, a Massachusetts business trust (the "Trust") on behalf of its GMO Global Properties Fund (the "Fund"), and GRANTHAM, MAYO, VAN OTTERLOO & CO., a Massachusetts limited liability company (the "Manager"). W I T N E S S E T H: That in consideration of the mutual covenants herein contained, it is agreed as follows: 1. SERVICES TO BE RENDERED BY MANAGER TO THE TRUST. (a) Subject always to the control of the Trustees of the Trust and to such policies as the Trustees may determine, the Manager will, at its expense, (i) furnish continuously an investment program for the Fund and will make investment decisions on behalf of the Fund and place all orders for the purchase and sale of its portfolio securities and (ii) furnish office space and equipment, provide bookkeeping and clerical services (excluding determination of net asset value, shareholder accounting services and the fund accounting services for the Fund being supplied by Investors Bank & Trust Company) and pay all salaries, fees and expenses of officers and Trustees of the Trust who are affiliated with the Manager. In the performance of its duties, the Manager will comply with the provisions of the Agreement and Declaration of Trust and By-laws of the Trust and the Fund's stated investment objective, policies and restrictions. (b) In placing orders for the portfolio transactions of the Fund, the Manager will seek the best price and execution available, except to the extent it may be permitted to pay higher brokerage commissions for brokerage and research services as described below. In using its best efforts to obtain for the Fund the most favorable price and execution available, the Manager shall consider all factors it deems relevant, including, without limitation, the overall net economic result to the Fund (involving price paid or received and any commissions and other costs paid), the efficiency with which the transaction is effected, the ability to effect the transaction at all where a large block is involved, availability of the broker to stand ready to execute possibly difficult transactions in the future and financial strength and stability of the broker. Subject to such policies as the Trustees may determine, the Manager shall not be deemed to have acted unlawfully or to have breached any duty created by this Contract or otherwise solely by reason of its having caused a Fund to pay a broker or dealer that provides brokerage and research services to the Manager an amount of commission for effecting a portfolio investment transaction in excess of the amount of commission another broker or dealer would have charged for effecting that transaction, if the Manager determines in good faith that such amount of commission was reasonable in relation to the value of the brokerage and research services provided by such broker or dealer, viewed in terms of either that particular transaction or the Manager's overall responsibilities with respect to the Trust and to other clients of the Manager as to which the Manager exercises investment discretion. (c) The Manager shall not be obligated under this agreement to pay any expenses of or for the Trust or of or for the Fund not expressly assumed by the Manager pursuant to this Section 1 other than as provided in Section 3. 2. OTHER AGREEMENTS, ETC. It is understood that any of the shareholders, Trustees, officers and employees of the Trust may be a partner, shareholder, director, officer or employee of, or be otherwise interested in, the Manager, and in any person controlled by or under common control with the Manager, and that the Manager and any person controlled by or under common control with the Manager may have an interest in the Trust. It is also understood that the Manager and persons controlled by or under common control with the Manager have and may have advisory, management service, distribution or other contracts with other organizations and persons, and may have other interests and businesses. 3. COMPENSATION TO BE PAID BY THE TRUST TO THE MANAGER. The Fund will pay to the Manager as compensation for the Manager's services rendered, for the facilities furnished and for the expenses borne by the Manager pursuant to Section 1, a fee, computed and paid monthly at the annual rate of 0.75% of the Fund's average daily net asset value. Such average daily net asset value of the Fund shall be determined by taking an average of all of the determinations of such net asset value during such month at the close of business on each business day during such month while this Contract is in effect. Such fee shall be payable for each month within five (5) business days after the end of such month. In the event that expenses of the Fund for any fiscal year should exceed the expense limitation on investment company expenses imposed by any statute or regulatory authority of any jurisdiction in which shares of the Trust are qualified for offer and sale, the compensation due the Manager for such fiscal year shall be reduced by the amount of such excess by a reduction or refund thereof. In the event that the expenses of the Fund exceed any expense limitation which the Manager may, by written notice to the Trust, voluntarily declare to be effective with respect to the Fund, subject to such terms and conditions as the Manager may prescribe in such notice, the compensation due the Manager shall be reduced, and, if necessary, the Manager shall bear the Fund's expenses to the extent required by such expense limitation. -2- If the Manager shall serve for less than the whole of a month, the foregoing compensation shall be prorated. 4. ASSIGNMENT TERMINATES THIS CONTRACT; AMENDMENTS OF THIS CONTRACT. This Contract shall automatically terminate, without the payment of any penalty, in the event of its assignment; and this Contract shall not be amended unless such amendment is approved at a meeting by the affirmative vote of a majority of the outstanding shares of the Fund, and by the vote, cast in person at a meeting called for the purpose of voting on such approval, of a majority of the Trustees of the Trust who are not interested persons of the Trust or of the Manager. 5. EFFECTIVE PERIOD AND TERMINATION OF THIS CONTRACT. This Contract shall become effective upon its execution, and shall remain in full force and effect continuously thereafter (unless terminated automatically as set forth in Section 4) until terminated as follows: (a) Either party hereto may at any time terminate this Contract by not more than sixty days' written notice delivered or mailed by registered mail, postage prepaid, to the other party, or (b) If (i) the Trustees of the Trust or the shareholders by the affirmative vote of a majority of the outstanding shares of the Fund, and (ii) a majority of the Trustees of the Trust who are not interested persons of the Trust or of the Manager, by vote cast in person at a meeting called for the purpose of voting on such approval, do not specifically approve at least annually the continuance of this Contract, then this Contract shall automatically terminate at the close of business on the second anniversary of its execution, or upon the expiration of one year from the effective date of the last such continuance, whichever is later; provided, however, that if the continuance of this Contract is submitted to the shareholders of the Fund for their approval and such shareholders fail to approve such continuance of this Contract as provided herein, the Manager may continue to serve hereunder in a manner consistent with the Investment Company Act of 1940 and the rules and regulations thereunder. Action by the Trust under (a) above may be taken either (i) by vote of a majority of its Trustees, or (ii) by the affirmative vote of a majority of the outstanding shares of the Fund. Termination of this Contract pursuant to this Section 5 shall be without the payment of any penalty. -3- 6. CERTAIN DEFINITIONS. For the purposes of this Contract, the "affirmative vote of a majority of the outstanding shares" of the Fund means the affirmative vote, at a duly called and held meeting of shareholders, (a) of the holders of 67% or more of the shares of the Fund present (in person or by proxy) and entitled to vote at such meeting, if the holders of more than 50% of the outstanding shares of the Fund entitled to vote at such meeting are present in person or by proxy, or (b) of the holders of more than 50% of the outstanding shares of the Fund entitled to vote at such meeting, whichever is less. For the purposes of this Contract, the terms "affiliated person", "control", "interested person" and "assignment" shall have their respective meanings defined in the Investment Company Act of 1940 and the rules and regulations thereunder, subject, however, to such exemptions as may be granted by the Securities and Exchange Commission under said Act; and the phrase "specifically approve at least annually" shall be construed in a manner consistent with the Investment Company Act of 1940 and the rules and regulations thereunder. 7. NONLIABILITY OF MANAGER. In the absence of willful misfeasance, bad faith or gross negligence on the part of the Manager, or reckless disregard of its obligations and duties hereunder, the Manager shall not be subject to any liability to the Trust, or to any shareholder of the Trust, for any act or omission in the course of, or connected with, rendering services hereunder. 8. INITIALS "GMO". The Manager owns the initials "GMO" which may be used by the Trust only with the consent of the Manager. The Manager consents to the use by the Trust of the name "GMO Trust" or any other name embodying the initials "GMO", in such forms as the Manager shall in writing approve, but only on condition and so long as (i) this Contract shall remain in full force and (ii) the Trust shall fully perform, fulfill and comply with all provisions of this Contract expressed herein to be performed, fulfilled or complied with by it. No such name shall be used by the Trust at any time or in any place or for any purposes or under any conditions except as in this section provided. The foregoing authorization by the Manager to the Trust to use said initials as part of a business or name is not exclusive of the right of the Manager itself to use, or to authorize others to use, the same; the Trust acknowledges and agrees that as between the Manager and the Trust, the Manager has the exclusive right so to authorize others to use the same; the Trust acknowledges and agrees that as between the Manager and the Trust, the Manager has the exclusive right so to use, or authorize others to use, said initials and the Trust agrees to take such action as may reasonably be requested by the Manager to give full effect to the provisions of this section (including, without limitation, consenting to such use of said initials). Without limiting the generality of the foregoing, the Trust agrees that, upon any termination of this Contract by either party or upon the violation -4- of any of its provisions by the Trust, the Trust will, at the request of the Manager made within six months after the Manager has knowledge of such termination or violation, use its best efforts to change the name of the Trust so as to eliminate all reference, if any, to the initials "GMO" and will not thereafter transact any business in a name containing the initials "GMO" in any form or combination whatsoever, or designate itself as the same entity as or successor to an entity of such name, or otherwise use the initials "GMO" or any other reference to the Manager. Such covenants on the part of the Trust shall be binding upon it, its trustees, officers, stockholders, creditors and all other persons claiming under or through it. 9. LIMITATION OF LIABILITY OF THE TRUSTEES AND SHAREHOLDERS. A copy of the Agreement and Declaration of Trust of the Trust is on file with the Secretary of The Commonwealth of Massachusetts, and notice is hereby given that this instrument is executed on behalf of the Trustees of the Trust as Trustees and not individually and that the obligations of this instrument are not binding upon any of the Trustees or shareholders individually but are binding only upon the assets and property of the Fund. -5- IN WITNESS WHEREOF, GMO TRUST and GRANTHAM, MAYO, VAN OTTERLOO & CO. LLC have each caused this instrument to be signed in duplicate on its behalf by its duly authorized representative, all as of the day and year first above written. GMO TRUST By_______________________________________ Title: GRANTHAM, MAYO, VAN OTTERLOO & CO. LLC By_______________________________________ Title: -6- EX-99.8 5 CUSTODIAN AGREEMENT Exhibit 8 December ___, 1996 Brown Brothers Harriman & Co. 40 Water Street Boston, MA 02109 Re: Custodian Agreement dated September 1, 1991 by and among GMO Trust, Grantham, Mayo, Van Otterloo & Co. LLC and Brown Brothers Harriman & Co. (the "Agreement") ----------------------------------------------- Ladies and Gentlemen: GMO Trust (the "Trust") hereby notifies you that it has established an additional series of shares, namely, the "GMO Global Properties Fund" (the "New Fund"). The Trust and the Manager (as defined in the Agreement) desire that you serve as custodian of the assets of the New Fund under the terms of the Agreement. If you agree to so serve as custodian for the New Fund, kindly sign and return to the Trust the enclosed counterpart hereof, whereupon the New Fund shall be deemed a "Fund" under the Agreement. This letter agreement shall constitute an amendment to the Agreement and, as such, a binding agreement among the Trust, the Manager and you in accordance with its terms. Very truly yours, GMO TRUST By__________________________________ Name: Title: GRANTHAM, MAYO, VAN OTTERLOO & CO. LLC By__________________________________ Name: Title: The foregoing is hereby accepted and agreed. BROWN BROTHERS HARRIMAN & CO. By__________________________________ Name: Title: EX-99.9.1 6 TRANSFER AGENCY AND SERVICE AGREEMENT Exhibit 9.1 December ___, 1996 Investors Bank & Trust Company Financial Product Services One Lincoln Plaza Boston, MA 02205-1537 Re: Transfer Agency and Service Agreement dated August 1, 1991 by and among GMO Trust, Grantham, Mayo, Van Otterloo & Co. LLC and Investors Bank & Trust Co. (the "Agreement") -------------------------------------------------------- Ladies and Gentlemen: Pursuant to Article 17 of the Agreement, GMO Trust (the "Company") hereby notifies you that it has established an additional series of shares, namely, the "GMO Global Properties Fund" (the "New Fund"), with respect to each of which the Company and the manager (as defined in the Agreement) desire that you serve as transfer agent under the terms of the Agreement. If you agree to so serve as transfer agent for the New Fund, kindly sign and return to the Company the enclosed counterpart hereof, whereupon each New Fund shall be deemed a "Fund" under the Agreement. This letter agreement shall constitute an amendment to the Agreement and, as such, a binding agreement among the Trust, the Manager and you in accordance with its terms. Very truly yours, GMO TRUST By__________________________________ Name: Title: GRANTHAM, MAYO, VAN OTTERLOO & CO. LLC By__________________________________ Name: Title: The foregoing is hereby accepted and agreed. INVESTORS BANK & TRUST COMPANY By__________________________________ Name: Title: EX-99.9.2 7 FORM OF NOTIFICATION EXHIBIT 9.2 GRANTHAM, MAYO, VAN OTTERLOO & CO. LLC NOTIFICATION OF FEE WAIVER AND EXPENSE LIMITATION ------------------ NOTIFICATION made February 6, 1997 by GRANTHAM, MAYO, VAN OTTERLOO & CO. LLC, a Massachusetts limited liability company (the "Advisor"), to GMO TRUST, a Massachusetts business trust (the "Trust"). WITNESSETH: WHEREAS, the Advisor has organized the Trust to serve primarily as an investment vehicle for certain large institutional accounts; and WHEREAS, the Advisor believes it would benefit from a high sales volume of shares of the Trust in that such a volume would maximize the Advisor's fee as investment advisor to each series of the Trust constituting a separate investment portfolio set forth below (each a "Fund" and, collectively, the "Funds"); and WHEREAS, the Advisor has agreed to furnish certain services or to bear the costs thereof so as to enable the Funds to offer competitive returns with respect to investments in the Funds. NOW, THEREFORE, pursuant to Section 3 of each Management Contract (each a "Management Contract") currently in effect between the Advisor and the Trust, on behalf of each Fund, the Advisor hereby notifies the Trust that the Advisor shall voluntarily, until further notice, reduce its compensation due under each Management Contract, and, if necessary, to the extent that a Fund's total annual operating expenses (excluding Shareholder Service Fees, brokerage commissions and other investment- related costs, hedging transaction fees, extraordinary, non-recurring and certain other unusual expenses (including taxes), securities lending fees and expenses and transfer taxes; and, in the case of the GMO Emerging Markets Fund, GMO Emerging Country Debt Fund, GMO Global Hedged Equity Fund and GMO Global Properties Fund, excluding custodial fees; and, in the case of the International Equity Allocation Fund, World Equity Allocation Fund, Global (U.S.+) Equity Allocation Fund and Global Balanced Allocation Fund, excluding expenses indirectly incurred by investment in other Funds of the Trust), will not exceed the following annual rate of such Fund's average daily net asset value:

Please be advised that all previous notifications by the Advisor with respect to expense limitations regarding any of the Funds shall hereafter be null and void and of no further force and effect. IN WITNESS WHEREOF, the Advisor has executed this Notification of Expense Limitation on the day and year first above written. GRANTHAM, MAYO, VAN OTTERLOO & CO. By: -------------------------------- Title: Partner The foregoing is hereby accepted: GMO TRUST on behalf of each Fund named above By: ------------------------------------- Title: President-Quantitative EX-99.9.3 8 AMENDED AND RESTATED SERVICING AGREEMENT Exhibit 9.3 AMENDED AND RESTATED SERVICING AGREEMENT The Servicing Agreement executed as of May 30, 1996 between GMO TRUST, a Massachusetts business trust (the "Trust") on behalf of each of its Class I, Class II, Class III, Class IV, Class V and Class VI (each a "Class" and collectively the "Classes") Shares (the "Shares") of each Fund listed on Exhibit I hereto, (collectively, the "Funds"), and GRANTHAM, MAYO, VAN OTTERLOO & CO. LLC, a Massachusetts limited liability company (the "Shareholder Servicer"), is hereby amended and restated on December ___, 1996 by the Trustees: W I T N E S S E T H: That in consideration of the mutual covenants herein contained, it is agreed as follows: 1. SERVICES TO BE RENDERED BY SERVICING AGENT TO THE TRUST. (a) The Shareholder Servicer will, at its expense, provide direct client service, maintenance and reporting to shareholders of each Class of Shares of each Fund set forth on Exhibit 1 hereto, such services and reporting to include, without limitation, professional and informative reporting, client account information, personal and electronic access to Fund information, access to analysis and explanations of Fund reports, and assistance in the correction and maintenance of client-related information. (b) The Shareholder Servicer shall not be obligated under this agreement to pay any expenses of or for the Trust or of or for the Fund not expressly assumed by the Shareholder Servicer pursuant to this Section 1. 2. OTHER AGREEMENTS, ETC. It is understood that any of the shareholders, Trustees, officers and employees of the Trust may be a partner, shareholder, director, officer or employee of, or be otherwise interested in, the Shareholder Servicer, and in any person controlled by or under common control with the Shareholder Servicer, and that the Shareholder Servicer and any person controlled by or under common control with the Shareholder Servicer may have an interest in the Trust. It is also understood that the Shareholder Servicer and persons controlled by or under common control with the Shareholder Servicer may have advisory, servicing, distribution or other contracts with other organizations and persons, and may have other interests and businesses. 3. COMPENSATION TO BE PAID BY THE TRUST TO THE SERVICING AGENT. Each Class of Shares of each Fund will pay to the Shareholder Servicer as compensation for the Shareholder Servicer's services rendered and for the expenses borne by the Shareholder Servicer with respect to such Class of Shares of such Fund pursuant to Section 1, a fee, computed and accrued daily, and paid monthly or at such other intervals as the Trustees shall determine, at the annual rate of such Class' average daily net asset value set forth on the Fee Rate Schedule attached as Exhibit II hereto. Such fee shall be payable for each month (or other interval) within five (5) business days after the end of such month (or other interval). If the Servicing Agent shall serve for less than the whole of a month (or other interval), the foregoing compensation shall be prorated. 4. ASSIGNMENT TERMINATES THIS CONTRACT; AMENDMENTS OF THIS CONTRACT. This Contract shall automatically terminate, without the payment of any penalty, in the event of its assignment; provided, however, in the event of consolidation or merger in which the Shareholder Servicer is not the surviving corporation or which results in the acquisition of substantially all the Shareholder Servicer's outstanding stock by a single person or entity or by a group of persons and/or entities acting in concert, or in the event of the sale or transfer of substantially all the Shareholder Servicer's assets, the Shareholder Servicer may assign any such agreement to such surviving entity, acquiring entity, assignee or purchaser, as the case may be. This Contract shall not be amended unless such amendment is approved by the vote, cast in person at a meeting called for the purpose of voting on such approval, of a majority of the Trustees of the Trust who are not interested persons of the Trust or of the Shareholder Servicer. 5. EFFECTIVE PERIOD AND TERMINATION OF THIS CONTRACT. This Contract shall become effective upon its execution, and shall remain in full force and effect continuously thereafter (unless terminated automatically as set forth in Section 4) until terminated as follows: (a) Either party hereto may at any time terminate this Contract (or this Contract's application to one or more Classes or Funds) by not more than sixty days' written notice delivered or mailed by registered mail, postage prepaid, to the other party, or (b) If (i) a majority of the Trustees of the Trust, and (ii) a majority of the Trustees of the Trust who are not interested persons of the Trust or of the Shareholder Servicer, by vote cast in person at a meeting called for the purpose of voting on such approval, do not specifically approve at least annually the continuance of this Contract, then this Contract shall automatically terminate at the close of business on the second anniversary of its execution, or -2- upon the expiration of one year from the effective date of the last such continuance, whichever is later. Termination of this Contract pursuant to this Section 5 shall be without the payment of any penalty. 6. CERTAIN DEFINITIONS. For the purposes of this Contract, the terms "affiliated person", "control", "interested person" and "assignment" shall have their respective meanings defined in the Investment Company Act of 1940 and the rules and regulations thereunder, subject, however, to such exemptions as may be granted by the Securities and Exchange Commission under said Act; and the phrase "specifically approve at least annually" shall be construed in a manner consistent with the Investment Company Act of 1940 and the rules and regulations thereunder. 7. NONLIABILITY OF SERVICING AGENT. In the absence of willful misfeasance, bad faith or gross negligence on the part of the Shareholder Servicer, or reckless disregard of its obligations and duties hereunder, the Shareholder Servicer shall not be subject to any liability to the Trust, or to any shareholder of the Trust, for any act or omission in the course of, or connected with, rendering services hereunder. 8. LIMITATION OF LIABILITY OF THE TRUSTEES AND SHAREHOLDERS. A copy of the Agreement and Declaration of Trust of the Trust is on file with the Secretary of The Commonwealth of Massachusetts, and notice is hereby given that this instrument is executed on behalf of the Trustees of the Trust as Trustees and not individually and that the obligations of this instrument are not binding upon any of the Trustees or shareholders individually but are binding only upon the assets and property of the Fund. -3- IN WITNESS WHEREOF, GMO TRUST and GRANTHAM, MAYO, VAN OTTERLOO & CO. LLC have each caused this instrument to be signed in duplicate on its behalf by its duly authorized representative, all as of the day and year first above written. GMO TRUST By_______________________________________ Title: GRANTHAM, MAYO, VAN OTTERLOO & CO. LLC By_______________________________________ Title: -4- EXHIBIT I --------- GMO Core Fund GMO Tobacco-Free Core Fund GMO Value Fund GMO Growth Fund GMO U.S. Sector Fund GMO Small Cap Value Fund GMO Fundamental Value Fund GMO Small Cap Growth Fund GMO REIT Fund GMO International Core Fund GMO Currency Hedged International Core Fund GMO Foreign Fund GMO Global Fund GMO International Small Companies Fund GMO Japan Fund GMO Emerging Markets Fund GMO Global Properties Fund GMO Domestic Bond Fund GMO Global Hedged Equity Fund GMO Short-Term Income Fund GMO International Bond Fund GMO Currency Hedged International Bond Fund GMO Global Bond Fund GMO Emerging Country Debt Fund GMO Inflation Indexed Bond Fund GMO International Equity Allocation Fund GMO Global (U.S.+) Equity Allocation Fund GMO World Equity Allocation Fund GMO Global Balanced Allocation Fund -5- SERVICE FEE SCHEDULE EXHIBIT II - -------------------- ---------- CLASS I SHARES FUND SERVICE FEE GMO Core Fund 0.28% GMO Tobacco-Free Core Fund 0.28% GMO Value Fund 0.28% GMO Growth Fund 0.28% GMO U.S. Sector Fund 0.28% GMO Small Cap Value Fund 0.28% GMO Fundamental Value Fund 0.28% GMO Small Cap Growth Fund 0.28% GMO REIT Fund 0.28% GMO International Core Fund 0.28% GMO Currency Hedged International Core Fund 0.28% GMO Foreign Fund 0.28% GMO Global Fund 0.28% GMO International Small Companies Fund 0.28% GMO Japan Fund 0.28% GMO Emerging Markets Fund 0.28% GMO Global Properties Fund 0.28% GMO Domestic Bond Fund 0.28% GMO Global Hedged Equity Fund 0.28% GMO International Bond Fund 0.28% GMO Currency Hedged International Bond Fund 0.28% GMO Global Bond Fund 0.28% GMO Emerging Country Debt Fund 0.28% GMO Inflation Indexed Bond Fund 0.28% GMO International Equity Allocation Fund 0.13% GMO Global (U.S.+) Equity Allocation Fund 0.13% GMO World Equity Allocation Fund 0.13% GMO Global Balanced Allocation Fund 0.13% -6- SERVICE FEE SCHEDULE EXHIBIT II (cont'd) - -------------------- ------------------- CLASS II SHARES FUND SERVICE FEE GMO Core Fund 0.22% GMO Tobacco-Free Core Fund 0.22% GMO Value Fund 0.22% GMO Growth Fund 0.22% GMO U.S. Sector Fund 0.22% GMO Small Cap Value Fund 0.22% GMO Fundamental Value Fund 0.22% GMO Small Cap Growth Fund 0.22% GMO REIT Fund 0.22% GMO International Core Fund 0.22% GMO Currency Hedged International Core Fund 0.22% GMO Foreign Fund 0.22% GMO Global Fund 0.22% GMO International Small Companies Fund 0.22% GMO Japan Fund 0.22% GMO Emerging Markets Fund 0.22% GMO Global Properties Fund 0.22% GMO Domestic Bond Fund 0.22% GMO Global Hedged Equity Fund 0.22% GMO International Bond Fund 0.22% GMO Currency Hedged International Bond Fund 0.22% GMO Global Bond Fund 0.22% GMO Emerging Country Debt Fund 0.22% GMO Inflation Indexed Bond Fund 0.22% GMO International Equity Allocation Fund 0.07% GMO Global (U.S.+) Equity Allocation Fund 0.07% GMO World Equity Allocation Fund 0.07% GMO Global Balanced Allocation Fund 0.07% -7- SERVICE FEE SCHEDULE EXHIBIT II (cont'd) Class III Shares Fund Service Fee GMO Core Fund 0.15% GMO Tobacco-Free Core Fund 0.15% GMO Value Fund 0.15% GMO Growth Fund 0.15% GMO U.S. Sector Fund 0.15% GMO Small Cap Value Fund 0.15% GMO Fundamental Value Fund 0.15% GMO Small Cap Growth Fund 0.15% GMO REIT Fund 0.15% GMO International Core Fund 0.15% GMO Currency Hedged International Core Fund 0.15% GMO Foreign Fund 0.15% GMO Global Bond Fund 0.15% GMO International Small Companies Fund 0.15% GMO Japan Fund 0.15% GMO Emerging Markets Fund 0.15% GMO Global Properties Fund 0.15% GMO Domestic Bond Fund 0.15% GMO Short-Term Income Fund 0.15% GMO Global Hedged Equity Fund 0.15% GMO International Bond Fund 0.15% GMO Currency Hedged International Bond Fund 0.15% GMO Global Fund 0.15% GMO Emerging Country Debt Fund 0.15% GMO Inflation Indexed Bond Fund 0.15% GMO International Equity Allocation Fund 0.00% GMO Global (U.S.+) Equity Allocation Fund 0.00% GMO World Equity Allocation Fund 0.00% GMO Global Balanced Allocation Fund 0.00% -8- SERVICE FEE SCHEDULE EXHIBIT II (cont'd) - -------------------- ---------- CLASS IV SHARES FUND SERVICE FEE - ---- ----------- GMO Core Fund 0.12% GMO Value Fund 0.12% GMO Growth Fund 0.12% GMO U.S. Sector Fund 0.12% GMO International Core Fund 0.11% GMO Emerging Markets Fund 0.10% CLASS V SHARES FUND SERVICE FEE - ---- ----------- GMO Core Fund 0.09% GMO Value Fund 0.09% GMO Growth Fund 0.09% GMO U.S. Sector Fund 0.09% GMO International Core Fund 0.07% GMO Emerging Markets Fund 0.05% CLASS VI SHARES FUND SERVICE FEE - ---- ----------- GMO Core Fund 0.07% GMO Value Fund 0.07% GMO Growth Fund 0.07% GMO U.S. Sector Fund 0.07% GMO International Core Fund 0.04% GMO Emerging Markets Fund 0.02% -9- EX-99.11 9 CONSENT OF INDEPENDENT ACCOUNTANTS EXHIBIT 11 ---------- CONSENT OF INDEPENDENT ACCOUNTANTS We hereby consent to the incorporation by reference in the Private Placement Memorandum and Statement of Additional Information constituting parts of this Post-Effective Amendment No. 34 to GMO Trust's registration statement under the Investment Company Act of 1940 on Form N-1A (the "Registration Statement") of our reports dated April 12, 1996, April 17, 1996 and April 23, 1996, relating to the financial statements and financial highlights of each series of GMO Trust, which appear in the related February 29, 1996 Annual Reports and which are also incorporated by reference into the Registration Statement. We also consent to the references to us under the headings "Investment Advisory and Other Services - - Independent Accountants" and "Financial Statements" in such Statement of Additional Information. We also consent to the incorporation by reference in such Registration Statement of our reports dated April 12, 1996, April 17, 1996 and April 23, 1996, relating to the February 29, 1996 financial statements and financial highlights of GMO Trust, which are incorporated by reference in the prospectuses and statements of additional information of Post-Effective Amendments No 29 (GMO Pelican Fund) and No. 32 (each series of GM0 Trust, except for the Pelican Fund) to the registration statement of GMO Trust and which are also incorporated by reference in this Registration Statement. Price Waterhouse LLP Boston, Massachusetts January 10, 1997 EX-27.SER01 10
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended February 29, 1996 and is qualified in its entirety by reference to such financial statements. 1 Core Fund YEAR FEB-29-1996 FEB-29-1996 2,683,007,287 3,362,042,325 100,847,993 0 0 3,462,890,318 67,454,307 0 216,121,691 283,575,998 0 2,314,886,733 163,404,368 149,509,336 9,884,952 0 180,108,269 0 674,434,366 3,179,314,320 71,408,642 6,419,038 0 13,681,463 64,146,217 403,829,023 457,594,296 925,569,536 0 (64,258,886) (221,987,205) 0 25,285,500 (25,442,869) 14,052,401 870,066,382 9,992,385 (1,721,805) 0 0 14,964,100 0 15,734,114 2,850,304,743 15.45 0.41 5.49 0.00 (1.89) 0.00 19.46 0.48 0 0.00

EX-27.SER04 11
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended February 29, 1996 and is qualified in its entirety by reference to such financial statements. 4 Growth Fund YEAR FEB-29-1996 FEB-29-1996 336,984,327 413,746,051 26,718,669 0 0 440,464,720 27,733,123 0 21,365,684 49,098,807 0 290,142,619 69,297,026 53,657,221 1,067,492 0 24,019,748 0 76,136,054 391,365,913 5,852,767 941,958 0 1,617,624 5,177,101 39,524,050 61,683,361 106,384,512 0 (4,668,104) (23,225,614) 0 28,535,818 (17,613,541) 4,717,528 152,359,596 558,495 9,725,239 0 0 1,685,025 0 1,858,869 337,004,892 4.45 0.08 1.54 0.00 (0.42) 0.00 5.65 0.48 0 0.00

EX-27.SER08 12
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended February 29, 1996 and is qualified in its entirety by reference to such financial statements. 8 Value Fund YEAR FEB-29-1996 FEB-29-1996 278,983,865 339,320,642 3,324,944 0 0 342,645,586 3,858,071 0 21,175,666 25,033,737 0 237,295,574 22,292,408 29,095,761 1,384,221 0 18,914,947 0 60,017,107 317,611,849 9,864,421 869,152 0 2,000,965 8,732,608 57,961,119 33,360,660 100,054,387 0 (9,263,106) (32,854,343) 0 1,619,182 (11,220,138) 2,797,603 (33,082,612) 1,914,719 (4,119,787) 0 0 2,296,190 0 2,464,225 328,027,141 12.05 0.39 3.71 0.00 (1.90) 0.00 14.25 0.61 0 0.00

EX-27.SER06 13
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended February 29, 1996 and is qualified in its entirety by reference to such financial statements. 6 Short Term Income Fund YEAR FEB-29-1996 FEB-29-1996 10,996,843 11,019,613 73,137 0 0 11,092,750 0 0 26,725 26,725 0 10,991,134 1,132,734 856,832 146,175 0 (94,054) 0 22,770 11,066,025 0 577,145 0 21,067 556,078 74,630 31,945 662,653 0 (509,777) 0 0 3,044,961 (2,819,011) 49,952 2,872,529 99,101 (167,936) 0 0 21,431 0 54,513 8,572,412 9.56 0.57 0.20 0.00 (0.56) 0.00 9.77 0.25 0 0.00

EX-27.SER03 14
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended February 29, 1996 and is qualified in its entirety by reference to such financial statements. 3 International Core Fund YEAR FEB-29-1996 FEB-29-1996 4,181,451,437 4,528,012,182 126,560,571 279,733,637 0 4,934,306,390 39,581,605 0 356,688,562 396,270,167 0 4,121,905,163 184,341,225 116,104,099 (5,469,509) 0 94,418,541 0 327,182,028 4,538,036,223 74,224,279 14,976,030 0 23,894,111 65,306,198 109,487,879 289,471,168 464,265,245 0 (62,905,553) (102,400,553) 0 83,979,899 (21,748,238) 6,005,465 1,946,390,371 0 100,721,946 0 0 25,419,063 0 28,809,394 3,389,208,429 22.32 0.36 3.09 0.00 (1.15) 0.00 24.62 0.71 0 0.00

EX-27.SER07 15
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended February 29, 1996 and is qualified in its entirety by reference to such financial statements. 7 Japan Fund YEAR FEB-29-1996 FEB-29-1996 132,821,526 131,836,083 15,085,697 9,196,965 0 156,118,745 16,148,713 0 13,863,073 30,011,786 0 127,976,536 14,792,650 6,591,242 0 (189,728) 0 (127,763) (1,552,086) 126,106,959 584,529 95,895 0 790,268 (109,844) 4,140,734 1,050,216 5,081,106 0 0 (12,090,051) 0 8,808,517 (2,001,579) 1,394,470 65,983,796 0 11,647,848 (401,346) 0 647,675 0 915,930 86,356,630 9.12 (0.01) 0.79 0.00 (1.38) 0.00 8.52 0.92 0 0.00

EX-27.SER09 16
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended February 29, 1996 and is qualified in its entirety by reference to such financial statements. 9 Tobacco Free Core Fund YEAR FEB-29-1996 FEB-29-1996 50,558,803 62,304,922 1,051,797 0 0 63,356,719 2,000,846 0 3,870,858 5,871,704 0 41,371,537 4,444,322 4,502,238 167,328 0 4,248,984 0 11,697,166 57,485,015 1,387,360 167,012 0 272,934 1,281,438 9,934,207 7,259,517 18,475,162 0 (1,114,110) (6,201,500) 0 781,571 (1,434,132) 594,645 9,516,284 0 515,529 0 0 284,306 0 386,859 56,861,166 10.65 0.28 3.71 0.00 (1.71) 0.00 12.93 0.48 0 0.00

EX-27.SER10 17
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended February 29, 1996 and is qualified in its entirety by reference to such financial statements. 10 Fundamental Value Fund YEAR FEB-29-1996 FEB-29-1996 181,017,167 223,270,485 1,293,014 0 0 224,563,499 143,225 0 11,991,928 12,135,153 0 161,524,955 14,123,445 14,581,927 875,858 0 7,774,215 0 42,253,318 212,428,346 6,369,970 324,869 0 1,496,155 5,198,684 15,932,806 30,653,753 51,785,243 0 (5,212,954) (10,547,076) 0 616,745 (1,900,841) 825,614 29,557,439 890,128 2,388,485 0 0 1,496,155 0 1,604,692 199,487,344 12.54 0.37 3.26 0.00 (1.13) 0.00 15.04 0.75 0 0.00

EX-27.SER13 18
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended February 29, 1996 and is qualified in its entirety by reference to such financial statements. 13 International Small Companies Fund YEAR FEB-29-1996 FEB-29-1996 190,949,046 195,554,669 9,699,879 32,341,641 0 237,596,189 17,121,507 0 1,510,952 18,632,459 0 210,963,609 16,902,821 15,585,433 476,295 0 3,752,355 0 3,771,471 218,963,730 4,495,477 628,663 0 1,499,671 3,624,469 4,417,938 13,287,476 21,329,883 0 (3,117,132) (2,401,896) 0 3,283,845 (2,315,294) 348,837 32,778,530 706,457 981,267 0 0 2,467,267 0 2,858,509 197,381,326 11.95 0.18 1.16 0.00 (0.34) 0.00 12.95 0.76 0 0.00

EX-27.SER11 19
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended February 29, 1996 and is qualified in its entirety by reference to such financial statements. 11 Core II Secondaries Fund YEAR FEB-29-1996 FEB-29-1996 221,501,092 241,886,269 6,787,969 0 0 248,674,238 6,196,613 0 10,944,194 17,140,807 0 206,204,739 16,666,567 17,325,736 686,982 0 4,220,996 0 20,420,714 231,533,431 3,243,700 518,116 0 838,310 2,923,506 35,136,350 2,918,309 40,978,165 0 (2,725,107) (38,332,108) 0 5,303,210 (8,644,888) 2,682,509 (4,247,216) 707,076 7,270,940 0 0 873,239 0 1,064,994 174,647,869 13.61 0.23 3.20 0.00 (3.15) 0.00 13.89 0.48 0 0.00

EX-27.SER14 20
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended February 29, 1996 and is qualified in its entirety by reference to such financial statements. 14 U.S. Sector Fund YEAR FEB-29-1996 FEB-29-1996 192,676,752 229,763,018 3,901,002 0 0 233,664,020 6,529,338 0 15,815,966 22,345,304 0 141,122,078 15,503,866 18,734,305 774,923 0 32,641,217 0 36,780,498 211,318,716 5,849,216 514,453 0 1,111,279 5,252,390 52,195,479 18,654,244 76,102,113 0 (5,069,167) (19,784,233) 0 1,735,802 (5,734,152) 767,911 4,027,618 918,110 (96,031) 0 0 1,134,431 0 1,281,119 231,516,522 11.06 0.29 3.90 0.00 (1.62) 0.00 13.63 0.48 0 0.00

EX-27.SER16 21
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended February 29, 1996 and is qualified in its entirety by reference to such financial statements. 16 International Bond Fund YEAR FEB-29-1996 FEB-29-1996 179,513,993 192,436,110 12,437,036 582,285 0 205,455,431 2,863,675 0 8,671,440 11,535,115 0 174,300,100 17,765,600 15,687,479 4,884,754 0 1,966,474 0 12,768,988 193,920,316 0 16,699,901 0 779,352 15,920,549 6,632,580 14,322,520 36,875,649 0 (10,442,087) (5,446,434) 0 11,762,649 (10,775,703) 1,091,175 42,730,945 3,765,102 (3,341,397) 0 0 779,352 0 1,037,010 194,872,468 9.64 0.62 1.55 0.00 (0.89) 0.00 10.92 0.40 0 0.00

EX-27.SER05 22
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended February 29, 1996 and is qualified in its entirety by reference to such financial statements. 5 Pelican Fund YEAR FEB-29-1996 FEB-29-1996 138,264,540 178,239,841 768,978 4,452 0 179,013,271 1,470,267 0 304,711 1,774,978 0 134,003,101 12,204,124 9,831,023 646,595 0 2,613,296 0 39,975,301 177,238,293 3,397,889 1,965,985 0 1,628,504 3,735,370 9,082,971 25,308,348 38,126,689 0 (3,369,047) (6,173,331) 0 2,841,802 (1,115,726) 647,025 59,318,522 280,272 (296,344) 0 0 1,390,969 0 1,628,504 154,549,331 11.99 0.31 3.04 0.00 (0.82) 0.00 14.52 1.05 0 0.00

EX-27.SER15 23
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended February 29, 1996 and is qualified in its entirety by reference to such financial statements. 15 Emerging Markets Fund YEAR FEB-29-1996 FEB-29-1996 926,742,924 898,092,615 11,943,059 3,791,639 0 913,827,313 4,631,539 0 2,016,254 6,647,793 0 954,919,906 86,054,424 40,355,453 7,846,974 0 (28,277,467) 0 (27,309,893) 907,179,520 13,673,072 2,192,601 0 8,053,755 7,811,918 (25,051,517) 66,409,381 49,169,782 0 (615,855) (7,081,456) 0 47,019,289 (2,004,988) 684,670 522,920,758 0 4,506,417 0 0 5,944,710 0 8,143,828 594,471,021 9.52 0.10 1.06 0.00 (0.14) 0.00 10.54 1.35 0 0.00

EX-27.SER17 24
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended February 29, 1996 and is qualified in its entirety by reference to such financial statements. 17 Emerging Country Debt Fund YEAR FEB-29-1996 FEB-29-1996 540,192,223 623,365,913 16,841,240 1,250,746 0 641,457,899 16,231,181 0 9,741,675 25,972,856 0 496,046,665 52,339,284 29,024,789 13,630,078 0 17,949,090 0 87,859,210 615,485,043 0 67,635,234 0 2,504,494 65,130,740 61,081,420 119,723,421 245,935,581 0 (55,195,795) (30,587,693) 0 34,834,354 (17,191,233) 5,671,374 372,033,699 2,358,106 (7,744,126) 0 0 2,504,503 0 3,314,606 500,868,125 8.39 1.35 3.84 0.00 (1.82) 0.00 11.76 0.50 0 0.00

EX-27.SER18 25
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended February 29, 1996 and is qualified in its entirety by reference to such financial statements. 18 Global Hedged Equity Fund YEAR FEB-29-1996 FEB-29-1996 348,492,841 382,835,454 3,012,573 848,731 0 386,696,758 360,615 0 3,402,387 3,763,002 0 358,608,814 35,975,948 21,216,892 2,926,013 0 (10,487,331) 0 31,886,260 382,933,756 7,173,291 3,070,970 0 2,477,026 7,767,235 (16,123,360) 31,582,518 23,226,393 0 (8,135,996) 0 0 18,601,167 (4,235,364) 393,253 168,295,635 745,109 110,686 0 0 2,071,406 0 2,676,295 318,675,757 10.12 0.29 0.47 0.00 (0.24) 0.00 10.64 0.78 0 0.00

EX-27.SER19 26
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended February 29, 1996 and is qualified in its entirety by reference to such financial statements. 19 Domestic Bond Fund YEAR FEB-29-1996 FEB-29-1996 321,777,755 323,690,023 1,501,580 653,125 0 325,844,728 0 0 14,895,383 14,895,383 0 303,088,382 29,888,776 20,670,984 3,439,616 0 3,567,277 0 854,070 310,949,345 0 19,134,985 0 707,127 18,427,858 14,899,226 (1,699,294) 31,627,790 0 (16,310,249) (11,149,215) 0 10,635,774 (3,664,474) 2,246,492 101,572,097 1,322,007 (103,743) 0 0 707,127 0 865,518 282,850,898 10.13 0.66 0.58 0.00 (0.97) 0.00 10.40 0.25 0 0.00

EX-27.SER20 27
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended February 29, 1996 and is qualified in its entirety by reference to such financial statements. 20 Currency Hedged International Bond Fund YEAR FEB-29-1996 FEB-29-1996 214,883,688 237,208,395 10,452,575 186,716 0 247,847,686 0 0 11,685,828 11,685,828 0 211,381,989 21,628,308 23,885,450 2,213,016 0 27,472 0 22,539,381 236,161,858 0 20,805,867 0 930,505 19,875,362 14,407,640 23,912,792 58,195,794 0 (19,852,732) (13,715,828) 0 9,674,966 (14,452,061) 2,519,953 (2,502,580) 2,072,925 37,085 0 0 1,163,131 0 1,483,311 232,622,008 9.99 1.05 1.62 0.00 (1.74) 0.00 10.92 0.40 0 0.00

EX-27.SER21 28
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended February 29, 1996 and is qualified in its entirety by reference to such financial statements. 21 Currency Hedged International Core Fund YEAR FEB-29-1996 FEB-29-1996 394,217,295 404,698,822 3,314,295 561,169 0 408,574,286 230,238 0 1,117,470 1,347,708 0 385,991,253 35,278,555 0 6,114,326 0 2,838,672 0 12,282,327 407,226,578 1,782,250 1,993,262 0 1,013,900 2,761,612 9,472,130 12,282,327 24,516,069 0 (1,491,247) (1,789,497) 0 35,069,613 (44,625) 253,567 407,226,578 0 0 0 0 1,097,558 0 1,647,265 222,244,180 10.00 0.23 1.44 0.00 (0.13) 0.00 11.54 0.69 0 0.00

EX-27.SER22 29
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended February 29, 1996 and is qualified in its entirety by reference to such financial statements. 22 Global Bond Fund YEAR FEB-29-1996 FEB-29-1996 30,715,132 30,240,346 1,323,627 34,375 0 31,598,348 0 0 525,930 525,930 0 31,527,501 3,143,053 0 145,359 0 (255,309) 0 (345,133) 31,072,418 0 321,498 0 16,812 304,686 (414,636) (345,133) (455,083) 0 0 0 0 3,143,053 0 0 31,072,418 0 0 0 0 17,307 0 72,104 29,189,806 10.00 0.05 (0.16) 0.00 0.00 0.00 9.89 0.34 0 0.00

EX-27.SER11CL1 30
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended August 31, 1996 and is qualified in its entirety by reference to such financial statements. 101 Core Fund, Class I 6-MOS FEB-28-1997 AUG-31-1996 2,716,861,139 3,150,005,640 13,966,225 0 0 3,163,971,865 14,539,443 0 102,157,618 116,697,061 0 2,362,142,401 326,936 0 7,987,272 0 242,089,815 0 435,055,316 5,995,766 16,449 2,123 0 5,701 12,871 49,451 (249,421) (187,099) 0 0 0 0 326,936 0 0 5,995,766 0 0 0 0 8,233,581 0 9,725,385 5,582,172 18.97 0.04 (0.67) 0.00 0.00 0.00 18.34 0.61 0 0.00

EX-27.SER12CL2 31
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended August 31, 1996 and is qualified in its entirety by reference to such financial statements. 102 Core Fund, Class II 6-MOS FEB-28-1997 AUG-31-1996 2,716,861,139 3,150,005,640 13,966,225 0 0 3,163,971,865 14,539,443 0 102,157,618 116,697,061 0 2,362,142,401 1,384,183 0 7,987,272 0 242,089,815 0 435,055,316 25,376,930 104,112 13,438 0 31,827 85,723 747,986 (1,582,769) (749,060) 0 (129,826) (1,499,489) 0 1,298,520 0 85,663 25,376,930 0 0 0 0 8,233,581 0 9,725,385 25,049,937 20.12 0.07 (0.60) (0.10) (1.16) 0.00 18.33 0.55 0 0.00

EX-27.SER13CL3 32
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended August 31, 1996 and is qualified in its entirety by reference to such financial statements. 103 Core Fund, Class III 6-MOS FEB-28-1997 AUG-31-1996 2,716,861,139 3,150,005,640 13,966,225 0 0 3,163,971,865 14,539,443 0 102,157,618 116,697,061 0 2,362,142,401 164,491,589 163,404,368 7,987,272 0 242,089,815 0 435,055,316 3,015,902,108 32,323,268 4,172,121 0 7,495,599 28,999,790 240,592,321 (237,546,860) 32,045,251 0 (30,866,238) (177,908,723) 0 8,879,792 18,120,509 10,327,938 (163,412,212) 9,884,952 180,108,269 0 0 8,233,581 0 9,725,385 3,114,435,965 19.46 0.18 0.04 (0.19) (1.16) 0.00 18.33 0.48 0 0.00

EX-27.SER04 33
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended August 31, 1996 and is qualified in its entirety by reference to such financial statements. 4 Growth Fund 6-MOS FEB-28-1997 AUG-31-1996 293,653,069 334,547,876 7,416,087 0 0 341,963,963 2,343,494 0 18,069,080 20,412,574 0 236,632,735 60,348,814 69,297,026 529,139 0 43,790,065 0 40,599,450 321,551,389 2,835,363 484,920 0 868,866 2,451,417 43,701,353 (35,536,605) 10,616,165 0 (2,989,770) (23,931,036) 0 1,549,841 (14,681,369) 4,183,316 (69,814,524) 1,067,492 24,019,748 0 0 905,068 0 1,105,801 360,823,000 5.65 0.04 0.12 0.00 (0.48) 0.00 5.33 0.48 0 0.00

EX-27.SER08 34
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended August 31, 1996 and is qualified in its entirety by reference to such financial statements. 8 Value Fund 6-MOS FEB-28-1997 AUG-31-1996 299,146,312 338,805,712 2,226,543 0 0 341,032,255 165,765 0 26,448,715 26,614,480 0 256,621,103 23,721,468 22,292,408 1,509,300 0 16,658,536 0 39,628,836 314,417,775 4,376,672 318,979 0 974,936 3,720,715 19,148,239 (20,388,271) 2,480,683 0 (3,595,636) (21,404,650) 0 509,997 (770,638) 1,689,701 (3,194,074) 1,384,221 18,914,947 0 0 1,118,778 0 1,316,196 318,751,000 14.25 0.16 (0.03) 0.00 (1.13) 0.00 13.25 0.61 0 0.00

EX-27.SER06 35
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended August 31, 1996 and is qualified in its entirety by reference to such financial statements. 6 Short Term Income Fund 6-MOS FEB-28-1997 AUG-31-1996 23,252,037 23,209,033 2,196,420 0 0 25,405,453 0 0 20,397 20,397 0 25,278,829 2,612,653 1,132,734 252,908 0 (103,677) 0 (43,004) 25,385,056 0 610,627 0 20,061 590,566 (9,623) (65,774) 515,169 0 (483,833) 0 0 3,114,034 (1,670,658) 36,543 14,319,031 146,175 (94,054) 0 0 25,240 0 49,446 20,155,000 9.77 0.22 (0.02) 0.00 (0.25) 0.00 9.72 0.20 0 0.00

EX-27.SER03 36
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended August 31, 1996 and is qualified in its entirety by reference to such financial statements. 3 International Core Fund 6-MOS FEB-28-1997 AUG-31-1996 4,347,028,540 4,516,570,224 64,400,761 38,634,989 0 4,619,605,974 36,473,043 0 329,870,956 366,343,999 0 3,907,873,359 175,896,874 184,341,225 58,175,243 0 140,448,857 0 146,764,516 4,253,261,975 81,786,136 10,172,141 0 15,673,176 76,285,101 128,103,567 (180,417,512) 23,971,156 0 (12,640,349) (82,073,251) 0 19,016,730 (31,049,450) 3,588,369 (284,774,248) (5,469,509) 94,418,541 0 0 16,915,544 0 20,168,338 4,473,938,000 24.62 0.43 (0.34) 0.00 (0.53) 0.00 24.18 0.69 0 0.00

EX-27.SER07 37
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended August 31, 1996 and is qualified in its entirety by reference to such financial statements. 7 Japan Fund 6-MOS FEB-28-1997 AUG-31-1996 280,399,353 267,677,616 379,546 29,685,599 0 297,742,761 21,066 0 34,283,938 34,305,004 0 277,129,017 32,080,230 14,792,650 (203,586) 0 (77,316) 0 (13,410,358) 263,437,757 442,765 153,859 0 610,482 (13,858) 50,447 (11,858,272) (11,821,683) 0 0 0 0 19,076,822 (1,789,242) 0 137,330,798 (189,728) (127,763) 0 0 654,196 0 872,094 173,013,000 8.52 0.00 (0.31) 0.00 0.00 0.00 8.21 0.70 0 0.00

EX-27.SER09 38
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended August 31, 1996 and is qualified in its entirety by reference to such financial statements. 9 Tobacco Free Core Fund 6-MOS FEB-28-1997 AUG-31-1996 51,763,405 57,250,025 239,311 0 0 57,489,336 177,591 0 3,301,051 3,478,642 0 42,687,046 4,514,874 4,444,322 146,239 0 5,723,414 0 5,453,995 54,010,694 525,618 95,028 0 126,134 494,512 5,816,445 (6,243,171) 67,786 0 (515,601) (4,342,015) 0 754,930 (1,074,672) 390,294 (3,474,321) 167,328 4,248,984 0 0 131,390 0 202,221 52,421,000 12.93 0.12 0.07 0.00 (1.16) 0.00 11.96 0.48 0 0.00

EX-27.SER10 39
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended August 31, 1996 and is qualified in its entirety by reference to such financial statements. 10 Fundamental Value Fund 6-MOS FEB-28-1997 AUG-31-1996 185,190,932 221,295,538 960,607 0 0 222,256,145 369,904 0 18,643,035 19,012,939 0 159,947,802 14,047,972 14,123,445 1,254,338 0 5,936,460 0 36,104,606 203,243,206 3,158,945 122,867 0 790,473 2,491,339 6,672,458 (6,148,712) 3,015,085 0 (2,112,859) (8,510,213) 0 6,586 (677,878) 595,819 (9,185,140) 875,858 7,774,215 0 0 790,473 0 916,947 210,173,000 15.04 0.18 0.03 0.00 (0.78) 0.00 14.47 0.75 0 0.00

EX-27.SER13 40
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended August 31, 1996 and is qualified in its entirety by reference to such financial statements. 13 International Small Companies Fund 6-MOS FEB-28-1997 AUG-31-1996 194,701,143 203,769,082 607,292 23,292,583 0 227,668,957 0 0 1,243,102 1,243,102 0 218,170,006 17,439,466 16,902,821 2,775,612 0 (1,402,268) 0 6,882,505 226,425,855 3,209,805 573,068 0 875,812 2,907,061 (1,751,254) 3,111,034 4,266,841 0 (607,744) (3,403,369) 0 932,056 (671,448) 276,037 7,462,125 476,295 3,752,355 0 0 1,454,408 0 1,749,676 230,788,000 12.95 0.17 0.10 0.00 (0.24) 0.00 12.98 0.75 0 0.00

EX-27.SER11 41
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended August 31, 1996 and is qualified in its entirety by reference to such financial statements. 11 Core II Secondaries Fund 6-MOS FEB-28-1997 AUG-31-1996 249,776,570 276,444,963 703,136 64,446,606 0 341,594,705 0 0 11,217,361 11,217,361 0 303,579,424 23,309,621 16,666,567 1,453,178 0 1,253,044 0 24,091,698 330,377,344 2,298,642 1,866,299 0 731,768 3,433,173 2,471,754 3,670,984 9,575,911 0 (2,666,977) (5,439,706) 0 7,919,600 (1,718,491) 441,945 98,843,913 686,982 4,220,996 0 0 762,258 0 965,730 304,213,000 13.89 0.15 0.49 0.00 (0.36) 0.00 14.17 0.48 0 0.00

EX-27.SER05 42
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended August 31, 1996 and is qualified in its entirety by reference to such financial statements. 5 Pelican Fund 6-MOS FEB-28-1997 AUG-31-1996 144,282,119 180,625,523 1,789,164 4,466 0 182,419,153 188,753 0 222,758 411,511 0 142,567,905 12,797,474 12,204,124 994,234 0 2,102,099 0 36,343,404 182,007,642 1,823,338 1,146,125 0 878,257 2,091,206 3,472,919 (3,631,897) 1,932,228 0 (1,743,567) (3,984,116) 0 927,821 (712,170) 377,699 4,769,349 646,595 2,613,296 0 0 832,034 0 968,377 183,372,000 14.52 0.16 0.00 0.00 (0.46) 0.00 14.22 0.95 0 0.00

EX-27.SER14 43
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended August 31, 1996 and is qualified in its entirety by reference to such financial statements. 14 U.S. Sector Fund 6-MOS FEB-28-1997 AUG-31-1996 213,891,494 233,809,311 984,748 0 0 234,794,059 539,995 0 8,746,093 9,286,088 0 186,375,402 19,210,683 15,503,866 614,511 0 18,444,220 0 20,073,838 225,507,971 2,317,176 348,814 0 535,777 2,130,213 18,606,954 (16,706,660) 4,030,507 0 (2,290,625) (32,803,951) 0 3,529,655 (1,334,220) 1,511,382 14,189,255 774,923 32,641,217 0 0 546,939 0 696,231 222,646,000 13.63 0.12 0.09 0.00 (2.10) 0.00 11.74 0.48 0 0.00

EX-27.SER16 44
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended August 31, 1996 and is qualified in its entirety by reference to such financial statements. 16 International Bond Fund 6-MOS FEB-28-1997 AUG-31-1996 204,063,285 212,047,045 8,696,890 57,840 0 220,801,775 5,297,555 0 12,699,467 17,997,022 0 172,537,116 17,563,164 17,765,600 8,133,415 0 13,801,190 0 8,333,032 202,804,753 0 7,194,831 0 377,492 6,817,339 14,111,565 (4,435,956) 16,492,948 0 (3,568,678) (2,276,849) 0 4,019,441 (4,626,675) 404,798 8,884,437 4,884,754 1,966,474 0 0 379,254 0 563,159 189,188,000 10.92 0.41 0.58 0.00 (0.36) 0.00 11.55 0.40 0 0.00

EX-27.SER15 45
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended August 31, 1996 and is qualified in its entirety by reference to such financial statements. 15 Emerging Markets Fund 6-MOS FEB-28-1997 AUG-31-1996 1,243,913,640 1,209,858,328 20,654,339 15,945,195 0 1,246,457,862 24,546,201 0 1,514,416 26,060,617 0 1,247,146,379 111,608,650 86,054,424 11,249,129 0 (6,358,044) 0 (31,640,219) 1,220,397,245 16,367,257 2,569,290 0 6,751,664 12,184,883 21,919,423 (4,330,326) 29,773,980 0 (8,782,728) 0 0 27,412,967 (2,262,129) 403,388 313,217,725 7,846,974 (28,277,467) 0 0 5,714,385 0 7,442,447 1,133,601,000 10.54 0.09 0.38 0.00 (0.08) 0.00 10.93 0.12 0 0.00

EX-27.SER17 46
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended August 31, 1996 and is qualified in its entirety by reference to such financial statements. 17 Emerging Country Debt Fund 6-MOS FEB-28-1997 AUG-31-1996 505,398,828 656,488,824 51,350,551 2,355 0 707,841,730 11,279,672 0 49,735,204 61,014,876 0 399,403,787 45,031,574 52,339,284 32,108,591 0 69,870,779 0 145,443,697 646,826,854 0 33,025,583 0 1,881,184 31,144,399 76,128,691 57,584,487 164,857,577 0 (12,665,886) (24,207,002) 0 4,780,799 (14,421,005) 2,332,496 31,341,811 13,630,078 17,949,090 0 0 1,627,727 0 2,202,106 649,442,000 11.76 0.71 2.65 0.00 (0.76) 0.00 14.36 0.58 0 0.00

EX-27.SER18 47
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended August 31, 1996 and is qualified in its entirety by reference to such financial statements. 18 Global Hedged Equity Fund 6-MOS FEB-28-1997 AUG-31-1996 300,699,579 312,064,318 6,745,757 1,633,095 0 320,443,170 956,828 0 2,357,263 3,314,091 0 301,306,310 29,771,691 35,975,948 4,131,701 0 (6,604,957) 0 18,296,025 317,129,079 4,669,233 1,088,841 0 1,501,714 4,256,360 9,329,574 (13,590,235) (4,301) 0 (422,864) 0 0 2,387,660 (8,615,714) 23,797 (65,804,677) 298,205 (15,934,531) 0 0 1,169,808 0 1,687,038 357,003,000 10.64 0.14 (0.12) 0.00 (0.01) 0.00 10.65 0.83 0 0.00

EX-27.SER19 48
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended August 31, 1996 and is qualified in its entirety by reference to such financial statements. 19 Domestic Bond Fund 6-MOS FEB-28-1997 AUG-31-1996 544,210,475 538,660,189 3,579,804 0 0 542,239,993 0 0 91,109,000 91,109,000 0 457,203,017 45,181,741 29,888,776 4,071,870 0 (2,630,576) 0 (7,513,318) 451,130,993 0 11,680,445 0 456,848 11,223,597 (3,637,045) (8,367,388) (780,836) 0 (10,591,343) (2,560,808) 0 14,851,216 (670,418) 1,112,167 140,181,648 3,439,616 3,567,277 0 0 456,847 0 664,166 364,952,000 10.40 0.28 (0.33) 0.00 (0.37) 0.00 9.98 0.25 0 0.00

EX-27.SER20 49
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended August 31, 1996 and is qualified in its entirety by reference to such financial statements. 20 Currency Hedged International Bond Fund 6-MOS FEB-28-1997 AUG-31-1996 343,169,932 359,039,272 12,752,268 74,411 0 371,865,951 12,496,996 0 10,238,437 22,735,433 0 299,691,288 29,089,838 21,628,308 11,891,234 0 20,241,430 0 17,306,566 349,130,518 0 10,570,099 0 541,580 10,028,519 21,014,646 (5,232,815) 25,810,350 0 (350,301) (800,688) 0 9,451,675 (2,075,035) 84,890 112,968,660 2,213,016 27,472 0 0 676,972 0 917,830 270,496,000 10.92 0.32 0.80 0.00 (0.04) 0.00 12.00 0.40 0 0.00

EX-27.SER21 50
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended August 31, 1996 and is qualified in its entirety by reference to such financial statements. 21 Currency Hedged International Core Fund 6-MOS FEB-28-1997 AUG-31-1996 498,815,329 506,799,670 4,543,449 2,614,640 0 513,957,759 1,918,639 0 3,867,971 5,786,610 0 490,112,713 44,087,812 35,278,555 12,845,398 0 722,304 0 4,490,734 508,171,149 7,524,292 2,344,414 0 1,662,544 8,206,162 7,635,617 (7,791,593) 8,050,186 0 (1,475,090) (9,751,985) 0 11,351,325 (3,419,505) 877,437 100,944,571 6,114,326 2,838,672 0 0 1,800,980 0 2,428,880 476,329,000 11.54 0.15 0.12 0.00 (0.28) 0.00 11.53 0.69 0 0.00

EX-27.SER22 51
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended August 31, 1996 and is qualified in its entirety by reference to such financial statements. 22 Global Bond Fund 6-MOS FEB-28-1997 AUG-31-1996 64,366,596 64,934,015 1,723,990 1,903 0 66,659,908 6,006 0 3,333,389 3,339,395 0 59,926,522 6,042,003 3,143,053 1,877,630 0 887,898 0 628,463 63,320,513 143,369 1,837,824 0 98,116 1,883,077 1,143,207 973,596 3,999,880 0 (150,806) 0 0 2,917,015 (27,833) 9,768 32,248,095 145,359 (255,309) 0 0 101,684 0 186,006 57,978,000 9.89 0.29 0.33 0.00 (0.03) 0.00 10.48 0.34 0 0.00

EX-27.SER23 52
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended August 31, 1996 and is qualified in its entirety by reference to such financial statements. 23 REIT 6-MOS FEB-28-1997 AUG-31-1996 77,112,096 79,006,534 192,585 1,398 0 79,200,517 0 0 89,684 89,684 0 76,102,948 7,464,598 0 609,173 0 535,267 0 1,863,445 79,110,833 596,106 80,006 0 66,939 609,173 535,267 1,863,445 3,007,885 0 0 0 0 7,464,598 0 0 79,110,833 0 0 0 0 72,759 0 108,278 40,675,000 10.00 0.08 0.52 0.00 0.00 0.00 10.60 0.69 0 0.00

EX-27.SER24CL1 53
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended August 31, 1996 and is qualified in its entirety by reference to such financial statements. 241 Foreign Fund, Class I 6-MOS FEB-28-1997 AUG-31-1996 575,331,857 564,128,177 2,727,708 6,084,523 0 572,940,408 2,202,193 0 1,003,447 3,205,640 0 580,085,691 354,251 0 1,719,661 0 (448,722) 0 (11,621,862) 3,476,181 7,947 2,434 0 4,365 6,016 (2,522) (27,311) (23,817) 0 0 0 0 354,251 0 0 3,476,183 0 0 0 0 715,455 0 1,015,715 3,464,970 9.88 0.02 (0.09) 0.00 0.00 0.00 9.81 0.88 0 0.00

EX-27.SER24CL3 54
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended August 31, 1996 and is qualified in its entirety by reference to such financial statements. 243 Foreign Fund, Class III 6-MOS FEB-28-1997 AUG-31-1996 575,331,857 564,128,177 2,727,708 6,084,523 0 572,940,408 2,202,193 0 1,003,447 3,205,640 0 580,085,691 57,710,422 0 1,719,661 0 (448,722) 0 (11,621,862) 566,258,587 1,979,647 449,179 0 715,181 1,713,645 (446,200) (11,594,551) (10,327,106) 0 0 0 0 57,723,777 (13,355) 0 566,258,585 0 0 0 0 715,455 0 1,015,715 558,697,943 10.00 0.03 (0.22) 0.00 0.00 0.00 9.81 0.75 0 0.00

EX-27.SER25CL1 55
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended August 31, 1996 and is qualified in its entirety by reference to such financial statements. 251 World Equity Allocation Fund, Class I 6-MOS FEB-28-1997 AUG-31-1996 10,183,099 9,634,863 5,597 0 0 9,640,460 0 0 7,171 7,171 0 9,928,909 582,229 0 33,867 0 218,749 0 (548,236) 5,639,148 20,037 0 0 (1,614) 18,423 120,854 (305,597) (166,320) 0 0 0 0 582,229 0 0 5,639,148 0 0 0 0 0 0 7,996 5,514,528 10.00 0.03 (0.34) 0.00 0.00 0.00 9.69 0.18 0 0.00

EX-27.SER25CL2 56
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended August 31, 1996 and is qualified in its entirety by reference to such financial statements. 252 World Equity Allocation Fund, Class II 6-MOS FEB-28-1997 AUG-31-1996 10,183,099 9,634,863 5,597 0 0 9,640,460 0 0 7,171 7,171 0 9,928,909 412,344 0 33,867 0 218,749 0 (548,236) 3,994,141 16,229 0 0 (785) 15,444 97,895 (242,639) (129,300) 0 0 0 0 412,344 0 0 3,994,141 0 0 0 0 0 0 7,996 3,998,001 10.00 0.04 (0.35) 0.00 0.00 0.00 9.69 0.12 0 0.00

EX-27.SER26 57
6 This schedule contains summary financial information extracted from GMO Trust, form N-SAR for the period ended August 31, 1996 and is qualified in its entirety by reference to such financial statements. 26 Global Balanced Allocation Fund 6-MOS FEB-28-1997 AUG-31-1996 2,999,978 3,073,494 3,769 0 0 3,077,263 0 0 4,233 4,233 0 3,000,000 300,000 0 (486) 0 0 0 73,516 3,073,030 0 0 0 486 (486) 0 73,516 73,030 0 0 0 0 300,000 0 0 3,073,030 0 0 0 0 0 0 4,255 1,618,659 10.00 0.00 0.24 0.00 0.00 0.00 10.24 0.18 0 0.00

~~-----END PRIVACY-ENHANCED MESSAGE-----~~